<SEC-DOCUMENT>0001144204-17-020911.txt : 20170418
<SEC-HEADER>0001144204-17-020911.hdr.sgml : 20170418
<ACCEPTANCE-DATETIME>20170418165526
ACCESSION NUMBER:		0001144204-17-020911
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20170601
FILED AS OF DATE:		20170418
DATE AS OF CHANGE:		20170418
EFFECTIVENESS DATE:		20170418

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			EXPONENT INC
		CENTRAL INDEX KEY:			0000851520
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
		IRS NUMBER:				770218904
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0103

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-18655
		FILM NUMBER:		17767454

	BUSINESS ADDRESS:	
		STREET 1:		EXPONENT INC
		STREET 2:		149 COMMONWEALTH DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025
		BUSINESS PHONE:		650-326-9400

	MAIL ADDRESS:	
		STREET 1:		EXPONENT INC
		STREET 2:		149 COMMONWEALTH DRIVE
		CITY:			MENLO PARK
		STATE:			CA
		ZIP:			94025

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FAILURE GROUP INC
		DATE OF NAME CHANGE:	19930831
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>v464399_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">UNITED STATES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">SECURITIES AND
EXCHANGE COMMISSION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Washington,
D.C. 20549</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt">SCHEDULE
14A</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Proxy Statement Pursuant
to Section 14(a) of the Securities</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">Exchange Act of 1934</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by the Registrant </FONT><FONT STYLE="font-family: Wingdings">x</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Filed
by a Party other than the Registrant </FONT><FONT STYLE="font-family: Wingdings">&uml;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Preliminary
                                         Proxy Statement</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Confidential,
                                         for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 15.85pt"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Definitive
                                         Proxy Statement</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Definitive
                                         Additional Materials</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Soliciting
                                         Material under &sect;240.14a-12</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Exponent, Inc.</P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">(Name of Registrant
as Specified In Its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 25%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Name of Person(s) Filing Proxy Statement,
if other than the Registrant)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Payment of Filing Fee (Check the appropriate
box):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">x</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">No
                                         fee required.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fee
                                         computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(1) Title
of each class of securities to which transaction applies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(2) Aggregate
number of securities to which transaction applies:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(3) Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which
the filing fee is calculated and state how it was determined):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(4) Proposed
maximum aggregate value of transaction:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(5) Total
fee paid:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Fee
                                         paid previously with preliminary materials.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 16pt; text-align: justify; text-indent: -16pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 16pt"><FONT STYLE="font-family: Wingdings">&uml;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Check
                                         box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and
                                         identify the filing for which the offsetting fee was paid previously. Identify the previous
                                         filing by registration statement number, or the Form or Schedule and the date of its
                                         filing.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(1) Amount
Previously Paid:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(2) Form,
Schedule or Registration Statement No.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 32.8pt; text-align: justify; text-indent: -16.8pt">(3) Filing
Party:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16pt">(4) Date Filed:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 16pt">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt">2017
NOTICE OF</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>ANNUAL
STOCKHOLDERS MEETING</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 12pt"><B>AND PROXY
STATEMENT</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><IMG SRC="def14a_logo.jpg" ALT=""><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><FONT STYLE="font-size: 12pt"><B>Exponent,
Inc.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>149 Commonwealth
Drive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>Menlo Park, CA
94025</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>NOTICE OF ANNUAL
MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>To Be Held on
June 1, 2017</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">TO THE STOCKHOLDERS:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Annual Meeting
of Stockholders (the &ldquo;Annual Meeting&rdquo;) of Exponent, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), will
be held on Thursday, June 1, 2017, at 8:00 a.m. Pacific time, at 149 Commonwealth Drive, Menlo Park, California 94025, for the
following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                         elect six directors for a term of one year;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                         ratify the appointment of KPMG LLP, an independent registered public accounting firm,
                                         as independent auditor for the Company for the fiscal year ending December 29, 2017;</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To approve,
                                         on an advisory basis, the fiscal 2016 compensation of the Company&rsquo;s named executive
                                         officers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To determine,
                                         on an advisory basis, how frequently the Company&rsquo;s stockholders should be provided
                                         with an advisory vote regarding the compensation of the Company&rsquo;s named executive
                                         officers;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To consider
                                         and approve an amendment of the Amended and Restated 2008 Equity Incentive Plan;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>To consider
                                         and approve an amendment of the 2008 Employee Stock Purchase Plan; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">To
                                         attend to other matters that may properly come before the Annual Meeting.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-indent: -20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders owning
the Company&rsquo;s shares at the close of business on April 4, 2017 (the &ldquo;Record Date&rdquo;) are entitled to notice of
and to vote at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">All stockholders
of record as of the Record Date are cordially invited to attend the Annual Meeting in person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please note that
if you plan to attend the Annual Meeting in person and hold your shares in &ldquo;street name,&rdquo; that is, through a broker
or other nominee, you will need to bring a copy of a brokerage statement reflecting your stock ownership as of the Record Date.
Check-in at the registration desk will be required.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">FOR THE BOARD OF DIRECTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><IMG SRC="pg03mg1.jpg" ALT="">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Richard L. Schlenker, <I>Corporate Secretary</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Menlo Park, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 18, 2017</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TABLE OF CONTENTS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="width: 90%"><A HREF="#a_031"><FONT STYLE="font-family: Times New Roman, Times, Serif">About the Annual Meeting</FONT></A></TD>
    <TD STYLE="width: 10%; text-align: right">3</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_032"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 1&mdash;Election of Directors</FONT></A></TD>
    <TD STYLE="text-align: right">6</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_033"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board Independence</FONT></A></TD>
    <TD STYLE="text-align: right">10</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_034"><FONT STYLE="font-family: Times New Roman, Times, Serif">Board Meetings, Committees, and Board Leadership</FONT></A></TD>
    <TD STYLE="text-align: right">11</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_035"><FONT STYLE="font-family: Times New Roman, Times, Serif">Report of the Audit Committee of the Board of Directors</FONT></A></TD>
    <TD STYLE="text-align: right">16</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_036"><FONT STYLE="font-family: Times New Roman, Times, Serif">Relationship with Independent Auditor</FONT></A></TD>
    <TD STYLE="text-align: right">18</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_037"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 2&mdash;Ratification of Appointment of Independent Auditor</FONT></A></TD>
    <TD STYLE="text-align: right">19</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_038"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 3&mdash;Advisory Vote on Named Executive Officer Compensation for Fiscal 2016</FONT></A></TD>
    <TD STYLE="text-align: right">20</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_039"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 4&mdash;Advisory Vote on Frequency of Stockholder Advisory Votes on Executive Compensation</FONT></A></TD>
    <TD STYLE="text-align: right">21</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_040"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 5&mdash;Approval of Amendment of the Amended and Restated 2008 Equity Incentive Plan</FONT></A></TD>
    <TD STYLE="text-align: right">22</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_041"><FONT STYLE="font-family: Times New Roman, Times, Serif">Proposal No. 6&mdash;Approval of Amendment of the 2008 Employee Stock Purchase Plan</FONT></A></TD>
    <TD STYLE="text-align: right">32</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_042"><FONT STYLE="font-family: Times New Roman, Times, Serif">Security Ownership of Certain Beneficial Owners and Management</FONT></A></TD>
    <TD STYLE="text-align: right">37</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_043"><FONT STYLE="font-family: Times New Roman, Times, Serif">Executive Officer Compensation</FONT></A></TD>
    <TD STYLE="text-align: right">39</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_044"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation Discussion and Analysis</FONT></A></TD>
    <TD STYLE="text-align: right">39</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_045"><FONT STYLE="font-family: Times New Roman, Times, Serif">Summary Compensation Table</FONT></A></TD>
    <TD STYLE="text-align: right">46</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_046"><FONT STYLE="font-family: Times New Roman, Times, Serif">Grants of Plan-Based Awards in Fiscal 2016 Table</FONT></A></TD>
    <TD STYLE="text-align: right">48</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_047"><FONT STYLE="font-family: Times New Roman, Times, Serif">Outstanding Equity Awards At Fiscal 2016 Year-End Table</FONT></A></TD>
    <TD STYLE="text-align: right">50</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_048"><FONT STYLE="font-family: Times New Roman, Times, Serif">Option Exercises and Stock Vested in Fiscal 2016 Table</FONT></A></TD>
    <TD STYLE="text-align: right">51</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><A HREF="#a_049"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nonqualified Deferred Compensation in Fiscal 2016 Table</FONT></A></TD>
    <TD STYLE="text-align: right">52</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_050"><FONT STYLE="font-family: Times New Roman, Times, Serif">Equity Compensation Plan Information in Fiscal 2016</FONT></A></TD>
    <TD STYLE="text-align: right">53</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_051"><FONT STYLE="font-family: Times New Roman, Times, Serif">Report of the Human Resources Committee of the Board of Directors</FONT></A></TD>
    <TD STYLE="text-align: right">54</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_052"><FONT STYLE="font-family: Times New Roman, Times, Serif">Certain Relationships and Related Transactions</FONT></A></TD>
    <TD STYLE="text-align: right">55</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_053"><FONT STYLE="font-family: Times New Roman, Times, Serif">Other Matters</FONT></A></TD>
    <TD STYLE="text-align: right">56</TD></TR>
<TR STYLE="vertical-align: top; background-color: White">
    <TD><A HREF="#a_054"><FONT STYLE="font-family: Times New Roman, Times, Serif">Appendix A &ndash; 2008 Equity Incentive Plan</FONT></A></TD>
    <TD STYLE="text-align: right">A-1</TD></TR>
<TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD><A HREF="#a_055"><FONT STYLE="font-family: Times New Roman, Times, Serif">Appendix B &ndash; 2008 Employee Stock Purchase Plan</FONT></A></TD>
    <TD STYLE="text-align: right">B-1</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 4; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPONENT, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 10%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PROXY STATEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FOR THE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2017 ANNUAL MEETING OF STOCKHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 10%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_031"></A>ABOUT THE ANNUAL MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The enclosed proxy
is solicited on behalf of the Board of Directors of Exponent, Inc., a Delaware corporation. The Annual Meeting of Stockholders
will be held at the Company&rsquo;s principal executive offices, 149 Commonwealth Drive, Menlo Park, California 94025, on Thursday,
June 1, 2017 at 8:00 a.m. Pacific time. The telephone number for this location is (650) 326-9400.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What is the Purpose of the Annual Meeting?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">At the Company&rsquo;s
Annual Meeting, stockholders will act upon matters outlined in the accompanying notice of the Annual Meeting and transact such
other business that may properly come before the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Who is Entitled to Vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Only stockholders
of record at the close of business on the Record Date, April 4, 2017, will receive notice of the Annual Meeting and are entitled
to vote at the Annual Meeting. Each outstanding share entitles its holder to cast one vote on each matter to be voted upon. There
are no cumulative voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Please note that
if you plan to attend the Annual Meeting in person and hold your shares in &ldquo;street name,&rdquo; that is, through a broker
or other nominee, you will need to bring a copy of a brokerage statement reflecting your stock ownership on the Record Date. If
you do not vote your proxy, your brokerage firm may either vote your shares on &ldquo;routine&rdquo; matters, or leave your shares
without a vote (a &ldquo;broker non-vote&rdquo;). Proposal No. 2 is a &ldquo;routine&rdquo; matter. As a result, your brokerage
firm is permitted to exercise discretionary voting authority to vote your shares for that proposal. Your brokerage firm may not
exercise discretionary voting authority on &ldquo;non-routine&rdquo; matters and as such may not vote your shares with respect
to Proposals No. 1, No. 3, No. 4, No. 5, and No. 6, unless you provide instructions to your brokerage firm with voting instructions.
We encourage you to provide instructions to your brokerage firm by voting your proxy. This ensures your shares will be voted at
the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">We have provided our
stockholders access to our proxy materials over the internet in accordance with rules and regulations adopted by the United States
Securities and Exchange Commission (&ldquo;SEC&rdquo;). Therefore, a Notice of Internet Availability of Proxy Materials (the &ldquo;Notice&rdquo;)
will be mailed on or about April 18, 2017 to all stockholders entitled to vote at the meeting. The Notice will have instructions
for stockholders on how to access Exponent&rsquo;s proxy materials via a website or how to request that a printed copy of the
proxy materials be mailed to them. The Notice will also have instructions on how to elect to receive all future proxy materials
electronically or in printed form. If you choose to receive future proxy materials electronically, you will receive an email each
year with instructions on how to access the proxy materials and proxy voting site.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 20pt">The SEC has adopted
rules that allow companies and intermediaries, such as brokers, to deliver a single copy of certain proxy materials to certain
stockholders who share the same address, a practice referred to as &ldquo;householding.&rdquo; Some banks, brokers and other nominees
will be householding Exponent&rsquo;s proxy materials, unless contrary instructions are received from the affected stockholders.
Once you have received notice from your broker or other nominee holder of your Exponent common stock that the broker or other
nominee holder will be householding the proxy materials to your address, householding will continue until you are notified otherwise
or until you revoke your consent. If, at any time, you no longer wish to participate in householding and would prefer to receive
separate proxy materials, or if you are receiving multiple copies of the proxy materials and wish to receive only one copy, please
notify your broker or other nominee holder of your Exponent common stock. We will deliver promptly, on written or oral request,
a separate copy of our proxy materials, including our annual report to stockholders, to each stockholder participating in householding.
To request that proxy materials be householded or to request separate copies of proxy materials, please contact us at: Corporate
Secretary, 149 Commonwealth Drive, Menlo Park, CA 94025 or by telephone at (650) 326-9400.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 5; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>How Do I Vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may vote by telephone,
vote via the internet, or vote in person. To vote by telephone or via the internet, please follow the instructions provided in
the Notice. If you elected to receive printed proxy materials, you may submit your proxy by mail. To vote by mail, you must sign
your proxy card and send it in the enclosed prepaid, addressed envelope. If you mark your voting instructions on the proxy card,
your shares will be voted as you instruct. If you return a signed card but do not provide voting instructions, your shares will
be voted as recommended by the Board of Directors:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">for
                                         the six named nominees to the Board of Directors;</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">for
                                         the ratification of the appointment of KPMG LLP, an independent registered public accounting
                                         firm, as the Company&rsquo;s auditor for the fiscal year ending December 29, 2017;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                         approve, on an advisory basis, the fiscal 2016 compensation of the Company&rsquo;s named
                                         executive officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">for
                                         a frequency of one year for the advisory vote on compensation of the Company&rsquo;s
                                         named executive officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                         approve an amendment of the 2008 Amended and Restated Equity Incentive Plan; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">to
                                         approve an amendment of the 2008 Employee Stock Purchase Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">If you choose to
vote in person, you will have an opportunity to do so at the Annual Meeting. You may either bring your Notice to the Annual Meeting,
or if you do not bring your Notice, the Company will pass out written ballots to anyone who was a stockholder as of the Record
Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What if I Change My Mind After I Vote?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">You may revoke your
proxy and change your vote at any time before the polls close at the Annual Meeting. You may do so by voting by telephone or via
the internet, by signing or delivering another proxy with a later date if you elected to receive printed proxy materials or by
voting in person at the Annual Meeting. Your proxy with the latest date is counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What Does it Mean if I Receive More than One Notice?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">It means you have
multiple accounts with the transfer agent and/or with brokers. Please provide voting instructions for all Notices you receive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>What Constitutes a Quorum and What Vote is Required to Approve
the Proposals?</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The presence of the
holders of record of a majority in voting interest of the shares of stock of the Company, as of the Record Date, entitled to be
voted at the meeting and present in person or by proxy at the meeting constitutes a quorum at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Shares that are voted
&ldquo;For&rdquo; or &ldquo;Against&rdquo; proposals, or that are voted for a frequency on Proposal No. 4, are treated as being
present at the Annual Meeting for purposes of establishing a quorum and are deemed to be &ldquo;votes cast&rdquo; at the Annual
Meeting with respect to the proposals. Abstentions and broker non-votes will also be included for purposes of determining whether
a quorum of shares is present at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 1 &ndash;
Election of Directors requires that each director nominee receives a majority of votes cast &quot;For&quot; his or her election.
Abstentions and broker non-votes are not counted as votes cast for or against a director nominee and as such will have no impact
on Proposal No. 1 &ndash; Election of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 2 &ndash;
Ratification of Appointment of Independent Auditor requires the affirmative vote of a majority of the shares present in person
or by proxy and entitled to vote thereon for approval. Abstentions will have the same effect as a vote against this proposal.
Proposal No. 2 - Ratification of Appointment of Independent Auditor is considered to be a &quot;routine&quot; matter and, as such,
the Company does not expect any broker non-votes on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 3 &ndash;
Advisory Vote on Named Executive Officer Compensation for Fiscal 2016 requires the affirmative vote of a majority of the shares
present in person or by proxy and entitled to vote thereon for approval. Abstentions will have the same effect as a vote against
this proposal. Proposal No. 3&mdash;Advisory Vote on Named Executive Officer Compensation for Fiscal 2016 is considered to be
a &quot;non-routine&quot; matter and as such, broker non-votes will have no impact on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 4 &ndash;
Advisory Vote on Frequency of Stockholder Advisory Votes on Named Executive Officer Compensation will be determined by a plurality
of votes, which means that the choice of frequency that receives the highest number of &ldquo;FOR&rdquo; votes will be considered
the advisory vote of our stockholders. Abstentions and broker non-votes will not count as votes cast &ldquo;FOR&rdquo; or &ldquo;AGAINST&rdquo;
any frequency choice, and will have no impact on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 5 &ndash;
Approval of Amendment of the Amended and Restated 2008 Equity Incentive Plan requires the affirmative vote of a majority of the
shares present in person or by proxy and entitled to vote thereon for approval. Abstentions will have the same effect as a vote
against this proposal. Proposal No. 5 &ndash; Approval of Amendment of the Amended and Restated 2008 Equity Incentive Plan is
considered to be a &ldquo;non-routine&rdquo; matter and as such, broker non-votes will have no impact on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 6 &ndash;
Approval of Amendment of the 2008 Employee Stock Purchase Plan requires the affirmative vote of a majority of the shares present
in person or by proxy and entitled to vote thereon for approval. Abstentions will have the same effect as a vote against this
proposal. Proposal No. 6 &ndash; Approval of Amendment of 2008 Employee Stock Purchase Plan is considered to be a &ldquo;non-routine&rdquo;
matter and as such, broker non-votes will have no impact on this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Proposal No. 2 &ndash;
Ratification of Appointment of Independent Auditor, Proposal No. 3 &ndash; Advisory Vote on Named Executive Officer Compensation
for Fiscal 2016, and Proposal No. 4 &ndash; Advisory Vote on Frequency of Stockholder Advisory Votes on Named Executive Officer
Compensation are advisory votes and as such are not binding on the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Signed, unmarked
proxy cards are voted as recommended by the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of the Record
Date, a total of 25,871,157 shares of the Company&rsquo;s common stock, $.001 par value, were issued and outstanding. For information
regarding security ownership by management and by the beneficial owners of more than 5% of the Company&rsquo;s common stock, see
&ldquo;Security Ownership of Certain Beneficial Owners and Management.&rdquo; The closing price of the Company&rsquo;s common
stock on the NASDAQ Global Select Market on the Record Date was $58.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_032"></A>PROPOSAL NO. 1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ELECTION OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nominees</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">A Board of six directors
is to be elected at the Annual Meeting. Unless otherwise instructed, the proxy holders will vote the proxies received by them
for the Company&rsquo;s six nominees named below. The term of office of each person elected as a director will continue until
the next Annual Meeting or until a successor has been elected and qualified. The Board has determined that a majority of the members
of the Board are independent directors within the meaning of applicable NASDAQ listing standards. The Board will reduce in size
from seven directors to six directors at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;The Company&rsquo;s
Bylaws require that each director be elected by the majority of votes cast with respect to such director in uncontested elections.
Each current director has provided an irrevocable, conditional resignation which is effective only if (i) he or she fails to receive
the required majority vote at any Annual Meeting at which he or she face re-election and (ii) the board accepts such resignation.
If an incumbent director fails to receive the required majority vote for re-election, the Nominating and Governance Committee
will act on an expedited basis to determine whether to accept the director&rsquo;s resignation and will submit such recommendation
for prompt consideration by the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The election of directors
pursuant to this Proposal is an uncontested election, and, therefore, the majority vote standard will apply. Abstentions and broker
non-votes will not have any effect on the outcome of this Proposal. In tabulating the voting results for the election of directors,
only &ldquo;FOR&rdquo; and &ldquo;AGAINST&rdquo; votes are counted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE BOARD OF DIRECTORS UNANIMOUSLY
RECOMMENDS A VOTE FOR THE NOMINEES LISTED BELOW:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Michael R. Gaulke</B></FONT></TD>
    <TD STYLE="width: 72%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">71</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">1994</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman of the Board of Directors
    of the Company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Mr. Gaulke joined the Company in
    1992, as Executive Vice President and Chief Financial Officer. He was named President in 1993, and he was appointed as a member
    of the Board of Directors of the Company in 1994. He served as Chief Executive Officer from 1996 to May 2009, and was appointed
    Chairman of the Board of Directors in May 2007. Mr. Gaulke served as Executive Chairman from May 2009 to June 2010. Prior
    to 1992, he held senior executive positions at Raynet Corporation and Spectra Physics, and was a consultant with McKinsey
    &amp; Company. The Company believes that Mr. Gaulke&rsquo;s leadership role in the Company, and extensive and unique experience
    with the operations of the Company, qualifies him to serve as a director of the Company. The Company also considered Mr. Gaulke&rsquo;s
    prior senior leadership experience in technology companies, his prior service on other public company boards and his prior
    experience on and contributions to the Board in connection with his nomination.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other Directorships:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman of the Board of Sutter Health,
    member of the Board of Sutter Health Bay Area, and a member of the Palo Alto Medical Foundation Community Board of Trustees.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Paul R. Johnston, Ph.D.</B></FONT></TD>
    <TD STYLE="width: 72%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2009</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Executive Officer of the Company</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify">Dr.&nbsp;Johnston joined the Company in 1981 and has assumed increasingly responsible positions
    over time, most recently being named Chief Executive Officer in 2009. Dr. Johnston was elected to the Board of Directors in
    May, 2009. In his prior roles, Dr.&nbsp;Johnston was previously responsible for Exponent&rsquo;s Health and Environmental
    businesses before assuming management of all of the Company&rsquo;s consulting groups. He has also managed the Company&rsquo;s
    network of offices. He is a Registered Professional Civil Engineer in the State of California. <FONT STYLE="font-family: Times New Roman, Times, Serif">The
    Company believes that Dr. Johnston&rsquo;s service as Chief Executive Officer of the Company, and extensive and unique experience
    with the operations of the Company, qualifies him to serve as a director of the Company. The Company also considered Dr. Johnston&rsquo;s
    prior experience on and contributions to the Board in connection with his nomination</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Carol Lindstrom</B></FONT></TD>
    <TD STYLE="width: 72%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">63</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2017</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Former Vice Chairman &ndash; Deloitte
    LLP</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ms. Lindstrom recently retired as
    vice chairman of Deloitte LLP, or Deliotte, a professional services firm, where she led strategic relationship management,
    and was also president of the Deloitte Foundation. She was a member of the Deloitte &amp; Touche Tohmatsu Global Board of
    Directors for eight years. Ms. Lindstrom held many management and client leadership positions during her Deloitte career,
    including managing director of global strategic relationship clients in the United States; managing director of Deloitte&rsquo;s
    e-business unit, dc.com; managing director of the Americas technology practice; managing director of the San Francisco and
    Orange County practices; and lead advisory and client service partner for many significant clients. Ms. Lindstrom joined Deloitte
    in 1995 after having served as a partner at Andersen Consulting for many years. The Company believes that Ms. Lindstrom&rsquo;s
    record of success in senior leadership positions with large professional service organizations qualifies her to serve as a
    director of the Company. </FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other Directorships:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Genpact Limited.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Karen A. Richardson</B></FONT></TD>
    <TD STYLE="width: 72%">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">54</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2013</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Former Chief Executive Officer of
    E.piphany</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ms. Richardson has over 25 years
    of experience in the technology industry. She served as Chief Executive Officer of E.piphany, a customer relationship management
    software company, from 2003 to 2005. Ms. Richardson held several senior executive positions at E.piphany from 1998 to 2003.
    Prior to joining E.piphany, Ms. Richardson served as Vice President of Sales at Netscape Communications Corporation, an internet
    software company, from 1995 to 1998. The Company believes that Ms. Richardson&rsquo;s record of success in senior leadership
    positions at technology companies qualifies her to serve as a director of the Company. The Company also considered Ms. Richardson&rsquo;s
    prior experience on and contributions to the Board in connection with her nomination.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other Directorships:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Member of the Boards of BT Group
    plc. and Worldplay Group plc.</FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><B>John B. Shoven, Ph.D.</B></TD>
    <TD STYLE="width: 72%; padding-left: 2.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">69</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2007</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Professor of Economics, Stanford
    University</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Dr. Shoven is currently the Charles
    R. Schwab Professor of Economics at Stanford University, where he has taught since 1973. He was the Director of the Stanford
    Institute for Economic Policy Research from 1989 to 1993 and from 1999 to 2015. He served as Chairman of the Economics Department
    at Stanford University from 1986 to 1989 and as Dean of the School of Humanities and Sciences from 1993 to 1998. Dr. Shoven
    earned his Ph.D. in economics from Yale University and his bachelor&rsquo;s degree in physics from University of California,
    San Diego. Dr. Shoven is a Fellow of the American Academy of Arts and Sciences, a recipient of the Paul A. Samuelson Award
    for Outstanding Scholarly Writing on Lifelong Financial Security, an award winning teacher at Stanford, and has published
    more than one hundred professional articles and twenty books. The Company believes that Dr. Shoven&rsquo;s extensive academic
    experience and service as director of other public companies qualifies him to serve as a director of the Company. The Company
    also considered Dr. Shoven&rsquo;s prior experience on and contributions to the Board in connection with his nomination.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other Directorships:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Chairman of the Board of Cadence
    Design Systems, Inc. and a member of the Boards of American Century Funds and Financial Engines, Inc.</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 28%"><B>Debra L. Zumwalt</B></TD>
    <TD STYLE="width: 72%; padding-left: 2.8pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Age:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">61</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Director Since:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">2014</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Principal Occupation:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Vice President and General Counsel,
    Stanford University</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD>
    <TD STYLE="padding-left: 2.8pt; text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Recent Business Experience:</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Ms. Zumwalt is currently the Vice
    President and General Counsel for Stanford University and its affiliated entities, including two hospitals. She has held this
    position since 2001. She is also a member of the University Cabinet. Ms. Zumwalt was a Partner with Pillsbury Winthrop Shaw
    Pittman LLP from 1993 to 2001 where she served on the executive board and as Managing Partner of the Silicon Valley office.
    The Company believes that Ms. Zumwalt&rsquo;s senior leadership positions and her extensive legal background qualifies her
    to serve as a director of the Company. The Company also considered Ms. Zumwalt&rsquo;s prior experience on and contributions
    to the Board in connection with her nomination.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Other Directorships</I></FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Huron Consulting Group, Inc.</FONT></TD></TR>
</TABLE>
<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_033"></A>BOARD INDEPENDENCE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board has determined
that the following current members of the Board are independent directors within the meaning of applicable NASDAQ listing standards:
Michael R. Gaulke, Carol Lindstrom, Karen A. Richardson, Stephen C. Riggins, John B. Shoven, Ph.D. and Debra L. Zumwalt. Under
applicable Securities and Exchange Commission and NASDAQ rules, the existence of certain &ldquo;related party&rdquo; transactions
above certain thresholds between a director and the Company are required to be disclosed and preclude a finding by the Board that
the director is independent. Except as discussed below regarding Ms. Zumwalt and transactions between Stanford University and
the Company, no transactions required to be disclosed under SEC rules, and no other transactions, arrangements or relationships,
existed or were considered by the Board in making its independence determinations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In making its determination
that Ms. Zumwalt is an independent director within the meaning of applicable NASDAQ listing standards, the Board considered transactions
between the Company and Stanford University (&ldquo;Stanford&rdquo;), of which Ms. Zumwalt is the Vice President and General Counsel.
During the past three fiscal years and during the current fiscal year to date, the Company performed consulting services for Stanford.
The total amount paid for these consulting services was significantly less than 1% of either organization&rsquo;s revenues. Given
the relatively small amounts involved as compared to the revenues of each of the Company and Stanford, the Board concluded that
the transactions at issue and Ms. Zumwalt&rsquo;s relationship with Stanford did not affect Ms. Zumwalt&rsquo;s status as an independent
director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_034"></A>BOARD MEETINGS, COMMITTEES, AND BOARD
LEADERSHIP</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board held four
meetings in fiscal 2016. Each director attended at least 75% of applicable Board meetings and committee meetings during fiscal
2016. The following table describes the Board&rsquo;s committees including their current composition. The members of each committee
are all independent directors within the meaning of applicable NASDAQ listing standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 30%; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Committee
    Name/Number of Members</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 40%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Function
    of Committee</B></FONT></TD>
    <TD NOWRAP STYLE="vertical-align: top; width: 1%; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="vertical-align: bottom; width: 28%; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Meetings
    in</B></FONT><BR>
    <FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Fiscal 2016</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="padding-left: 17.35pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="padding-left: 17.35pt; text-indent: -9pt">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0">AUDIT COMMITTEE</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Stephen C. Riggins&mdash;Chairperson<BR>
        Carol Lindstrom<BR>
        Karen A. Richardson<BR>
        John B. Shoven, Ph.D.<BR>
        Debra L. Zumwalt</P></TD>
    <TD STYLE="padding-left: 17.35pt; text-indent: -9pt">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;<FONT STYLE="font-family: Times New Roman, Times, Serif">Monitors
        the preparation of quarterly and annual financial reports by the Company&rsquo;s management</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Appoints
        and removes the Company&rsquo;s independent auditor, approves the scope of their audit services and related fees, as well
        as any other services being provided to the Company, supervises their work (including resolution of any disagreements
        between management and the independent auditor regarding financial reporting) and oversees the independence of the Company&rsquo;s
        auditor</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;In
        consultation with management and the independent auditor considers the integrity of the Company&rsquo;s financial reporting
        process and controls regarding finance and accounting</FONT></P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">8 meetings</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>HUMAN RESOURCES</B><BR>
        <B>COMMITTEE</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Debra L. Zumwalt&mdash;Chairperson<BR>
        Carol Lindstrom<BR>
        Karen A. Richardson<BR>
        Stephen C. Riggins<BR>
        John B. Shoven, Ph.D.</P></TD>
    <TD STYLE="padding-left: 17.35pt; text-indent: -9pt">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Oversees
        the general compensation and benefit policies for all employees and the specific compensation plan for officers of the
        Company</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Oversees
        the succession plan for the position of Chief Executive Officer</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Oversees
        the employee development and management succession programs at the Company</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Approves
        awards under the Company&rsquo;s stock-based employee incentive plans</FONT></P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">5 meetings</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NOMINATING AND</B><BR>
        <B>GOVERNANCE</B><BR>
        <B>COMMITTEE</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">John B. Shoven, Ph.D.&mdash;Chairperson<BR>
        Carol Lindstrom<BR>
        Karen A. Richardson<BR>
        Stephen C. Riggins<BR>
        Debra L. Zumwalt</P></TD>
    <TD STYLE="padding-left: 17.35pt; text-indent: -9pt">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Identifies
        individuals qualified to become Board members</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Makes
        recommendations to the Board regarding nominations for the Board</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Oversees
        the Board&rsquo;s annual evaluation of its performance</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Reviews
        and recommends to the Board compensation for non-employee directors</FONT></P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 9.35pt; text-indent: -9.35pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&nbsp;&nbsp;Oversees
        corporate governance</FONT></P></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif">4 meetings</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The responsibilities
of the Audit Committee, the Human Resources Committee and the Nominating and Governance Committee are set forth in written charters
for each committee, which are available on the Company&rsquo;s website at: http://www.exponent.com/corporate-governance/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Board Leadership Structure and Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
Company currently separates the positions of Chief Executive Officer and Chairman of the Board. At this time the Board believes
that having an independent director serve as Chairman of the Board is the appropriate leadership structure for the Company. However,
our Corporate Governance Guidelines permit the roles of the Chairman of the Board and the Chief Executive Officer to be filled
by the same or different individuals. In the event that the Chairman of the Board is not an independent director, the independent
members of the Board may designate a &ldquo;Lead Independent Director.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
Board has delegated oversight for matters involving certain specific areas of risk exposure to its committees. Each committee
reports to the Board of Directors at regularly scheduled Board meetings, and more frequently if appropriate, with respect to the
matters and risks for which the committee provides oversight. The Audit Committee oversees the integrity of the Company&rsquo;s
financial statements, risks related to the Company&rsquo;s financial reporting process and internal controls, and the independent
auditors&rsquo; qualifications, independence and performance. The Human Resources Committee is responsible primarily for the design
and oversight of the Company&rsquo;s executive compensation policies, plans and practices. A key objective of the Human Resources
Committee is to ensure that the Company&rsquo;s overall executive compensation program appropriately links pay to performance
and aligns the interests of the Company&rsquo;s executives with its stockholders, while seeking to encourage an appropriate level
of risk-taking behavior consistent with the Company&rsquo;s long-term strategy. The Human Resources Committee also monitors the
design and administration of the Company&rsquo;s compensation programs to ensure that they include appropriate safeguards to avoid
encouraging unnecessary or excessive risk taking by Company employees. Another important element of risk mitigation is ensuring
a balanced, engaged and independent board. The Nominating and Governance Committee is primarily responsible for identifying and
recommending nominees for director and overseeing the annual board evaluation of its performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>Nominating and Governance Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As described in the
previous table, the Nominating and Governance Committee of the Board identifies individuals qualified to become Board members,
recommends that the Board select the director nominees for the next annual meeting of stockholders, oversees the Board&rsquo;s
annual evaluation of its performance and reviews and recommends to the Board compensation for non-employee directors. The committee
is also responsible for developing and recommending to the Board a set of corporate governance guidelines applicable to the Company
and for periodically reviewing such guidelines. The members of the Nominating and Governance Committee are all independent directors
within the meaning of applicable NASDAQ listing standards. The responsibilities of this committee are set forth in the Nominating
and Governance Committee Charter, which is available on the Company&rsquo;s website at: http://www.exponent.com/corporate-governance/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The information below
describes the criteria and process that the Nominating and Governance Committee use to evaluate candidates to the Board of Directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Criteria for Nomination
to the Board of Directors</I>. The Nominating and Governance Committee considers the appropriate balance of experience, skills
and characteristics required of the Board of Directors, and seeks to insure that at least a majority of the directors are independent
under the rules of the NASDAQ Global Select Market, that members of the Audit Committee meet the financial literacy requirements
under the rules of the NASDAQ Global Select Market and at least one of them qualifies as an &ldquo;audit committee financial expert&rdquo;
under the rules of the SEC. Nominees for director are recommended to the Board on the basis of the appropriate size, function
and needs of the Board, taking into account that the Board as a whole should have competency in the following areas: (i) industry
knowledge; (ii) accounting and finance; (iii) business judgment; (iv) management; (v) leadership; (vi) business strategy; and
(vii) corporate governance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><I>Stockholders&rsquo;
Proposals for Nominees.</I> The Nominating and Governance Committee will consider written proposals from stockholders for nominees
for director. Any such nominations should be submitted to the Nominating and Governance Committee c/o the Secretary of the Company,
149 Commonwealth Drive, Menlo Park, CA 94025, and should include, in addition to the other information required under our Bylaws,
the following information: (a)&nbsp;all information relating to such nominee that is required to be disclosed pursuant to Regulation&nbsp;14A
under the Securities Exchange Act of 1934 (including such person&rsquo;s written consent to being named in the proxy statement
as a nominee and to serving as a director if elected); (b)&nbsp;the name(s) and address(es) of the stockholder(s) making the nomination
and the number of shares of the Company&rsquo;s common stock which are owned beneficially and of record by such stockholder(s);
and (c)&nbsp;appropriate biographical information and a statement as to the qualifications of the nominee. The nomination should
be submitted in the time frame described in the Bylaws of the Company and under the caption, &ldquo;Stockholder Proposals and
Nominations for the 2018 Annual Meeting.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Process for Identifying
and Evaluating Nominees.</I> The Nominating and Governance Committee believes the Company is well served by its current directors,
and in the ordinary course re-nominates incumbent directors who continue to be qualified for Board service, have performed well
and are willing to continue as directors. If an incumbent director is not standing for re-election, or if a vacancy on the Board
occurs between annual stockholder meetings, the Nominating and Governance Committee may seek out potential candidates for Board
appointment who meet the criteria for selection as a nominee and have the specific qualities or skills being sought. Director
candidates are selected based on input from members of the Board, senior management of the Company and, if the Nominating and
Governance Committee deems appropriate, a third-party search firm. The Nominating and Governance Committee will evaluate each
candidate&rsquo;s qualifications and check relevant references. In addition, such candidates will be interviewed by at least one
member of the Nominating and Governance Committee. Candidates meriting serious consideration will meet with the majority of the
members of the Board. Based on this input, the Nominating and Governance Committee will evaluate which of the prospective candidates
is qualified to serve as a director and whether the Committee should recommend to the Board that this candidate be appointed to
fill a current vacancy on the Board, or presented for approval of the stockholders, as appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company has not
adopted a formal policy with respect to stockholder nominees. The Company expects that the evaluation process for a stockholder
nominee would be similar to the process outlined above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Board Nominees
for the 2017 Annual Meeting</I>. Mr. Gaulke, Dr. Johnston, Ms. Richardson, Dr. Shoven, and Ms. Zumwalt are current directors standing
for re-election. Ms. Lindstrom has been a director of the Company since February of 2017 but has not previously been subject to
stockholder election. Ms. Lindstrom was initially identified by the Nominating and Governance Committee as a candidate for director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>How to Contact
the Board of Directors. </I>Interested parties wishing to contact the non-management directors of the Company may do so by writing
to them at the following address: Corporate Secretary, 149 Commonwealth Drive, Menlo Park, CA 94025. All letters received will
be categorized by the Company&rsquo;s Corporate Secretary, and then forwarded to the Company&rsquo;s non-management directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company does
not have a policy requiring the directors to attend the annual stockholders&rsquo; meeting. However, all of the Company&rsquo;s
directors in office at the time of our last annual stockholders&rsquo; meeting attended that meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>Code of Business
Conduct and Corporate Governance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Board of Directors
has adopted a Code of Business Conduct and Ethics, which applies to all of the Company&rsquo;s employees, officers and members
of the Board of Directors. The Company has also adopted a Code of Ethics applicable to its senior financial officers, including
its Chief Executive Officer, Executive Vice President and Chief Financial Officer, and Vice President, Corporate Controller and
Treasurer. Copies of both documents are available on the Company&rsquo;s website at: http://www.exponent.com/corporate-governance/.
The Company intends to disclose any waivers from these codes in a report on Form 8-K filed with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><B>Risk Management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
Company takes a comprehensive approach to risk management and seeks to employ risk management principles in all of its management
processes. This comprehensive approach is reflected in the reporting processes pursuant to which management provides information
to the Board to support the Board&rsquo;s role in oversight, approval and decision-making. The Board maintains oversight responsibility
for the management of the Company&rsquo;s risks, and closely monitors the information it receives from management to provide oversight
and guidance to our management team concerning the assessment and management of risk. The Board approves the Company&rsquo;s high
level goals, strategies and policies to set the tone and direction for appropriate levels of risk taking within the business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">Our
Board also reviews the Company&rsquo;s enterprise risk management (ERM) program to ensure that an appropriate ERM process is in
place. This review includes a discussion of the major risk exposures identified by senior management and steps implemented to
monitor and mitigate such exposures on an ongoing basis. In addition to these reviews, our senior executives with responsibility
for various business functions provide the Board and its committees with periodic updates regarding the Company&rsquo;s strategies
and objectives, and the risks inherent thereto. Members of management most knowledgeable of relevant issues attend Board meetings
to provide additional insight into items being discussed, including risk exposures. In addition, our directors have access to
Company management at all times and at all levels to discuss any matters of interest, including those related to risk.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt"><B>Compensation
of Directors</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Members of our Board
of Directors who are employees of the Company do not receive additional compensation for their services as directors of the Company.
Non-employee members of the Board of Directors receive:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">An
                                         annual cash retainer of $65,000;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">An
                                         annual restricted stock unit grant valued at $112,500 that cliff vests on the day prior
                                         to the Company&rsquo;s next Annual Stockholder Meeting following the grant date;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">$12,000
                                         for service on the Audit Committee;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">$40,000
                                         for serving as Chairman of the Board of Directors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">$15,000
                                         for serving as Chairperson of the Audit Committee;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">$10,000
                                         for serving as Chairperson of the Nominating and Governance Committee; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: left">$10,000
                                         for serving as Chairperson of the Human Resources Committee.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: left; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Director Stock Ownership Guidelines</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that the
financial interests of our directors should be aligned with those of our stockholders. On June 3, 2010 our Nominating and Governance
Committee adopted stock ownership guidelines for all non-employee directors. The stock ownership guideline for non-employee directors
is equal to two times the director&rsquo;s annual cash retainer for board service. Stock that counts towards satisfaction of our
stock ownership guidelines includes shares owned outright by the non-employee director or his or her immediate family members
residing in the same household or in trust and restricted stock units, whether or not vested. The value of shares owned outright
is calculated as Exponent&rsquo;s prior 365-day average closing common stock price. The value of restricted stock units is the
grant date fair value. The calculation is done at the beginning of each year. Non-employee directors are required to achieve their
stock ownership guideline within five years of the date the guidelines were adopted or the start of their service, whichever is
later. If a person&rsquo;s stock ownership guideline increases, that person has a five-year period to achieve the new guideline.
Until the guideline is achieved, the person is required to retain at least 50% of net shares delivered through our Restricted
Stock Unit Program or the exercise of stock options. Net shares refer to those that remain after shares are sold or netted to
pay the exercise price of stock options and withholding taxes. As of April 4, 2017, all non-employee directors met the stock ownership
guidelines or are expected to meet the applicable ownership guidelines within the specified time period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><B>DIRECTOR COMPENSATION
IN FISCAL 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information regarding outside director compensation during fiscal 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fees Earned or<BR> Paid
    in Cash ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock Awards (1)(2)($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Total ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 55%; text-align: left; padding-left: 0.7pt">Michael R. Gaulke</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">105,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">112,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">217,500</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Karen A. Richardson</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">77,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">189,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Stephen C. Riggins</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">92,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">204,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">John B. Shoven, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Debra L. Zumwalt</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">87,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">112,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">199,500</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent
                                         the value of unvested restricted stock unit awards granted during fiscal 2016 in accordance
                                         with ASC 718. All equity-based awards have dividend equivalent rights (&rdquo;DER&rdquo;),
                                         which entitle the holder of the award to the same dividend value per share as holders
                                         of common stock. DER are subject to the same vesting and other terms and conditions as
                                         the corresponding stock award. DER are accumulated and paid when the underlying stock
                                         awards vest and are forfeited if the underlying stock awards are forfeited. See the notes
                                         to our consolidated financial statements in our Annual Report on Form 10-K for the year
                                         ended December 30, 2016 regarding assumptions underlying the valuation of equity awards.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Each of our outside directors was
                                         granted 2,146 restricted stock units during 2016 with a grant date fair value of $112,500.
                                         The following director restricted stock unit awards were outstanding as of December 30,
                                         2016: Mr. Gaulke - 2,146, Ms. Richardson &ndash; 2,146, Mr. Riggins - 2,146, Dr. Shoven
                                         - 2,146 and Ms. Zumwalt &ndash; 2,146.</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>


<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><A NAME="a_035"></A>REPORT OF THE AUDIT COMMITTEE
OF THE BOARD OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following
Report of the Audit Committee of the Board of Directors does not constitute soliciting material and should not be considered filed
or incorporated by reference into any other Company filing under the Securities Act of 1933 or the Securities Exchange Act of
1934, except to the extent the Company specifically incorporates this Report by reference therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
of the Board of Directors is responsible for general oversight of the Company&rsquo;s financial accounting and reporting process.
The Committee&rsquo;s primary responsibilities fall into three broad categories:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">first,
                                         the Committee is charged with monitoring the preparation of quarterly and annual financial
                                         reports by the Company&rsquo;s management, including discussions with management and
                                         the Company&rsquo;s independent auditor about quarterly and annual financial statements
                                         and key accounting and reporting matters;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify; text-indent: -20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">second,
                                         the Committee is responsible for matters concerning the relationship between the Company
                                         and its independent auditor, including their appointment or removal; approving the scope
                                         of their audit services and related fees, as well as any other services being provided
                                         to the Company; and overseeing the independence of the Company&rsquo;s auditor; and</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify; text-indent: -20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify">third,
                                         the Committee in consultation with management and the independent auditor considers the
                                         integrity of the Company&rsquo;s financial reporting processes and controls regarding
                                         finance and accounting.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 40pt; text-align: justify; text-indent: -20pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee&rsquo;s
responsibilities are presented in detail in the complete charter of the Committee, which is available on the Company&rsquo;s website
at: http://www.exponent.com/corporate-governance/. The charter reflects standards set forth in the applicable SEC regulations
and the NASDAQ Global Select Market rules. Audit Committee members are independent as defined by these regulations and rules.
The Board of Directors has determined that Mr. Riggins is an &ldquo;audit committee financial expert&rdquo; as such term is defined
by these rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee has
implemented procedures to ensure that during the course of each fiscal year it devotes the attention it considers necessary or
appropriate to each of the matters assigned to it under the Committee&rsquo;s charter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In overseeing the
preparation of the Company&rsquo;s financial statements, the Committee met with both management and the Company&rsquo;s independent
auditor to review and discuss all quarterly and annual financial statements prior to their issuance and to discuss significant
accounting issues. Management advised the Committee that all financial statements were prepared in accordance with accounting
principles generally accepted in the United States, and the Committee discussed the statements with both management and the independent
auditor. The Committee discussed with KPMG LLP the matters required to be discussed pursuant to applicable auditing standards
adopted by the Public Company Accounting Oversight Board together with the guidelines established by the SEC and the Sarbanes-Oxley
Act, including, among other items, matters related to the conduct of the audit of the consolidated financial statements by the
independent registered public accounting firm and its audit of the effectiveness of internal control over financial reporting
pursuant to Section 404.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
has received from KPMG LLP the written disclosures and the letter required by the applicable requirements of the Public Company
Accounting Oversight Board regarding KPMG&rsquo;s communications with the Audit Committee concerning independence. We have discussed
with KPMG matters relating to its independence, including a review of both audit and non-audit services, and considered the compatibility
of non-audit services with KPMG&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On the basis of these
reviews and discussions, the Committee recommended to the Board of Directors that the Board approve the inclusion of the Company&rsquo;s
audited financial statements in the Company&rsquo;s Annual Report on Form 10-K for the fiscal year ended December 30, 2016, for
filing with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Members of the Audit Committee</P></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Stephen C. Riggins, Chairperson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Carol Lindstrom</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Karen A. Richardson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">John B. Shoven, Ph.D.</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Debra L. Zumwalt</P>
        <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt">&nbsp;</P>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="a_036"></A>RELATIONSHIP WITH
INDEPENDENT AUDITOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">KPMG LLP has been
the independent auditor that audits the financial statements of the Company since 1987. In accordance with standing policy, KPMG
LLP periodically changes the personnel who work on the audit. In addition to performing the audit of the Company&rsquo;s consolidated
financial statements, KPMG LLP provided various other services during fiscal 2016. The aggregate fees incurred during fiscal 2016
and fiscal 2015 for each of the following categories of services are set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="border-collapse: collapse; width: 82%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fiscal 2016 Fees</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Fiscal 2015 Fees</TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left">Audit Fees</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">716,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">706,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Audit-Related Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Tax Fees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">99,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">111,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 1pt">All Other Fees</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt">Total Fees</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">815,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">817,000</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Audit Fees.</I>
Consists of fees incurred for professional services rendered for the audit of the Company&rsquo;s consolidated financial statements
and review of the interim consolidated financial statements included in quarterly reports. This includes fees for review of the
tax provision and fees for accounting consultations on matters reflected in the financial statements. Audit fees also include
audit or other attest services required by statute or regulation (foreign or domestic) such as comfort letters, consents, reviews
of SEC filings, statutory audits in non-U.S. locations and reports on issuers&rsquo; internal controls required under the Sarbanes-Oxley
Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><I>Audit-Related
Fees.</I> Consists of fees billed for assurance and related services that are reasonably related to the performance of the audit
or review of the Company&rsquo;s consolidated financial statements and are not reported under &ldquo;Audit Fees.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>Tax Fees</I>.
Consists of fees billed or expected to be billed for professional services for tax compliance, tax advice and tax planning. These
services include assistance regarding federal, state and international tax compliance, tax audit defense, customs and duties,
mergers and acquisitions, and international tax planning.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.5pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>All Other Fees.
</I>No other fees were incurred during fiscal years 2016 or 2015.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Policy on Audit Committee Pre-Approval
of Audit and Permissible Non-Audit Services of Independent Auditor</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 22.3pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee&rsquo;s
policy is to pre-approve all audit and permissible non-audit services provided by the independent auditor. These services may
include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to
one year and any pre-approval is detailed as to the particular service or category of services and is generally subject to a specific
budget. The independent auditor and management are required to periodically report to the Audit Committee regarding the extent
of services provided by the independent auditor in accordance with this pre-approval, and the fees for the services performed
to date. The Audit Committee may also pre-approve particular services on a case-by-case basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_037"></A>PROPOSAL NO. 2</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>RATIFICATION OF APPOINTMENT OF</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>INDEPENDENT AUDITOR</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Audit Committee
of the Board of Directors has appointed KPMG LLP, an independent registered public accounting firm, to audit the financial statements
of the Company for the year ending December 29, 2017. KPMG LLP has audited the Company&rsquo;s financial statements since 1987.
A representative of KPMG LLP is expected to be present at the Annual Meeting, will have the opportunity to make a statement if
he or she so desires, and is expected to be available to respond to appropriate questions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The ratification
of the appointment of KPMG LLP will require the affirmative vote of a majority of shares of our common stock present in person
or represented by proxy at the Annual Meeting and entitled to vote on the proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event that
the stockholders do not approve the selection of KPMG LLP, the Audit Committee of the Board of Directors will reconsider the appointment
of the independent auditor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE FOR THE RATIFICATION OF THE APPOINTMENT OF KPMG LLP AS THE COMPANY&rsquo;S INDEPENDENT AUDITOR FOR FISCAL 2017.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_038"></A>PROPOSAL NO. 3</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADVISORY VOTE ON NAMED EXECUTIVE OFFICER
COMPENSATION FOR FISCAL 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Dodd-Frank Wall
Street Reform and Consumer Protection Act of 2010 (the &quot;Dodd-Frank Act&quot;) enables the Company&rsquo;s stockholders to
vote to approve, on an advisory or non-binding basis, the compensation of our named executive officers, as disclosed in this proxy
statement in accordance with SEC rules. Although the vote is advisory and is not binding on us or on our Board of Directors, our
Human Resources Committee will take into account the outcome of the vote when considering future executive compensation decisions
and will evaluate whether any actions are necessary to address stockholder concerns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that our
compensation philosophy has allowed us to attract, retain, and motivate qualified executive officers who have contributed to our
success. For more information regarding the compensation of our named executive officers and our compensation philosophy, we encourage
you to read the section of this proxy entitled &ldquo;Executive Officer Compensation &ndash; Compensation Discussion and Analysis,&rdquo;
the compensation tables and the narrative discussion following the compensation tables for a more detailed discussion of our compensation
policies and practices.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are asking for
stockholder approval of the compensation of our named executive officers in accordance with SEC rules (including without limitation,
Section 14A of the Securities Exchange Act of 1934, as amended). This vote is not intended to address any specific item of compensation,
but rather the overall compensation of our named executive officers and the policies and practices described in this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The affirmative vote
of a majority of the shares of our common stock present in person or represented by proxy at the Annual Meeting and entitled to
vote on the proposal is required for advisory approval of this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>The
Board of Directors unanimously recommends a vote FOR the approval of the compensation of our named executive officers as disclosed
in this proxy statement on an advisory basis pursuant to the compensation disclosure rules of the SEC.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_039"></A>PROPOSAL NO. 4</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ADVISORY VOTE ON FREQUENCY OF STOCKHOLDER
ADVISORY VOTES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>ON NAMED EXECUTIVE OFFICER COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Dodd-Frank Act
also enables the Company&rsquo;s stockholders to vote, on an advisory or non-binding basis, on how frequently they would like
to cast an advisory vote on the compensation of our named executive officers. By voting on this proposal, stockholders may indicate
whether they would prefer an advisory vote on named executive officer compensation once every one, two, or three years. This &ldquo;say
on frequency&rdquo; vote is required to be held at least once every six years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">After consideration
of the frequency alternatives, our Board of Directors believes that conducting an advisory vote on named executive officer compensation
on an annual basis is appropriate for the Company and its stockholders at this time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Stockholders are
asked to specify one of four votes on this proposal: one year, two years, three years or abstain. Stockholders are not voting
to approve or disapprove of the Board of Directors&rsquo; recommendation. The proxy holders will vote all proxies received for
an advisory vote to approve named executive officer compensation every year unless instructed otherwise. Approval of the frequency
of an advisory vote to approve named executive officer compensation will be determined by a plurality of votes, which means that
the choice of frequency that receives the highest number of &ldquo;FOR&rdquo; votes will be considered the advisory vote of the
stockholders. Abstentions and broker non-votes will not count as votes cast &quot;<FONT STYLE="text-transform: uppercase">for</FONT>&quot;
or &quot;<FONT STYLE="text-transform: uppercase">against</FONT>&quot; any frequency choice, and will have no direct effect on
the outcome of this proposal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>the
Board of Directors recommends a vote for A FREQUENCY OF ONE YEAR FOR THE advisory vote on the compensation of our named executive
officers.</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_040"></A>PROPOSAL NO. 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF AMENDMENT OF THE AMENDED
AND RESTATED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>2008 EQUITY INCENTIVE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In 2008, we adopted
the 2008 Equity Incentive Plan (the &ldquo;2008 Plan&rdquo; or the &ldquo;Plan&rdquo;), which replaced our prior equity-based
compensation plans. The 2008 Plan was approved by stockholders on May 29, 2008 and currently has up to 4,828,150 shares of our
common stock authorized for grants of stock awards and stock options to selected employees, directors and independent contractors.
As of April 4, 2017, we have granted restricted stock units and stock options covering 4,417,708 shares of our common stock and,
as a result, have 410,442 shares of common stock remaining available for grant under the 2008 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">On April 3, 2017,
the Board of Directors adopted an amendment to the 2008 Plan to increase the number of shares available for grant by 1,100,000
shares (bringing the remaining total number of shares currently available for issuance under the 2008 Plan to 1,510,442 and the
aggregate number of shares under the 2008 Plan to 5,928,150), subject to stockholder approval of the amendment. Based on our current
plans and growth expectations, we believe that the shares requested in this proposal will be sufficient for the Company&rsquo;s
needs for four years but could last for a shorter period of time if actual practice does not match historic rates or our Share
price or headcount change materially.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">An affirmative vote
for Proposal No. 5 is a vote to (a) approve an increase in the number of shares available for grant under the 2008 Plan by 1,100,000
shares, which under the terms of the Plan will extend the Plan term for 10 years from the date of such approval, (b) reapprove
the material terms of the performance goals and grant limits under the 2008 Plan to enable the Company to continue to have a stockholder-approved
arrangement under which compensation awarded to certain senior management may qualify as performance-based compensation for purposes
of Section 162(m) of the Internal Revenue Code of 1986, as amended, (c) further limitations on the re-use of shares under the
Plan, including the prevention of re-issuance of shares not issued under net-settled stock appreciation rights and the prevention
of re-issuance of shares re-purchased from the proceeds of the exercise of stock options and (d) a prohibition on the payment
of dividends and dividend equivalents until the vesting of the awards under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section 162(m) imposes
a $1 million limit on the amount that a public company may deduct for compensation paid to the company&rsquo;s CEO or any of the
company&rsquo;s three other most highly compensated executive officers (other than the CFO). This limitation does not apply to
compensation that meets the requirements under Section 162(m) for &ldquo;qualifying performance-based&rdquo; compensation (i.e.,
compensation paid only if the individual&rsquo;s performance meets pre-established objective goals based on performance criteria
approved by stockholders). One of the requirements for compensation to qualify as performance-based under Section 162(m) is that
the material terms of the performance goals for such compensation be disclosed to and approved by stockholders every five years.
In accordance with Section 162(m), the material terms that the stockholders approve constitute the framework to establish programs
and awards under which compensation provided by the company can qualify as performance-based compensation for purposes of Section
162(m); however, there can be no guarantee that amounts payable under these programs and awards will be treated as qualified performance-based
compensation under Section 162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Equity compensation
is a critical part of the Company&rsquo;s total compensation program which is essential to the Company&rsquo;s long-term success.
The Company believes that its current equity compensation program is an important element in the retention of employees who are
its key revenue generators.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Why we believe you should vote for
Proposal No. 5</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company believes
that as a high-end consulting firm its people are its key asset and this requires a unique approach to equity compensation. The
Company seeks to balance the need to attract, motivate and retain top talent in a highly competitive business with the need to
manage its annual use of equity. Almost all of its competitors are privately held organizations owned by their key revenue generators.
To remain competitive the use of equity is necessary to attract, motivate and retain the highest caliber principal consultants
and senior management. Equity awards continue to represent a significant portion of the compensation package for most of its key
revenue generators, not just senior management. During fiscal 2016, the Company granted equity awards to approximately 150 employees.
The Company strongly believes that granting equity awards encourages employees to think and behave like owners, rewarding them
when value is created for stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Equity needs to be
distributed more broadly than to senior management alone to ensure key revenue producers are focused on growing the business and
incentivized to maximize stockholder value. The Company believes its current equity compensation program has had a significant
positive impact on its financial results and overall business strategy. The Company started its current program in 2004. Net revenues
have increased 138% from $125.9 million in fiscal 2003 to $299.2 million in fiscal 2016 and operating income has increased 266%
from $16.9 million to $61.9 million over the same period of time. The Company&rsquo;s market capitalization increased from $155.4
million at the end of fiscal 2003 to $1.5 billion at the end of fiscal 2016 reflecting a total stockholder return of approximately
865% since 2003. In deciding whether to approve this proposal, stockholders should also consider the following key factors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Use
                                         of restricted stock units to pay a portion of bonuses.</I> The Company&rsquo;s bonus
                                         pool is based on the profitability of the Company and is distributed based on each individual&rsquo;s
                                         relative contribution to the overall performance of the Company. In 2004, the Company
                                         started to pay a portion of its key revenue producers and senior management&rsquo;s earned
                                         annual bonuses in restricted stock units as a way to further align the interests of its
                                         employees with that of its stockholders and to further retain top talent. At the discretion
                                         of the Company, 20% to 40% of this group&rsquo;s annual bonus is paid with fully vested
                                         restricted stock unit awards which are settled with shares of common stock four years
                                         from the grant date. This strategy uses equity as a substitute for cash in delivering
                                         performance based pay to its employees. Each individual who has part of their bonus settled
                                         with a fully vested restricted stock unit award is also granted a matching number of
                                         unvested restricted stock unit awards that cliff vest four years from the date of grant.
                                         This program has resulted in an increase in stock ownership for the top performing consultants
                                         by tying up a portion of their annual bonus with restricted stock units, which are matched
                                         by the Company with unvested restricted stock units. By tying this program to individual
                                         bonuses, the Company ensures that the top performing consultants receive the highest
                                         portion of equity compensation. This program has been well received by the Company&rsquo;s
                                         employees and stockholders, has improved retention and we believe has contributed to
                                         the Company&rsquo;s strong results over the past several years. While the fully vested
                                         units issued in lieu of cash do not have the retention power of the unvested units, the
                                         Company believes that they are an important part of aligning its key revenue producers&rsquo;
                                         and stockholders&rsquo; interests, although this increases the number of shares issued
                                         annually and as a result it also increases the Company&rsquo;s burn rate.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Impact
                                         of stock repurchase. </I>Between January 1, 2014 and December 30, 2016 the Company utilized
                                         excess cash to re-purchase 1,872,000 shares of its common stock for a total of $78.7
                                         million. These repurchases are equal to 7% of the shares outstanding at April 4, 2017.
                                         The share repurchase program has been well received by stockholders and accretive to
                                         earnings although it has negatively impacted the calculation of total potential dilution.
                                         Had the Company not made these repurchases, its total potential dilution, assuming the
                                         amendment to the 2008 Plan is adopted, would be 8.2% at April 4, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We believe that we
have demonstrated a commitment to sound equity compensation practices in recent years. We recognize that equity compensation awards
dilute stockholder equity, so we have carefully managed our equity incentive compensation. Our equity compensation practices are
intended to be competitive and consistent with market practices, and we believe our historical share usage has been responsible
and mindful of stockholder interests. Total potential dilution is equal to the total number of unvested equity awards outstanding
plus the pool of shares remaining for future awards, divided by the total number of common shares outstanding, the number of unvested
equity awards outstanding, and the pool of shares remaining for future awards. Our total potential dilution, assuming the amendment
to the 2008 Plan is adopted, was 8.7% as of April 4, 2017:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Stock Options</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: justify">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify; border-bottom: Black 1pt solid">Fiscal Year (1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Number<BR> Outstanding</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Exercise<BR> Price
    ($)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Weighted<BR> Average<BR> Remaining<BR> Term
    (yrs.)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Total<BR> Unvested<BR> Stock<BR> Awards<BR>
    Outstanding</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Shares<BR> Available (2)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Common<BR> Shares<BR> Outstanding</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Total<BR> Equity<BR> Dilution</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 16%; text-align: justify">2014</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">395,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">19.21</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">5.85</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">886,780</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">1,435,342</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">25,741,948</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; text-align: right">9.5</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">285,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26.42</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.59</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">779,977</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,077,325</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,720,598</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7.7</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">319,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">31.58</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.47</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">695,314</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">709,918</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,597,038</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.3</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">Current (3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">375,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35.54</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6.98</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">592,663</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">410,442</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,871,157</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5.1</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-weight: bold; text-align: justify">New Shares</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1,100,000</TD><TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD COLSPAN="8" STYLE="font-weight: bold; text-align: justify">Total equity dilution including new shares</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">8.7</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">As reported in the Company&rsquo;s
                                         Form 10-K filing at the end of each fiscal year.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Excludes the 2008 Employee Stock Purchase
                                         Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">As of April 4, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Burn rate is equal
to total awards granted divided by the basic weighted average shares outstanding. The Company&rsquo;s three-year average burn
rate for fiscal 2014 through fiscal 2016 was 1.5%:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: justify; border-bottom: Black 1pt solid">Fiscal Year (1)</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Stock Option<BR> Grants</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Restricted Stock Unit<BR> Award Grants</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Basic Weighted<BR> Average Shares</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center; border-bottom: Black 1pt solid">Burn Rate</TD><TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; text-align: justify; padding-left: 5.4pt">2014</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">45,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">378,348</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">26,910,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1.6</TD><TD STYLE="width: 1%; text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">2015</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">331,191</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,606,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify; padding-left: 5.4pt">2016</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">302,672</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">26,488,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1.4</TD><TD STYLE="text-align: left">%</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-weight: bold; text-align: justify; padding-left: 5.4pt">3-yr average</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: right">1.5</TD><TD STYLE="font-weight: bold; text-align: left">%</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">As reported in the Company&rsquo;s
                                         Form 10-K filing at the end of each fiscal year.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>2008 Plan Highlights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The 2008 Plan includes
provisions designed to serve stockholders&rsquo; interests and promote effective corporate governance, including the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>No
                                         &ldquo;Evergreen&rdquo; Provision</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2008 Plan fixes the
                                         number of shares available for future grants and does not provide for any increase based
                                         on an increase in the number of outstanding shares of common stock.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>No
                                         Discounted Stock Options</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2008 Plan prohibits the granting
                                         of stock options at an exercise price that is less than the fair market value of the
                                         common stock on the date the stock option is granted.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Limitation
                                         on Reuse of Shares</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2008 Plan contains limits on the re-use
                                         of Shares including: (i)<I> </I>Shares tendered or withheld to satisfy any Company withholding
                                         obligation will not become available for re-issuance under the Plan, (ii) Shares not
                                         issued under net-settled stock appreciation rights will not become available for re-issuance
                                         under the Plan, and (iii) Shares re-purchased from the proceeds of the exercise of stock
                                         options will not become available for re-issuance under the Plan.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>No
                                         Stock Option Re-pricings</I>.&nbsp;&nbsp;&nbsp;&nbsp;The 2008 Plan explicitly prohibits
                                         re-pricing of awards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>No
                                         Payment of Dividends and Dividend Equivalents on Unvested Awards. </I>The 2008 Plan explicitly
                                         prohibits payment of dividends and dividend equivalents until the vesting of the awards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Limitations
                                         on Material Amendments</I>.&nbsp;&nbsp;&nbsp;&nbsp;Neither the 2008 Plan nor any award
                                         may be materially amended unless stockholder approval is obtained.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><I>Administered
                                         by Independent Directors. </I>An independent Committee of the Board of Directors will
                                         administer the 2008 Plan (although it may delegate certain responsibilities to others,
                                         as described below).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is
a summary of the material terms of the 2008 Plan, as amended. It is qualified by reference to the full text of the Plan, as amended.
A copy of the 2008 Plan, as amended, is filed as an exhibit to our Form 10-K for the fiscal year-ended December 30, 2016. A copy
of the proposed amendment and the 2008 Plan, as amended, is attached as Appendix A to this proxy statement. Stockholders are encouraged
to review the 2008 Plan and proposed amendment carefully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Types of Awards<I>.
</I></B>The Plan permits the Company to issue stock options (both incentive stock options designed to comply with Section 422
of the Internal Revenue Code (the Code) and nonstatutory stock options which will not so comply), stock awards (including stock
appreciation rights, stock units, stock grants and other similar equity awards), and cash awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Stock Subject
to the Plan</B>. As of April 4, 2017, we have granted restricted stock units and stock options covering 4,417,708 shares of our
common stock. As a result, we have 410,442 shares of common stock remaining available for grant under the 2008 Plan. If this proposal
is approved, an additional 1,100,000 shares of our common stock will be available for issuance under the 2008 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Administration<I>.
</I></B>The Company anticipates that the Plan will be administered by the Human Resources Committee of its Board (generally referred
to as the &ldquo;Administrator&rdquo; of the Plan); however, with respect to grants to certain non-officer employees, the Administrator
may from time to time delegate its authority to one or more officers of the Company. In any event, the Company will administer
the Plan in accordance with applicable law including with applicable NASDAQ listing standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Eligibility<I>.
</I></B>Awards may be granted under the Plan to Exponent (and its affiliates&rsquo;) employees (including officers), independent
contractors and members of the Company&rsquo;s Board of Directors (including non-employee or outside board members). Incentive
stock options may be granted only to employees of Exponent or its subsidiaries. The Administrator, in its discretion, selects
the employees to whom stock options and other stock awards, as well as cash awards, may be granted, the time or times at which
such awards are granted, and the terms of such awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of April 4, 2017,
approximately ten officers (as defined in Rule 16a-1(f) under the Exchange Act), six non-employee directors, and 1,013 employees
of the Company would have been eligible to receive grants under the 2008 Plan had the Plan amendment been effective as of such
date. The Company has historically not granted equity awards to independent contractors. As of April 4, 2017, approximately 155
employees participate in the 2008 Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Because benefits
under the Plan will depend on the Administrator&rsquo;s actions and the fair market value of common stock at various future dates,
it is not possible to determine the benefits that will be received by employees, officers (including named executive officers),
directors, and independent contractors if the amendment is approved by the stockholders. No grants have been made and no shares
issued, with regard to the share increase for which stockholder approval is sought under the Plan. Additional information about
our equity award grants during fiscal 2016 to our named executive officers is set forth in the Grant of Plan-Based Awards table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For certain additional
information concerning securities authorized for issuance under the Company&rsquo;s equity compensation plans as of December 30,
2016, see &ldquo;Equity Compensation Plan Information&rdquo; elsewhere in this proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Section&nbsp;162(m)
Limitations<I>. </I></B>Section&nbsp;162(m) of the Code generally disallows a tax deduction to public companies for compensation
in excess of $1&nbsp;million paid to the company's Chief Executive Officer or any of the three other most highly compensated officers.
Certain performance-based compensation is specifically exempt from this deduction limit if it otherwise meets the requirements
of Section&nbsp;162(m). Stock options and other equity awards pursuant to which the recipient's compensation is based solely on
the appreciation of the value of the underlying shares from the date of grant (i.e. with the exercise prices equal to the fair
market value at grant) until the date of the income recognition event may qualify as performance-based compensation if the company
satisfies certain requirements in connection with the Plan under which the awards are granted. Specifically, the Plan must be
stockholder-approved and must contain a limit on the number of shares that may be granted to any one individual under the Plan
during a specified period. Accordingly, the Plan has provided that no employee may be granted options and other stock awards covering
more than 400,000 shares in any calendar year, except that an employee may be granted equity awards covering up to an additional
800,000 shares during the year in which the employee&rsquo;s service to Exponent commences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Plan also provides
that Exponent may grant cash awards designed to qualify as performance-based compensation and specifies that the maximum amount
payable under a cash award to any employee during a single calendar year is $1,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Additional requirements
apply to certain forms of compensation, such as stock units and cash awards, in order for them to qualify as performance-based
compensation, including a requirement that payment of the value of such awards be contingent upon achievement of performance goals
that are established in a manner specified under Section 162(m) of the Code. The Plan permits Exponent to issue awards incorporating
such performance objectives and provides that these performance objectives (&quot;Qualifying Performance Criteria&quot;) may be
based upon either achievement in terms of absolute targets or increase (or in appropriate cases, decrease) in: cash flow; earnings
(including gross margin, earnings before interest, taxes, depreciation, amortization and stock-based compensation, earnings before
taxes, and net earnings); earnings per share; stock price; return on equity or average stockholders&rsquo; equity; total stockholder
return; return on assets or net assets; return on investment; revenue before reimbursements; income or net income; operating income
or net operating income, in aggregate or per share; operating profit or net operating profit; operating margin; return on operating
revenue; contract awards or backlog; overhead or other expense reduction; growth in stockholder value relative to the moving average
of the S&amp;P 500 Index or S&amp;P SmallCap 600 Index; objective strategic plan development and implementation (including individual
objective performance goals that relate to achievement of the Company&rsquo;s or any business unit&rsquo;s strategic plan). The
Human Resources Committee may appropriately adjust any evaluation of performance under a Qualifying Performance Criteria to exclude
any of the following events that occurs during a performance period: (A) asset write-downs; (B) litigation or claim judgments
or settlements; (C) the effect of changes in tax law, accounting principles or other such laws or provisions affecting reported
results; (D) accruals for reorganization and restructuring programs; and (E) any gains or losses classified as extraordinary or
as discontinued operations in the Company&rsquo;s financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To the extent that
the Administrator determines that an award will be granted subject to Qualifying Performance Criteria, such criteria will be specified
with respect to a particular award by the Board's Human Resources Committee or the independent members of the Board in a manner
designed to comply with Section 162(m). These criteria may be applied to Exponent as a whole or to a business unit, affiliate
or business segment, either individually, alternatively or in any combination, and may be measured either annually or cumulatively
over a period of years, on an absolute basis, or relative to a pre-established target, to previous years&rsquo; results or to
a designated comparison group, in each case as specified by the Administrator in the award agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company will
be required under Section 162(m) to generally seek stockholder approval of the Plan&rsquo;s Qualifying Performance Criteria at
least every five years. The Plan also allows the Board or Human Resources Committee to grant Plan awards that do not comply with
the Section 162(m) requirements at any time, as well as to grant awards outside of the Plan (to the extent otherwise permitted
under applicable law).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Plan Characterization.
</B>The Plan is not subject to the provisions of the Employment Retirement Income Security Act of 1974, as amended, and is not
qualified under Section 401(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Adjustments upon
Changes in Capitalization, Merger or Sale of Assets. </B>Subject to any required action by Exponent&rsquo;s stockholders, (1)&nbsp;the
number of shares covered by each outstanding award, (2)&nbsp;the price per share subject to each outstanding award and (3)&nbsp;the
share limitations as set forth in the Plan (including those established under Section 162(m)), will each be proportionately adjusted
for any increase or decrease in the number of issued shares resulting from a stock split, reverse stock split, stock dividend,
combination or reclassification of Exponent&rsquo;s stock, payment of dividend or distribution in a form other than stock (excepting
normal cash dividends) that has a material effect on the fair market value of the shares of common stock or any other increase
or decrease in the number of issued shares of Exponent&rsquo;s stock effected without receipt of consideration by Exponent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of a
liquidation or dissolution and unless otherwise determined by the Administrator, any unexercised options or other stock awards
pursuant to which shares have not yet been issued will terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of a
change in control of Exponent, as defined in the Plan and determined by the Administrator, and under the proposal upon the consummation
of such event, the Administrator, in its discretion, may provide for the assumption, substitution or adjustment of each outstanding
award, accelerate the vesting of options and terminate any restrictions on stock awards or cash awards, or cancel awards including
for a cash payment to the awardee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Nontransferability
of Awards.</B> Unless otherwise determined by the Administrator, awards granted under the Plan are not transferable other than
by will or the laws of descent and distribution, and options may be exercised during the optionee&rsquo;s lifetime only by the
optionee. The Administrator will have the sole discretion to permit the transfer of an award to family members and other persons
and entities permitted under the rules applicable to the Form S-8 registration statement (as now or hereafter in effect, or to
any successor form); however, the transferability of incentive stock options is restricted under the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Amendment and
Termination of the Stock Plan.</B> The Board may amend, alter or suspend the Plan, or any part thereof, at any time and for any
reason. However, Exponent will obtain stockholder approval for any amendment to the Plan to the extent required by applicable
laws or stock exchange rules. In addition, unless approved by Exponent stockholders, no such amendment will be made that would:
(1)&nbsp;increase the maximum number of shares for which awards may be granted under the Plan, other than an increase pursuant
to a change in capitalization, dissolution or change in control, (2)&nbsp;increase the share or cash limit described above, (3)&nbsp;reprice
or otherwise reduce the exercise price of outstanding options other than an adjustment pursuant to a change in capitalization,
dissolution or change in control, or (4)&nbsp;expand the class of persons eligible to receive awards under the Plan. No such action
by the Board or stockholders may alter or impair any award previously granted under the Plan without the written consent of the
participant (except for certain changes specified in the Plan). Unless terminated earlier, the Plan will terminate ten years from
the date of its last approval by the stockholders to add shares under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Summary of Options,
Stock Awards and Cash Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Options</B>. Each
option is evidenced by a stock option agreement between Exponent and the optionee and is subject to the following additional terms
and conditions. The Plan allows the Administrator broad discretion to determine the terms of individual options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Exercise Price.
</I></B>The Administrator determines the exercise price of options at the time the options are granted. The exercise price of
options granted under the Plan may not be less than 100% of the fair market value of the common stock on the date such option
is granted (incentive stock options granted to employees who are also 10% stockholders must have an exercise price equal to 110%
of the fair market value of the stock on the date of grant). Exponent may grant options with exercise prices equal to less than
100% of the fair market value of the underlying option shares on the date of grant in connection with an acquisition by Exponent
of another company. The fair market value means, as of any date, the value of a share of Common Stock or other property as determined
by the Administrator, in its discretion, or by the Company, subject to the Plan&rsquo;s requirement that if the Company&rsquo;s
common stock is trading on a national or regional securities exchange or market system, the fair market value will generally be
the closing price for that day as quoted on that exchange or system.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As of April 4, 2017,
the closing price of our common stock was $58.25 per share. No option may be repriced to reduce the exercise price of such option
without stockholder approval (except in connection with a change in Exponent&rsquo;s capitalization, such as a stock split or
a recapitalization).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Exercise of
Option; Form of Consideration</I></B><I>.</I> The Administrator determines when options become vested and exercisable, and in
its discretion may accelerate the vesting and/or exercisability of any outstanding option. Exponent&rsquo;s standard employee
option vesting schedule is twenty-five percent per year. The means of payment for shares issued upon exercise of an option are
specified in each option agreement. The Plan permits payment to be made by cash, check, wire transfer, other shares of common
stock of Exponent (with some restrictions), broker assisted same-day sales, cashless net-exercise arrangements, any other form
of consideration permitted by applicable law, or any combination of these methods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Term of Option</I></B><I>.
</I>The term of an option may be no more than ten years from the date of grant (or up to ten and one-half years in certain jurisdictions
outside of the United States). No option may be exercised after the expiration of its term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Termination
of Employment.</I></B> If an optionee&rsquo;s employment terminates for any reason (other than as described below), then all options
held by the optionee under the Plan generally will be exercisable until the earlier of three months following the optionee&rsquo;s
termination or the expiration of the term of the option; provided that the Administrator may in the stock option agreement specify
a period of time (but not beyond the expiration date of the option) following the optionee&rsquo;s termination during which the
optionee may exercise the option as to shares that were vested and exercisable as of the optionee&rsquo;s termination date. The
term of an option may also be extended automatically for specified periods following termination of the optionee&rsquo;s employment
under certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Death or Disability.
</I></B>Generally, if an optionee&rsquo;s employment terminates as a result of optionee&rsquo;s death or disability, then all
options that are vested and exercisable as of the date of termination may be exercised for one year following the date of termination
due to optionee&rsquo;s death or disability, provided that no option may be exercised after the expiration of its term.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Other Provisions.
</I></B>The stock option agreement may contain other terms, provisions and conditions not inconsistent with the Plan, as may be
determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Stock Awards.
</B>Each stock award is evidenced by an award agreement between Exponent and the participant. The Plan allows the Administrator
broad discretion to determine the terms of individual stock awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>General Terms.
</I></B>Each stock award agreement will contain provisions regarding (1)&nbsp;the number of shares subject to such stock award
or a formula for determining such number, (2)&nbsp;the purchase price of the shares, if any, and the means of payment for the
shares, (3)&nbsp;the performance criteria (including the Qualifying Performance Criteria), if any, and level of achievement versus
these criteria that will determine the number of shares granted, issued, retainable and vested, as applicable, (4)&nbsp;such terms
and conditions on the grant, issuance, vesting and forfeiture of the shares, as applicable, as may be determined from time to
time by the Administrator, (5)&nbsp;restrictions on the transferability of the stock award, and (6)&nbsp;such further terms and
conditions, in each case not inconsistent with the Plan, as may be determined from time to time by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Vesting.</I>
</B>The vesting of a stock award may (but need not) be subject to performance criteria (including Qualifying Performance Criteria),
continued service of the participant, other market conditions or a combination of these conditions. The Administrator has the
authority to accelerate vesting of an outstanding stock award. Exponent&rsquo;s restricted stock unit grant program is discussed
in more detail below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B><I>Termination
of Employment. </I></B>In the case of stock awards, including stock units, unless the Administrator determines otherwise, the
award agreement will generally provide that the unvested stock or stock units will be forfeited upon the participant's termination
of employment. Unvested stock or stock units will continue to vest in the case of retirement at 59 &frac12; years or older, provided
that the award holder does all consulting work through the Company and does not become an employee for a past or previous client
(direct or indirect) or competitor of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Cash Awards. </B>Cash
awards granted under the Plan will generally be made to individuals who are, or who the Company anticipates may be, among its
most highly compensated officers (such individuals being those employees whose compensation may not be fully deductible by Exponent
under Code Section 162(m) if it exceeds with respect to a given year the limits imposed by that section). Each cash award granted
under the Plan will be subject to Qualifying Performance Criteria and will be reflected in an agreement containing provisions
regarding (1)&nbsp;the target and maximum amount payable to the participant as a cash award, (2)&nbsp;the Qualifying Performance
Criteria and level of achievement versus the criteria that will determine the amount of such payment, (3)&nbsp;the period as to
which performance will be measured for establishing the amount of any payment, (4)&nbsp;the timing of any payment earned by virtue
of performance, (5)&nbsp;restrictions on the alienation or transfer of the cash award prior to actual payment, (6)&nbsp;forfeiture
provisions, and (7)&nbsp;such further terms and conditions, in each case not inconsistent with the Plan, as may be determined
from time to time by the Administrator. The maximum amount payable as a cash award that is settled for cash may be a multiple
of the target amount payable. The maximum amount payable pursuant to a cash award granted under the Plan for any fiscal year may
not exceed U.S. $1,000,000. Nothing in the Plan prevents the Company from granting cash awards outside of the Plan to any individual.</P>


<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Federal Income
Tax Consequences of Options, Stock Awards and Cash Awards under the Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>The following
is only a summary of the effect of U.S. federal income taxation upon awardees and Exponent with respect to the grant, vesting
and exercise of awards under the Plan. It does not purport to be complete and does not discuss the tax consequences arising in
the context of the employee&rsquo;s death or the income tax laws of any municipality, state or foreign country in which the employee&rsquo;s
income or gain may be taxable.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Incentive Stock
Options. </B>An optionee who is granted an incentive stock option does not recognize taxable income at the time the option is
granted or upon its exercise, although the exercise is an adjustment item for alternative minimum tax purposes and may subject
the optionee to the alternative minimum tax. Alternative minimum tax is an alternative method of calculating the income tax you
must pay each year, which includes certain additional items of income and tax preferences and disallows or limits certain deductions
otherwise allowable for regular tax purposes. Alternative minimum tax is payable only to the extent that alternative minimum tax
income exceeds &ldquo;regular&rdquo; federal income tax for the year (computed without regard to certain credits and special taxes).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Upon a disposition
of the shares acquired on exercise of an incentive stock option more than two years after grant of the option and one year after
exercise of the option, the optionee will recognize long-term capital gain or loss equal to the difference between the sale price
and the exercise price. If the holding periods are not satisfied, then: (1)&nbsp;if the sale price exceeds the exercise price,
the optionee will recognize capital gain equal to the excess, if any, of the sale price over the fair market value of the shares
on the date of exercise and will recognize ordinary income equal to the difference, if any, between the lesser of the sale price
or the fair market value of the shares on the exercise date and the exercise price; or (2)&nbsp;if the sale price is less than
the exercise price, the optionee will recognize a capital loss equal to the difference between the exercise price and the sale
price. Unless limited by Section&nbsp;162(m) of the Code, Exponent is entitled to a deduction in the same amount as and at the
time the optionee recognizes ordinary income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Nonstatutory Stock
Options. </B>An optionee does not recognize any taxable income at the time a nonstatutory stock option is granted. Upon exercise
of vested shares, the optionee recognizes taxable income generally measured by the excess of the then fair market value of the
shares over the exercise price. Any taxable income recognized in connection with an option exercise by an employee of Exponent
is subject to tax withholding by Exponent. Unless limited by Section&nbsp;162(m) of the Code, Exponent is generally entitled to
a deduction in the same amount as and at the time the optionee recognizes ordinary income. Upon a disposition of such shares by
the optionee, any difference between the sale price and the exercise price, to the extent not recognized as taxable income as
provided above, is treated as long-term or short-term capital gain or loss, depending on the length of the holding period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Stock Awards.
</B>Stock awards will generally be taxed in the same manner as nonstatutory stock options, meaning that the employee will generally
recognize income in an amount equal to the excess of the fair market value of the shares (typically measured as of the vesting
date) over any amount the employee paid for the shares. Except with respect to Restricted Stock Units, an employee who receives
unvested shares of stock under a stock award may generally make an election at the time of grant to recognize income based upon
the fair market value of the stock on the grant date. Certain of the Company&rsquo;s restricted stock unit awards incorporate
income recognition deferral features, which delay the date on which the employee recognizes income for certain purposes. Ordinary
income recognized by an employee with respect to a stock award will be subject to tax withholding by Exponent. Unless limited
by Section&nbsp;162(m) of the Code, Exponent is generally entitled to a deduction in the same amount as and at the time the employee
recognizes ordinary income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Cash Awards. </B>Upon
receipt of cash, the recipient will have taxable ordinary income, in the year of receipt, equal to the amount of cash received.
Any cash received will be subject to tax withholding by Exponent. Unless limited by Section&nbsp;162(m) of the Code, Exponent
will be entitled to a tax deduction in the amount and at the time the recipient recognizes compensation income.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Accounting Treatment</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Exponent will recognize
compensation expense in connection with awards granted under the Plan as required under applicable accounting standards. Exponent
currently amortizes compensation expense associated with equity awards over an award&rsquo;s requisite service period and establishes
fair value of equity awards in accordance with applicable accounting standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>New 2008 Plan
Benefits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No awards have been
granted, and no shares of common stock have been issued, on the basis of the proposed 1,100,000 share increase under the Plan
amendment. It is not possible to determine the specific amounts and types of awards that may be awarded in the future under the
Plan amendment because the grant and actual pay-out of awards under the 2008 Plan are subject to the discretion of the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Aggregate Past
Grants Under the 2008 Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In accordance with
SEC rules, the following table sets forth summary information with respect to the number of shares of our common stock subject
to stock options made under the 2008 Plan to our named executive officers, all current executive officers as a group, directors,
associates of such executive officer, directors and nominees, each other person who received or is to receive 5% of such options,
warrants or rights and all employees (other than executive officers) as a group as of April 4, 2017. This table does not include
restricted stock units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold">Individual or Group</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Number
                                         of Shares</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Underlying
                                         Awards</B></P></TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Paul R. Johnston, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 82%; text-align: left">Chief Executive Officer</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; text-align: right">277,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Richard L. Schlenker</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Executive Vice President, Chief Financial Officer and Corporate Secretary</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">198,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Catherine Ford Corrigan, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Steven J. Murray, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Group Vice President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Harri K. Kytomaa, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Group Vice President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current executive officers as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">515,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current directors who are not executive officers as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each nominee for election as a director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each associate of any such director, executive officer or nominees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each other person who received or is to receive 5% of such awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All employees, other than executive officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Registration with
the SEC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We intend to file
a Registration Statement on Form S-8 relating to the issuance of shares of common stock under the Plan amendment with the Securities
and Exchange Commission pursuant to the Securities Act of 1933, as amended, as soon as practicable after approval of the Plan
amendment by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In considering the
recommendation of our Board of Directors with respect to the approval of the amendment and the material terms of the 2008 Plan,
as amended, stockholders should be aware that the members of our Board of Directors have certain interests, which may present
them with conflicts of interest in connection with this proposal. As discussed above, directors are eligible to receive awards
under the 2008 Plan. For more information about equity grants to our directors, see <I>&ldquo;Compensation of Directors&rdquo;
</I>above. Our Board of Directors recognizes that approval of this proposal may benefit our directors and their successors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Approval of the amendment
of the Amended and Restated 2008 Equity Incentive Plan will require the affirmative vote of a majority of shares present in person
or represented by proxy at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE &ldquo;FOR&rdquo; APPROVAL OF AMENDMENT OF THE AMENDED AND RESTATED 2008 EQUITY INCENTIVE PLAN.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_041"></A>PROPOSAL NO. 6</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>APPROVAL OF AMENDMENT OF THE 2008 EMPLOYEE
STOCK PURCHASE PLAN</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In 2008, we adopted
the 2008 Employee Stock Purchase Plan (ESPP), which replaced our prior Employee Stock Purchase Plan established in 1992. The ESPP
was approved by stockholders on May 29, 2008 and currently has 38,056 shares of our common stock authorized for issuance. On April
3, 2017, the Board of Directors adopted an amendment to the ESPP to increase the number of shares authorized for issuance by 200,000
shares (bringing the remaining total number of shares currently available for issuance under the ESPP to 238,056 and the aggregate
number of shares under the ESPP to 600,000), subject to stockholder approval of the amendment. Based on our current plans and
growth expectations, we believe that the shares requested in this proposal will be sufficient for the Company&rsquo;s needs for
the next six years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The ESPP is designed
to qualify as an &ldquo;employee stock purchase plan&rdquo; under Section 423 of the Internal Revenue Code. It allows employees
to purchase stock through regular payroll deductions at a 5% discount to the market value of Exponent common stock on the last
date of each offering period (Purchase Date). Management and the Board of Directors believe that it is important for employees
to have the ability to participate in ownership of the Company. This benefit is an integral, long-standing, and valued aspect
of the Company&rsquo;s benefit plan; to lose this benefit would be a loss both to the Company and its employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Exponent expects
that, based upon the structure of the <FONT STYLE="font-family: Times New Roman, Times, Serif">ESPP</FONT>, the Company will not
be required to record compensation expenses for financial statement purposes in connection with the rights to purchase stock granted
to employees under <FONT STYLE="font-family: Times New Roman, Times, Serif">the ESPP</FONT>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following is
a summary of the material terms of the ESPP. It is qualified by reference to the full text of the plan, which is attached as Appendix
B to this proxy statement. Stockholders are encouraged to review the ESPP carefully.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Administration<I>.</I></B><I>&nbsp;&nbsp;&nbsp;&nbsp;</I>The
ESPP may be administered by the Board or by a committee appointed by the Board (the Administrator). Currently, the ESPP is being
administered by the Human Resources Committee of the Board. In any event, Exponent will administer the ESPP in accordance with
applicable law including with applicable Nasdaq listing standards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Eligibility.</B>&nbsp;&nbsp;&nbsp;&nbsp;Any
person who is customarily employed by Exponent (or any of its majority-owned subsidiaries designated by the Board of Directors)
for at least 20 hours per week and more than five months in any calendar year and is not deemed to own stock or options to purchase
stock constituting 5% or more of the total voting power of stock of Exponent is eligible to participate in the ESPP, provided
that the employee is employed prior to the commencement of an Offering Period (as defined below) and is not an individual providing
services to Exponent or its subsidiaries as an independent contractor and is reclassified as a common law employee for any reason
except federal income and employment tax purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">As of April 4<B>,
</B>2017, approximately ten officers (as defined in Rule 16a-1(f) under the Exchange Act), and 1,013 employees of the Company
would have been eligible to participate in the ESPP had the Plan amendment been effective as of such date. As of April 4, 2017,
approximately 164 employees participate in the ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Plan Characterization.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
ESPP is not subject to the provisions of the Employment Retirement Income Security Act of 1974, as amended, and is not qualified
under Section 401(a) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Adjustments upon
Changes in Capitalization, Merger or Sale of Assets.</B>&nbsp;&nbsp;&nbsp;&nbsp;Subject to any required action by Exponent&rsquo;s
stockholders, (1) the number of shares covered by each outstanding option, (2) the price per share subject to each outstanding
option and (3) the maximum number of shares that may be purchased by a participant on any purchase date will each be proportionately
adjusted for any increase or decrease in the number of issued shares resulting from a stock split or the payment of stock dividend
or any other increase or decrease in the number of issued shares of Exponent&rsquo;s stock effected without receipt of consideration
by Exponent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of a
dissolution or liquidation of Exponent, each Offering Period under the ESPP then in progress will terminate immediately prior
to the consummation of such proposed action, unless otherwise provided by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the event of a
change in control transaction of Exponent, each outstanding right to purchase shares under the ESPP will be assumed or an equivalent
right will be substituted by Exponent&rsquo;s successor corporation or a parent or subsidiary of such successor corporation unless
Exponent&rsquo;s Board determines in lieu of such assumption or substitution that a participant will have the right to exercise
the option as to all the optioned stock. Each Offering Period then in progress will be shortened and a new Purchase Date will
be set (the &ldquo;New Purchase Date&rdquo;), as of which date any Offering Period then in progress will terminate. The New Purchase
Date will be on or before the date of consummation of the change in control and the Administrator will notify each participant
in writing prior to the New Purchase Date, that the Purchase Date for his or her purchase right has been changed to the New Purchase
Date and that his or her purchase right will be fully exercisable on the New Purchase Date, unless prior to such date he or she
has withdrawn from the Offering Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Nontransferability
of Awards.</B>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise determined by the Administrator, purchase rights granted under the ESPP
are not transferable other than by will or the laws of descent and distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Offering Dates.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
ESPP currently consists of a series of three-month offering periods (&ldquo;Offering Periods&rdquo;) commencing on the first business
day of each fiscal quarter of each year and ending on the last business day of the fiscal quarter, with the last day of each Offering
Period being designated a &ldquo;Purchase Date.&rdquo; The Company has the ability to change the timing, duration and structure
of the Offering Periods without seeking stockholder approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Purchase Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;The
purchase price per share at which shares are sold under the ESPP is ninety-five per cent (95%) of the fair market value of the
common stock on the applicable Purchase Date. The fair market value on a given date will be the closing price on the Purchase
Date of a share of Exponent&rsquo;s common stock (or, in the event that the common stock is not traded on such date, on the immediately
preceding trading date). The Board may not provide for a discount greater than 5% from the Purchase Date fair market value. As
of April 4, 2017, the closing price of our common stock was $58.25 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Participation
in the ESPP; Payment of Purchase Price.</B>&nbsp;&nbsp;&nbsp;&nbsp;Eligible employees may participate in the ESPP by completing
a subscription agreement in the form provided by Exponent and filing it with Exponent on a date prescribed by the Administrator
prior to the first business day of the applicable Offering Period. The subscription agreement currently authorizes payroll deductions
of up to fifteen per cent of the participant&rsquo;s eligible compensation. The purchase price of the shares is accumulated by
payroll deductions during the applicable Offering Period. Eligible compensation is defined in the ESPP to include base salary,
wages, commissions, overtime, and paid time off but exclusive of payments for shift premiums, incentive compensation, inventive
payments, bonuses, equity compensation amounts and other compensation. A participant may discontinue his or her participation
in the ESPP at any time during the Offering Period prior to a Purchase Date, and may decrease the rate of his or her payroll deductions
to zero percent once during an ongoing Offering Period by completing and filing a new subscription agreement. Payroll deductions
will commence on the first payroll following the Offering Date and will end on the last payroll paid on or prior to the Purchase
Date of the Offering Period. No interest accrues on the payroll deductions of a participant in the ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Purchase of Stock;
Exercise of Option.</B>&nbsp;&nbsp;&nbsp;&nbsp;By executing a subscription agreement to participate in the ESPP, the participant
accepts the grant of an ESPP option to purchase shares during an Offering Period. The number of shares purchased by a participant
will be determined by dividing the amount of the participant&rsquo;s total payroll deductions for such offering accumulated prior
to the Purchase Date by the purchase price applicable for the Offering Period. Unless the participant&rsquo;s participation is
discontinued, each participant&rsquo;s option for the purchase of shares will be exercised automatically on each Purchase Date
at the applicable price. Notwithstanding the foregoing, no participant will be permitted to purchase shares under the ESPP which
(with all rights to purchase stock under all similar stock plans of Exponent or of a parent or of any of Exponent&rsquo;s subsidiaries)
exceed $25,000 in fair market value, determined as of the Offering Date of the Offering Period in which the participant is participating
during each calendar year in which an option to purchase stock under the ESPP is outstanding. In addition, no participant will
be permitted to purchase more than a specified number of shares on any Purchase Date. The maximum number is currently set at 5,000
shares although the Company can change this limit at its discretion and the per-period share limit will adjust upon a stock split
or similar transaction. Furthermore, if the number of shares which would otherwise be placed under option at the beginning of
an Offering Period exceeds the number of shares then available under the ESPP, a pro rata allocation of the available shares will
be made in as equitable a manner as is practicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Withdrawal.</B>&nbsp;&nbsp;&nbsp;&nbsp;A
participant&rsquo;s interest may be terminated in whole, but not in part, by signing and delivering to Exponent a notice of withdrawal
from the ESPP. Such withdrawal may be elected prior to a Purchase Date under the ESPP under procedures established by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Any withdrawal by
the participant of accumulated payroll deductions for a given Offering Period automatically terminates the participant&rsquo;s
interest in that Offering Period. All of the participant&rsquo;s contributions credited to his or her account will be paid to
him or her promptly after receipt of his or her notice of withdrawal. A participant&rsquo;s withdrawal from an Offering Period
does not have an effect upon such participant&rsquo;s eligibility to participate in subsequent Offering Periods under the ESPP;
however, the participant may not re-enroll in the same Offering Period after withdrawal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Termination of
Employment.</B>&nbsp;&nbsp;&nbsp;&nbsp;Upon termination of the participant&rsquo;s continuous status as an employee prior to a
Purchase Date of an Offering Period for any reason, including retirement or death, the contributions credited to his or her account
will be returned to him or her, without interest, or, in the case of his or her death, to the person or persons entitled thereto,
and his or her option will be automatically terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Amendment and
Termination of the ESPP.</B> The Plan shall continue until the earlier to occur of termination by the Board, issuance of all of
the shares of common stock reserved for issuance under the Plan, or June 1, 2027. The Administrator may amend, alter or discontinue
the ESPP, but Exponent will obtain stockholder approval for any amendment to the ESPP to the extent required by applicable laws
or stock exchange rules. In addition, unless approved by the stockholders of the Company, no such amendment will be made that
would increase the maximum number of shares for which a purchase right may be granted under the ESPP or expand the class of persons
eligible to receive purchase rights under the ESPP. No such action by the Administrator or the stockholders may impair any option
without the written consent of the participant except as described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 32.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">An Offering Period,
or the ESPP, may be terminated by the Administrator on a Purchase Date or by the Administrator&rsquo;s setting a new Purchase
Date with respect to an Offering Period then in progress if the Administrator determines that termination of the ESPP and/or the
Offering Period is in the best interests of Exponent and its stockholders, or if continuation of the ESPP and/or the Offering
Period would cause Exponent to incur accounting charges in connection with the ESPP that the Administrator determines to be contrary
to the best interests of the Company and its stockholders. Without stockholder consent and without regard to whether any participant
rights may be considered to have been adversely affected, the Administrator or a committee may change the Offering Periods, limit
the frequency and/or number of changes in the amount of contributions withheld from a participant&rsquo;s compensation during
an Offering Period, establish the exchange ratio applicable to amounts withheld in a currency other than U.S. dollars, permit
payroll withholding in excess of the amount designated by a participant in order to adjust for delays or mistakes in Exponent&rsquo;s
processing of properly completed withholding elections, change the amount of the discount from the fair market value of a share
for purposes of establishing the purchase price for a future Offering Period, (but subject to the limitation described above)
establish reasonable waiting and adjustment periods and/or accounting and crediting procedures to ensure that amounts applied
toward the purchase of common stock for each participant properly correspond with amounts withheld from the participant&rsquo;s
compensation, and establish such other limitations or procedures as the Administrator determines in its sole discretion advisable
which are consistent with the ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Federal Income
Tax Consequences of the ESPP.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The ESPP, and the
right of participants to make purchases thereunder, is intended to qualify for the federal income tax treatment provided to employee
stock purchase plans and their participants under the provisions of Sections 421 and 423 of the Code. Under these provisions,
no income will be taxable to a participant until the shares purchased under the ESPP are sold or otherwise disposed of. Upon sale
or other disposition of the shares, the participant will generally be subject to tax in a manner that depends upon the holding
period of the shares. If the shares are sold or otherwise disposed of (including by gift) more than two years from the grant date
for (typically the first day of the offering period) and more than one year from the date the shares are purchased, the participant
will recognize ordinary income measured as the lesser of (a) the excess of the fair market value of the shares at the time of
such sale or disposition over the purchase price, or (b) an amount equal to five percent (5%) of the fair market value of the
shares as of the first day of the Offering Period. Any additional gain or loss will be treated as long-term capital gain or loss.
If the shares are sold or otherwise disposed of (including by gift) before the expiration of either of these holding periods,
the participant will recognize ordinary income generally measured as the excess of the fair market value of the shares on the
date the shares are purchased over the purchase price. Any additional gain or loss on such sale or disposition will be long-term
or short-term capital gain or loss, depending on whether or not the disposition occurs more than one year after the date the shares
are purchased. Exponent is not entitled to a deduction for amounts taxed as ordinary income or capital gain to a participant except
to the extent of ordinary income recognized by a participant upon a sale or disposition of shares prior to the expiration of the
holding periods described above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>New ESPP Benefits</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The benefits that
will be received by or allocated to eligible employees under the ESPP cannot be determined at this time because the amount of
contributions set aside to purchase the Shares under the ESPP (subject to the limitations discussed above) is entirely within
the discretion of each participant. If the proposed amendment of the ESPP had been in effect for the prior fiscal year, the Company
does not expect that the number of shares purchased by participants in the ESPP during that year would have been materially different
that the number of shares purchased as set forth in the table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Aggregate Past
Grants Under the ESPP</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In accordance with
SEC rules, the following table sets forth summary information with respect to the number of shares of our common stock purchased
under the ESPP by our named executive officers, all current executive officers as a group, directors, associates of such executive
officer, directors and nominees, each other person who received or is to receive 5% of such options, warrants or rights and all
employees (other than executive officers) as a group as of March 31, 2017<B> </B>for the most recent completed offering period
ended March 31, 2017<B> </B>and under the ESPP for all completed offering periods.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold">Individual or Group</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center">Most Recent<BR> Offering Period</TD><TD NOWRAP STYLE="font-weight: bold">&nbsp;</TD><TD NOWRAP>&nbsp;</TD>
    <TD COLSPAN="2" NOWRAP STYLE="text-align: center"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>All
                                         Offering</B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Periods</B></P></TD><TD NOWRAP>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Paul R. Johnston, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Chief Executive Officer</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Richard L. Schlenker</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left; padding-left: 0.125in; text-indent: -0.125in">Executive Vice President, Chief Financial Officer and Corporate Secretary</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">125</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">9,152</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Catherine Ford Corrigan, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Steven J. Murray, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Group Vice President&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Harri K. Kytomaa, Ph.D.</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: justify">Group Vice President</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,264</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: justify">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current executive officers as a group</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">166</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,055</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All current directors who are not executive officers as a group&#9;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each nominee for election as a director</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each associate of any such director, executive officer or nominees</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Each other person who received or is to receive 5% of such awards</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">All employees, other than executive officers</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,901</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">343,889</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Registration with
the SEC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We intend to file
a Registration Statement on Form S-8 relating to the issuance of shares of common stock under the ESPP amendment with the Securities
and Exchange Commission pursuant to the Securities Act of 1933, as amended, as soon as practicable after approval of the Plan
amendment by our stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Required Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Approval of the amendment
of the 2008 Employee Stock Purchase Plan will require the affirmative vote of a majority of shares present in person or represented
by proxy at the Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD OF DIRECTORS UNANIMOUSLY RECOMMENDS
A VOTE &ldquo;FOR&rdquo; APPROVAL OF THE AMENDMENT OF THE 2008 EMPLOYEE STOCK PURCHASE PLAN.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_042"></A>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL
OWNERS AND MANAGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
indicates beneficial ownership of the Company&rsquo;s common stock as of April 4, 2017. It includes stockholders known by the
Company to beneficially own more than 5% of the Company&rsquo;s common stock, the Company&rsquo;s directors, the executive officers
of the Company named in the Summary Compensation Table, and the directors and executive officers of the Company as a group. A
total of 25,871,157 shares of the Company&rsquo;s common stock were issued and outstanding as of April 4, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Name and Address of Beneficial
    Owners</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Number
    of<BR> Shares Beneficially<BR> Owned (1)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD NOWRAP STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt">Percent
    of<BR> Total (1)</FONT></TD><TD NOWRAP STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; text-align: left"><FONT STYLE="font-size: 10pt">BlackRock, Inc. (2)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">2,867,989</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 10pt">11.1</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">55
    East 52<SUP>nd </SUP>Street</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 10pt">New York, NY 10055</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Neuberger Berman Group LLC (2)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,429,641</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">9.4</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 10pt">1290 Avenue of the Americas</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 10pt">New York, NY 10104</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">The Vanguard Group (2)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2,094,330</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">8.1</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 10pt">100 Vanguard Blvd.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 10pt">Malvern, PA 19355</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Richard L. Schlenker (3)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">321,276</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">1.2</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Paul R. Johnston, Ph.D. (4)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">167,585</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Michael R. Gaulke (5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">91,622</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">John B. Shoven, Ph.D. (5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">29,692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Catherine Ford Corrigan Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">26,232</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Steven J. Murray, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">19,880</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Harri K. Kytomaa, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">17,307</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Karen A. Richardson (5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">8,484</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Debra L. Zumwalt (5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">7,412</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Stephen C. Riggins (5)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">3,296</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">Carol Lindstrom</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"></TD><TD STYLE="text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">All Directors &amp; Executive Officers (16 persons) (6)</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">726,679</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 10pt">2.8</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 10pt">%</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">*</TD><TD STYLE="text-align: justify">Represents less
                                         than one percent of the outstanding common stock of the Company.</TD>
</TR></TABLE>



<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(1)</TD><TD STYLE="text-align: justify">The number and
                                         percentage of shares beneficially owned is determined under rules of the Securities and
                                         Exchange Commission (&ldquo;SEC&rdquo;), and the information is not necessarily indicative
                                         of beneficial ownership for any other purpose. Under SEC rules, beneficial ownership
                                         includes any shares as to which the individual has sole or shared voting power or investment
                                         power and also any shares that the individual has the right to acquire within sixty days
                                         of April 4, 2017, through the exercise of any stock option or other right. The denominator
                                         of the calculation consists of shares the director&rsquo;s and executive officer&rsquo;s
                                         have the right to acquire through the exercise of any stock option or other right within
                                         sixty days of April 4, 2017, plus the Company&rsquo;s total shares outstanding as of
                                         April 4, 2017. Unless otherwise indicated in the footnotes, each person has sole voting
                                         and investment power (or shares such powers with his or her spouse) with respect to the
                                         shares shown as beneficially owned.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(2)</TD><TD STYLE="text-align: justify">Based on information
                                         contained in a report on Schedule 13G/A filed on January 12, 2017 for BlackRock, Inc.,
                                         who has sole voting power over 2,813,031 and sole dispositive power over 2,867,989 shares,
                                         a report on Schedule 13G/A filed with the SEC on February 14, 2017 for Neuberger Berman
                                         Group LLC, who has shared voting and dispositive power over all of these shares, a report
                                         on Schedule 13G/A filed on February 10, 2017 for The Vanguard Group, who has sole voting
                                         power over 50,711 shares, shared voting power over 4,077 shares, sole dispositive power
                                         over 2,040,849 shares and shared dispositive power over 53,481 shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(3)</TD><TD STYLE="text-align: justify">Includes 127,500
                                         shares of common stock subject to options exercisable within sixty days of April 4, 2017.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(4)</TD><TD STYLE="text-align: justify">Includes 106,250
                                         shares of common stock subject to options exercisable within sixty days of April 4, 2017.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(5)</TD><TD STYLE="text-align: justify">Includes 2,146
                                         shares of common stock to be issued upon the conversion of restricted stock units within
                                         sixty days of April 4, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 22.5pt; text-align: center">(6)</TD><TD STYLE="text-align: justify">Includes 233,750
                                         shares of common stock subject to options exercisable within sixty days of April 4, 2017
                                         and 10,730 shares of common stock to be issued upon the conversion of restricted stock
                                         units within sixty days of April 4, 2017.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-align: justify; text-indent: -22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Section 16(a) Beneficial Ownership Reporting Compliance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Company believes
that during fiscal 2016, all filings with the SEC, by its executive officers, directors and 10% stockholders complied with requirements
for reporting ownership or changes in ownership of Company common stock pursuant to Section 16(a) of the Securities Exchange Act
of 1934.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Committee Interlocks and Insider Participation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During fiscal 2016,
Mr. Riggins, Ms. Richardson, Dr. Shoven, and Ms. Zumwalt served as members of the Human Resources Committee. No member of the
Human Resources Committee is or was formerly an officer or an employee of the Company or any of its subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">No interlocking relationship
exists between the Company&rsquo;s Board of Directors or Human Resources Committee and the Board of Directors or Compensation
Committee of any other company, nor has any such interlocking relationship existed in the past.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_043"></A>EXECUTIVE OFFICER COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_044"></A>COMPENSATION DISCUSSION AND ANALYSIS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">This Compensation
Discussion and Analysis explains our compensation philosophy, objectives, policies and practices with respect to our Chief Executive
Officer, our Executive Vice President and Chief Financial Officer and our other three most highly-compensated executive officers,
as determined in accordance with applicable SEC rules and as set out in the &ldquo;Summary Compensation Table&rdquo;. We collectively
refer to these five individuals as our &ldquo;named executive officers.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>General Philosophy.</B>
Our fundamental compensation philosophy is to align management&rsquo;s incentives with the long-term interests of our stockholders,
create a sense of partnership and to provide a retention vehicle. We strive to compensate our named executive officers competitively
with executives and consulting professionals throughout the industry and geographies in which we operate. Executive officer compensation
is based on the performance of the Company, individual achievements and the competitive environment. Individual performance assessments
are based on appraisals of financial performance, professional accomplishments and leadership that meet the level of excellence
demanded. We use a total compensation approach for our named executive officers, in which each element of compensation is reviewed
individually and considered collectively with the other elements of our compensation program to ensure that it is consistent with
the objectives of both that particular element of compensation and our overall compensation program. During our Board and Committee
Meetings on September 29, 2016, we considered the results of the &ldquo;say on pay&rdquo; proposal from our 2016 proxy, on which
98.1% of votes cast by our stockholders were in support of our executive compensation policies and decisions for fiscal 2015. Our
approach for fiscal 2016 on compensation policies and decisions remained consistent with our 2015 approach and no substantial changes
were made during fiscal 2016. Our compensation program consists of the following elements: base salary, bonus, equity compensation
and other benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Board Process.</B>
The responsibility for determining the compensation of our named executive officers has been delegated by the Board of Directors
to the Human Resources Committee (which is hereinafter referred to as the &ldquo;Committee&rdquo;). As described in more detail
below, the Committee&rsquo;s responsibilities include establishing the general compensation policies for all employees and overseeing
the specific compensation for officers of the Company. The Committee regularly reviews these compensation programs and makes adjustments
as appropriate to accomplish its objectives. The Committee met five times during fiscal 2016.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">In the case of the
Chief Executive Officer, the Committee reviews the Chief Executive Officer&rsquo;s written assessment of his performance, evaluates
the performance of the Chief Executive Officer relative to his objectives and determines the appropriate compensation. For the
other executive officers, the Chief Executive Officer evaluates their performance and presents his evaluation and compensation
recommendations to the Committee for review and approval. The Committee also approves all equity compensation grants. The Charter
of the Committee is available on our website at: http://www.exponent.com/corporate-governance/.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Charter of the
Committee provides for the Committee to retain, and terminate as necessary, a compensation consultant. During 2016, the Committee
engaged Compensia, an executive compensation consulting firm, to provide recommendations regarding the framework for performance
objectives, as discussed below, and a group of publicly-traded professional service companies with revenue, operating income and
business focus comparable to Exponent that will be used to develop competitive compensation data for our Chief Executive Officer
and our Executive Vice President and Chief Financial Officer. For fiscal 2016, the Committee reviewed competitive compensation
data for the chief executive officer and chief financial officer of nine publicly-traded professional service companies recommended
by Compensia with revenue, operating income, market capitalization, and business focus comparable to Exponent. Those companies
included The Advisory Board, The Corporate Executive Board, CRA International, Heidrick and Struggles, Huron Consulting Group,
ICF International, Korn/Ferry International, Navigant Consulting, and Resources Connection. There were no changes in comparable
companies from 2015. During 2016, the Committee also reviewed executive compensation survey data compiled by Radford, a compensation
survey provider, for chief executive officers and chief financial officers of publicly-traded companies in Northern California
with annual revenues in the $200 million to $999 million range. The Committee does not target compensation against a specific percentile
or range of percentiles within any peer group, because there are no comparable companies that offer the same technical capability
and breadth of services as Exponent. We use the data for a general understanding of the marketplace. The competitive compensation
data for base salary, total cash compensation and long-term incentives and the executive compensation survey data provided by Radford
were reviewed by the Committee to ensure that the Chief Executive Officer and the Executive Vice President and Chief Financial
Officer&rsquo;s compensation are not outliers relative to the peer group reviewed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation and Risk Management </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; background-color: white">The
Committee does not believe that our executive compensation program encourages excessive or unnecessary risk-taking. By dividing
our executives&rsquo; compensation into three key elements, the Committee believes it has properly weighted the performance compensation
eligible to be earned by our executives appropriately between short-term and long-term goals. Additionally, the annual bonus for
all executive officers is capped at two times their target bonus and 40% of each executive officer&rsquo;s annual bonus is settled
with fully vested restricted stock units that are not delivered for four years. These provisions add protection against disproportionately
large short-term incentives. The primary component of our equity compensation program is restricted stock units which cliff vest
four years from the date of grant. The delayed vesting encourages our executives&rsquo; sustained focus on the long-term performance
of the Company and encourages retention. The Committee believes our executive compensation program promotes proper alignment of
our executives&rsquo; interests with those of the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Elements of Compensation Program</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Base Salary.</B>
We believe that competitive base salaries are necessary to attract and retain management talent critical to achieving our business
objectives. We strive to provide base salaries commensurate with comparable executives at professional service organizations with
similar revenue, operating income, market capitalization, business focus and location and with consulting professionals of similar
background and experience working for both professional service organizations and in private practice. Base salaries are reviewed
annually and adjusted to realign salaries with market levels after taking into account our performance, as well as the individual&rsquo;s
responsibilities, experience and performance. The level of total compensation relative to our other executive officers, senior
scientific and engineering consultants that we hire and those that have left to compete with us are also considered when determining
executive officer base salaries. On July 29, 2016, Exponent&rsquo;s Board of Directors appointed Dr. Catherine Corrigan as its
President. Dr. Paul Johnston continues to serve as the Company&rsquo;s Chief Executive Officer. Upon her appointment as President,
Dr. Corrigan&rsquo;s base salary was set at $550,000. On October 1, 2016, the Committee appointed Dr. Harri Kytomaa as a Group
Vice President. Upon his appointment as a Group Vice President, Dr. Kytomaa&rsquo;s base salary was set at $415,000. Both salaries
reflected a level that the Committee concluded was appropriate based on their experience and comparable compensation data.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Effective April 1,
2017, the annual base salary for Dr. Johnston, Chief Executive Officer, increased 4% from $675,000 to $700,000. Dr. Johnston&rsquo;s
increased annual base salary reflected a level that the Committee concluded was appropriate based upon Dr. Johnston&rsquo;s performance
and the competitive compensation data. Effective April 1, 2017, the annual base salary for Mr. Schlenker, Executive Vice President
and Chief Financial Officer, increased 5% from $440,000 to $460,000. Mr. Schlenker&rsquo;s increased annual base salary reflected
a level that the Committee concluded was appropriate based upon Mr. Schlenker&rsquo;s performance and the competitive compensation
data. Effective April 1, 2017, the annual base salary for Dr. Corrigan, President, increased 5% from $550,000 to $575,000. Dr.
Corrigan&rsquo;s increased annual base salary reflected a level that the Committee concluded was appropriate based upon Dr. Corrigan&rsquo;s
performance during fiscal 2016. Effective April 1, 2017, the annual base salary for Dr. Murray, Group Vice President, increased
7% from $375,000 to $400,000. Dr. Murray&rsquo;s increased annual base salary reflected a level that the Committee concluded was
appropriate based upon Dr. Murray&rsquo;s performance during fiscal 2016. For fiscal 2016, the Committee concluded that the annual
salary for Dr. Kytomaa, Group Vice President of $415,000 was competitive and would not be increased.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Bonus.</B> Annual
bonuses are designed to create an incentive and to reward named executive officers for their contributions to our performance by
making a significant portion of their total compensation variable. Our bonus plan covers all employees, including named executive
officers, and the bonus pool is equal to 33% of our pre-tax income before bonuses, stock-based compensation, realized gain/loss
on foreign exchange and interest income. An additional amount of up to the amount of the Chief Executive Officer&rsquo;s target
bonus may be added to the bonus pool if the Chief Executive Officer&rsquo;s targets for revenue and profit are exceeded, as discussed
below. Our bonus pool has historically been 33% and the Committee determined that this amount was competitive for fiscal 2016.
The total amount available in the bonus pool for fiscal 2016 was $37,120,000. Generally 40% of each named executive officer&rsquo;s
annual bonus is settled with fully vested restricted stock unit awards, rather than cash, to provide a longer term incentive, under
which each executive officer has the right to receive shares of our common stock four years from the date of grant. The remainder
of each executive officer&rsquo;s annual bonus is paid in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Where a named executive
officer has responsibilities for both providing direct consulting services to clients and managing a business unit, his or her
performance is generally weighted toward the direct consulting activities. For a named executive officer who has broader corporate
responsibilities, such as our Executive Vice President and Chief Financial Officer, his performance is based on that officer&rsquo;s
overall contribution to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">On
February 29, 2016 the Committee adopted a performance threshold which, if met or exceeded, will allow bonuses and all restricted
stock unit awards to qualify as performance based compensation eligible for deductibility under Section 162(m). The 2016 performance
threshold was $45 million of EBITDAS </FONT>(EBITDAS is a non-GAAP financial measure defined as net income before income taxes,
interest income, depreciation and amortization and stock-based compensation)<FONT STYLE="font-family: Times New Roman, Times, Serif">,
which must be exceeded prior to the payout of any bonus under this plan and the grant of any restricted stock units under this
plan to our current executive officers. If the $45 million of EBITDAS is exceeded, the Committee can approve a payout of up to
200% of the 2016 target bonus for each executive officer. The 2016 target bonus for the Chief Executive Officer and the Executive
Vice President and Chief Financial Officer was their current base salary plus an additional 40% for matching restricted stock units.
The 2016 target bonus for all of the remaining executive officers was 80% of their current base salary plus an additional 40% for
matching restricted stock units. Actual EBITDAS for fiscal 2016 was $87,903,000, which exceeded the performance threshold and thus
all executive officer bonuses and all restricted stock unit awards granted to executive officers qualify as performance based compensation
eligible for deductibility under Section 162(m).</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For fiscal 2016, the
Chief Executive Officer&rsquo;s performance was evaluated using a process developed with the help of Compensia, based on performance
objectives in three categories: revenue, profitability, and leadership.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><B>Performance
Awards.</B> Our 2008 Equity Incentive Plan authorizes the grant of performance awards to our executive officers. Performance awards
are payable only to the extent certain performance targets, based on objective business criteria specified by the Committee, are
achieved in the relevant measurement period. Performance awards are payable in cash or restricted stock units, at the discretion
of the Committee. At the beginning of each year, the Committee must determine the performance goals and the achievement necessary
for the bonus payout. After the conclusion of the performance period, the Committee certifies (1) the extent to which each executive
officer has achieved the applicable prior fiscal year&rsquo;s performance targets, and (2) the appropriate amount, if any, to be
paid with respect to such performance-based annual incentive award. Even if the performance targets are achieved, the Committee
may reduce the amount of an award through &ldquo;negative discretion&rdquo; and thereby reduce the payment made under a performance
award, but the Committee cannot increase the amount of such award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">On February
29, 2016, the Committee determined the performance award opportunity to be granted to Dr. Johnston, Chief Executive Officer, for
fiscal 2016. In doing so, the Committee established the performance targets, the performance required to achieve payout under the
award and maximum amounts payable under this award. The Committee set the target bonus level and maximum payout at amounts they
believe are competitive. Dr. Johnston&rsquo;s target award was set at $225,000 (one-third of Dr. Johnston&rsquo;s base salary)
with the maximum amount payable set at twice the target. Performance between the applicable targets would be paid on a straight-line
basis. In establishing the target for Dr. Johnston&rsquo;s 2016 performance award, the Committee decided that 60% of the award,
to the extent earned, would be payable in cash and 40% of the award would be payable in fully vested restricted stock units under
which Dr. Johnston has the right to receive shares of our common stock four years from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">Two performance
targets were established. The revenue performance target was a 5% increase in revenues before reimbursements. This target is measured
on a scale of 0 to 2 with 0 being equal to 5% revenue decline, 1 being equal to 5% revenue growth, and 2 being equal to 15% revenue
growth. Performance between the targets is prorated on a straight-line basis. We did not meet this quantitative goal with actual
revenues before reimbursements growth of 1.18%. This resulted in a quantitative performance factor for this objective of 0.62 on
a scale of 0 to 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">The profit
performance target was to meet the adjusted EBITDAS target margin. The adjusted EBITDAS margin is the calculated margin (EBITDAS/revenues
before reimbursements) excluding the realized gain/loss on foreign exchange. The EBITDAS target margin for fiscal 2016 was 29.83%
increased or decreased by five basis points for each 1% of revenue before reimbursements growth above or below 5%. This is also
measured on a scale of 0 to 2 with 0 being equal to 200 basis points below the EBITDAS target margin, 1 being equal to the EBITDAS
target margin, and 2 being equal to 200 basis points above the EBITDAS target margin. We did not meet this quantitative goal and
fell short of the EBITDAS target margin by 33 basis points. This resulted in a quantitative performance factor for this objective
of 0.84 on a scale of 0 to 2.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">On February
16, 2017, the Committee certified and determined the amount payable to Dr. Johnston with respect to the cash and equity components
of his performance award for fiscal 2016. Both of the performance targets were weighted equally. This resulted in a composite performance
factor of 0.73 on a scale of 0 to 2. Accordingly, the formula amount payable for the performance award was $164,000 (target of
$225,000 multiplied by the composite performance factor of 0.73).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in"><B>Qualitative
Bonuses.</B> The target for Dr. Johnston&rsquo;s qualitative bonus was set at $450,000 (two-thirds of Dr. Johnston&rsquo;s base
salary) for fiscal 2016 with the maximum payout set at twice the target. The Committee set the target bonus level and maximum payout
at amounts they believe are competitive. Performance was evaluated based on objectives in three categories: revenue, profitability
and leadership. The performance objectives for revenue and profit are weighted 25% each and the performance objective for leadership
is weighted 50%. The Committee may reduce the qualitative bonus from the target amount at their discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">With respect
to the revenue objective, the determination was based on the judgment of the Committee, taking into consideration factors such
as how well we accomplished strategic growth initiatives and added top talent. For the profit objective, the determination was
based on the judgment of the Committee, taking into consideration factors such as how we were able to control expenses and manage
headcount growth. The leadership objective was based on the judgment of the Committee taking into consideration factors such as
management of enterprise risk and our overall strategic direction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">In determining
the appropriate qualitative bonus, the Committee considered Dr. Johnston&rsquo;s contributions to achieving each of the three objectives.
In making a qualitative assessment of the revenue objective the Committee determined that this objective was not met. Efforts were
made in this area including a focus on strategic growth initiatives and driving our marketing and business development processes
to become more industry focused. However, we did not achieve our anticipated growth. In making a qualitative assessment of the
profit objective the Committee determined that this objective was exceeded. Following the downturn in our business during the second
quarter of 2016 we reduced the size of our consulting staff and slowed our recruiting efforts to protect our profitability. We
successfully maintained our utilization above 70%, which we have done every year since 2010. With respect to the leadership objective,
the Committee recognized that this objective was significantly exceeded due to the management of enterprise risk, the strategic
direction provided, the retention of key Principals and succession planning at the level of President and the Operating Committee.
Based on the Committee&rsquo;s qualitative evaluation, the composite performance factor was 1.30 on a scale of 0 to 2. Accordingly,
the amount payable for the qualitative bonus was $586,000 (target of $450,000 multiplied by the composite performance factor of
1.30). The Committee decided that 60% of the qualitative bonus will be paid in cash and 40% of the qualitative bonus will be settled
with fully vested restricted stock units under which Dr. Johnston has the right to receive shares of our common stock four years
from the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in">The bonuses
for the other named executive officers were determined on a total compensation basis based on their relative contribution to our
overall performance. Where a named executive officer has responsibilities for both providing direct consulting services to clients
and managing a business unit, his or her performance is generally weighted toward the direct consulting activities. The size of
our bonus pool was also considered when determining the annual bonuses for our other named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in; text-align: justify; text-indent: 0.25in"><B>Equity
Compensation.</B> Our equity compensation program is designed to align the named executive officers and stockholders&rsquo; interests,
create a sense of partnership and long-term incentives, provide a mechanism for retention and provide a competitive total compensation
package. We use a combination of restricted stock units and stock options to achieve these objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Generally 40% of each
named executive officer&rsquo;s annual bonus is settled with fully vested restricted stock unit awards. The percentage of each
named executive officer&rsquo;s annual bonus settled with vested restricted stock unit awards may be less than 40% when called
for by the terms of an employment agreement or when other equity grants made were deemed adequate to align named executive officers
and stockholders&rsquo; interests. Under these restricted stock unit awards, each executive officer has the right to receive shares
of our common stock four years from the date of grant. Each named executive officer who received a fully vested restricted stock
unit award is also granted a matching number of unvested restricted stock unit awards. These unvested restricted stock unit awards
cliff vest four years from the date of grant provided the holder has met certain employment conditions. In the case of retirement
at 59 &frac12; years or older, all unvested restricted stock unit awards will continue to vest, provided that the named executive
officer does all consulting work through the Company and does not become an employee for a past or present client (direct or indirect)
or competitor of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our practice is to
determine each named executive officer&rsquo;s bonus and the dollar amount of vested and unvested restricted stock unit awards
following the availability of financial results for the prior year. With the exception of significant promotions and new hires,
we generally grant restricted stock unit awards once a year during the allocation of our bonus pool. For restricted stock unit
awards our 2008 Equity Incentive Plan defines the fair market value of the restricted stock unit awards as the closing price of
our stock on the day of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">During the annual
review process in February 2016, the Committee granted a stock option to purchase 24,000 shares of our common stock to Dr. Johnston,
Chief Executive Officer, and a stock option to purchase 16,000 shares of our common stock to Mr. Schlenker, Executive Vice President
and Chief Financial Officer. These stock option grants reflect levels that the Committee concluded were generally appropriate based
upon past practices within the Company, each individual&rsquo;s total stock ownership and the amount needed to remain competitive.
For stock option awards the exercise price is equal to the closing price of our stock on the date of grant. Our option awards vest
ratably over a four-year period beginning on the grant date, subject to continued employment. All stock option awards continue
to vest in the case of retirement at 59 &frac12; years or older, provided that the named executive officer does all consulting
work through the Company and does not become an employee for a past or present client (direct or indirect) or competitor of the
Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Unvested restricted
stock unit awards and stock options are occasionally granted for select new hires and promotions. On July 29, 2016, Exponent&rsquo;s
Board of Directors appointed Dr. Catherine Corrigan as its President. Dr. Paul Johnston continues to serve as the Company&rsquo;s
Chief Executive Officer. Upon her appointment as President, Dr. Corrigan received a stock option grant for 24,000 shares. This
option grant reflects a level that the Committee concluded was appropriate based upon past practices within the Company, Dr. Corrigan&rsquo;s
total stock ownership and the amount needed to remain competitive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif"><B>Executive
Stock Ownership Guidelines. </B> We believe that the financial interests of our executive officers should be aligned with those
of our stockholders. Our stock ownership guidelines are determined as a multiple of the named executive officer&rsquo;s annual
base salary. Individual guidelines are three times for the Chief Executive Officer, two times for the </FONT>Executive Vice President
and <FONT STYLE="font-family: Times New Roman, Times, Serif">Chief Financial Officer and one time for the other named executive
officers. Stock that counts towards satisfaction of our stock ownership guidelines includes shares owned outright by the named
executive officer or his or her immediate family members residing in the same household or in trust and restricted stock units,
whether or not vested. The value of shares owned outright is Exponent&rsquo;s prior 365-day average closing common stock price.
The value of restricted stock units is the grant date fair value. The calculation is done at the beginning of each year. Named
executive officers are required to achieve their stock ownership guideline within five years of the date the guidelines were adopted.
If a person&rsquo;s stock ownership guideline increases, that person has a five-year period to achieve the new guideline. Until
the guideline is achieved, the person is required to retain at least 50% of the net shares delivered through our Restricted Stock
Unit Program or the exercise of stock options. Net shares refer to those that remain after shares are sold or netted to pay the
exercise price of stock options and withholding taxes. As of April 4, 2017, all the named executive officers met the stock ownership
guidelines or are expected to meet the applicable ownership guidelines within the specified time period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Hedging and Pledging.
</B> Our insider trading policy prohibits directors, officers, and employees from selling short or otherwise engaging in hedging
or offsetting transactions involving Exponent securities, including the trading of those securities on margin. Our policies do
not permit any director or officer, including our named executive officers, to pledge Exponent securities as collateral.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; color: #191919"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #191919"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in; color: #191919"><B>Clawback
Policy.</B> We have a &ldquo;clawback&rdquo; policy for the recovery of excessive incentive-based compensation. In the event that
we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under
the U.S. federal securities laws, we will use reasonable efforts to recover from any current or former officer of the Company who
was paid or granted incentive based compensation and whom the Board has determined has willfully committed an act of fraud, dishonesty
or recklessness in the performance of his or her duties as an officer that contributed to the noncompliance that resulted in the
Company&rsquo;s obligation to prepare the accounting restatement, all excessive incentive-based compensation. Incentive-based compensation
includes the amount of the culpable employee&rsquo;s annual incentive awards paid under our cash incentive program, stock options
and performance-based equity or equity-based awards (or any amount attributable to such awards) paid or granted to the culpable
employee under our long-term incentive equity program, and any other incentive-based compensation paid or granted in respect of
Company and/or individual performance to a culpable employee pursuant to an &ldquo;incentive plan&rdquo; as such term is defined
in Item 402(a)(6)(iii) of Regulation S-K under the Exchange Act. The policy applies to financial statements filed in a rolling
three-year, lookback period. This clawback policy is in addition to any policies or recovery rights that are required under applicable
laws, including the Sarbanes Oxley Act and the Dodd Frank Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; color: #191919">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>No Compensation
Consultant Conflicts of Interest.</B> We are not aware of any conflict of interest that has been raised by the work performed in
2016 by Compensia. During 2016 the Human Resources Committee reviewed the six independence factors enumerated by the Securities
and Exchange Commission and determined that Compensia was independent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Nonqualified Deferred
Compensation.</B> To attract and retain high performing executive officers and consultants we have a nonqualified deferred compensation
plan under which we provide certain highly compensated employees, including the named executive officers, the opportunity to elect
to defer the receipt of compensation. Participants in the plan may elect to defer up to 100% of their compensation including base
salary and bonus. We also retain the discretion to make company contributions for any participant. For additional information,
please refer to the Nonqualified Deferred Compensation table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Other Benefits.</B>
Executive officers participate in our other benefit plans on the same terms as other employees. These plans include medical and
dental insurance, life insurance, an employee stock purchase plan and company contributions to each employee&rsquo;s defined contribution
retirement account. We also provide paid vacation and other paid holidays to all employees, including named executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Tax Deductibility of Pay</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Section 162(m) of
the Internal Revenue Code of 1986, as amended, generally places a limit of $1,000,000 on the amount of annual compensation that
we may deduct in any one year with respect to certain executive officers unless the compensation is qualifying performance-based
compensation where certain requirements are met. It is the intent of the Committee to have bonuses and equity compensation qualify
for full deductibility to the extent feasible and consistent with our overall compensation objectives. Our 2008 Equity Incentive
Plan is designed to enable compensation recognized in connection with bonuses, including performance awards and qualitative bonuses,
and equity compensation, including the exercise of stock options and the settlement of restricted stock units to qualify as performance-based
compensation eligible for deductibility under Section 162(m). Base salary does not qualify as an exception to the deduction limit
under Section 162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">For fiscal 2017 the
Committee established a performance threshold which, if met or exceeded, will allow qualitative bonuses and all restricted stock
unit awards to qualify as performance based compensation eligible for deductibility under Section 162(m). The 2017 performance
threshold is $44 million of EBITDAS, which must be exceeded prior to the payout of any bonus under this plan and the grant of any
restricted stock units under this plan to our current executive officers. If the $44 million of EBITDAS is exceeded, the Committee
can approve a payout of up to 200% of the 2017 target bonus for each executive officer. The 2017 target bonus for the Chief Executive
Officer and the Executive Vice President and Chief Financial Officer is their current base salary plus an additional 40% for matching
restricted stock units. The 2017 target bonus for all of the remaining executive officers is 80% of their current base salary plus
an additional 40% for matching restricted stock units.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Compensation Accounting Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee also
considers the accounting and cash flow implications of various forms of executive compensation. In our financial statements, we
record salaries and bonuses as expenses in the amount paid, or to be paid, to the named executive officers. Accounting rules also
require us to record an expense in our financial statements for equity awards, even though equity awards are not paid as cash to
employees. The Committee believes, however, that the many advantages of equity compensation more than compensate for the non-cash
accounting expense associated with these types of awards. We currently amortize compensation expense associated with equity awards
over an award&rsquo;s requisite service period and establish fair value of equity awards in accordance with applicable accounting
standards. Based upon the structure of our employee stock purchase plan program we are not required to record compensation expenses
for financial statement purposes in connection with employees&rsquo; rights to purchase our stock granted under this program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Potential Payments upon Termination
or Change-in-Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">Our restricted stock
unit award agreements state that in the event of a change in control of the Company, the successor shall assume or substitute equivalent
awards on the same terms and conditions. If the award holder is involuntarily terminated within a two-year period beginning on
the date of the change of control for any reason other than the award holder&rsquo;s failure to substantially perform the duties
of the award holder&rsquo;s position, all awards are vested and settled on the date of termination. <FONT STYLE="font-family: Times New Roman, Times, Serif">Assuming
a change in control and involuntary termination of employment, the value of restricted stock unit awards that would have vested
based on the closing price of our common stock on December 30, 2016 of $60.30 for each named executive officer was as follows:
Dr. Johnston $2,256,487, Mr. Schlenker $1,417,050, Dr. Corrigan $1,201,357, Dr. Murray $836,120, and Dr. Kytomaa $772,503. </FONT>We
do not have any other contracts, agreements (including employment agreements), plans or arrangements, whether written or unwritten,
providing for payments to a named executive officer at, following, or in connection with any termination of a named executive officer
or a change in control or a change in a named executive officer&rsquo;s responsibilities.</P>


<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_045"></A>SUMMARY COMPENSATION TABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
summarizes information regarding compensation earned by our named executive officers during fiscal 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Stock</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Option</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Name and</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Salary ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Bonus ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Awards ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">Awards ($)</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center"><FONT STYLE="font-size: 8pt">All Other</FONT></TD><TD STYLE="font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Principal
    Position</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Year</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(2)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(3)
    (5)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(4)
    (5)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Compensation
    ($)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Total
    ($)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 23%; text-align: left"><FONT STYLE="font-size: 8pt">Paul R. Johnston, Ph.D.</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">668,750</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">450,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">660,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">307,334</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">46,812</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">(6)&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 8%; text-align: right"><FONT STYLE="font-size: 8pt">2,132,896</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Chief Executive Officer</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">644,231</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">495,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">720,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">319,298</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">45,096</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,223,625</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2014</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">619,231</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">540,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">720,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">330,340</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">43,346</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2,252,917</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Richard L. Schlenker</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">435,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">300,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">420,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">204,890</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">30,450</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,390,340</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Executive Vice President,</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">415,385</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">315,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">440,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">212,866</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">29,077</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,412,328</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.25in"><FONT STYLE="font-size: 8pt">Chief Financial Officer
    and Corporate Secretary</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">2014</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">400,000</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">330,000</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">440,000</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">220,226</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">28,000</FONT></TD><TD STYLE="text-align: left; vertical-align: top"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">1,418,226</FONT></TD><TD STYLE="text-align: right; vertical-align: top"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Catherine Ford Corrigan, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">521,346</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">330,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">400,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">324,946</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">123,972</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(7)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,700,264</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 9pt"><FONT STYLE="font-size: 8pt">President</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2015</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">497,692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">300,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">420,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,838</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,252,530</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2014</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">487,692</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">315,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">400,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">34,138</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,236,830</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Steven J. Murray, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">366,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">285,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">360,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">25,637</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">1,036,887</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Group Vice President</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">Harri K.Kytomaa, Ph.D.</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">2016</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">381,250</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">210,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">260,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">-</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">26,687</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(6)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">877,937</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 9pt"><FONT STYLE="font-size: 8pt">Group Vice President</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">The base salaries for our Named Executive Officers took
effect for 2016, 2015 and 2014 on April 2, 2016, March 28, 2015, and March 29, 2014, respectively. As such the amounts in this
column reflect three months at their prior year base salaries and nine months at their current year base salaries. Fiscal 2016,
fiscal 2015, and fiscal 2014 included 52 weeks of activity.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent the value of
cash bonuses earned during the year indicated and paid in the first quarter of the subsequent year, excluding the portion settled
with vested restricted stock unit awards.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent the values of
vested and unvested restricted stock unit awards granted during the year indicated, regardless of when earned. The value of restricted
stock units granted during the first quarter of 2017 to settle a portion of each named executive officer&rsquo;s fiscal 2016 bonus
are not included in this column.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent the Black-Scholes
value calculated for stock options granted during the year indicated, regardless of when earned.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">The values of equity-based awards for these columns represent
the grant date fair value of the awards in accordance with ASC 718. All equity-based awards have dividend equivalent rights (&rdquo;DER&rdquo;),
which entitle the holder of the award to the same dividend value per share as holders of common stock. DER are subject to the
same vesting and other terms and conditions as the corresponding stock award or option award. DER are accumulated and paid when
the underlying stock awards or option awards vest and are forfeited if the underlying stock awards or option awards are forfeited.
See the notes to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 30, 2016
regarding assumptions underlying the valuation of equity awards.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent the value of
Company contributions to each named executive officer&rsquo;s defined contribution retirement account earned during the year indicated.
The Company provides a defined contribution retirement plan for all of its employees whereby the Company contributes to each eligible
employee&rsquo;s account 7% of the employee&rsquo;s eligible base salary plus overtime. These contributions are made to the 401(k)
plan up to the statutory maximum. Any portion of the 7% contribution in excess of the statutory maximum is made to the Company&rsquo;s
nonqualified deferred compensation plan.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(7)</TD><TD STYLE="text-align: justify">The amounts shown in this column include:</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Company contribution to defined contribution retirement account</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&#9;36,494</FONT></TD><TD STYLE="text-align: left">(6)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left">Relocation expenses</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&#9;64,193</FONT></TD><TD STYLE="text-align: left">(8)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt">Tax gross up associated with relocation expenses</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">$&#9;23,285</FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">(8)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 87%; padding-bottom: 2.5pt">Total</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="width: 10%; border-bottom: Black 2.5pt double; text-align: right">123,972</TD><TD STYLE="width: 1%; padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(8)</TD><TD STYLE="text-align: justify">On July 29, 2016, Exponent&rsquo;s Board of Directors appointed
Dr. Catherine Corrigan as its President. Dr. Paul Johnston continues to serve as the Company&rsquo;s Chief Executive Officer.
In connection with this appointment, Dr. Corrigan relocated from our Philadelphia, Pennsylvania office to our Menlo Park, California
office. In connection with the relocation we reimbursed Dr. Corrigan for certain relocation expenses. including a tax gross up
for all taxable relocation expenses.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">In connection with the relocation,
we purchased Dr. Corrigan&rsquo;s primary residence in Pennsylvania for an appraised value of $1.25 million, which we intended
to resell. The house was not sold as of December 30, 2016. On March 13, 2017 we sold the house. The difference between the amount
that we paid for the house and the proceeds from the sale of the house, less selling costs, of $370,000 will be reported as other
compensation for Dr. Corrigan in our 2017 summary compensation table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_046"></A>GRANTS OF PLAN-BASED AWARDS IN FISCAL
2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information regarding grants of plan-based awards to our named executive officers during fiscal 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Name</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Grant
    Date</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Human
    <BR> Resource <BR> Committee <BR> Approval <BR> Date</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">All
    Other Stock <BR> Awards:&nbsp;&nbsp;<BR> Number of <BR> Shares of Stock <BR> or Units (#)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">All
    Other <BR> Option <BR> Awards:&nbsp;&nbsp;<BR> Number of <BR> Securities <BR> Underlying <BR> Options (#) (5)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Exercise
    or <BR> Base Price <BR> of Option <BR> Awards <BR> ($/Sh)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Closing
    Market <BR> Price of <BR> Underlying <BR> Security on <BR> Date of Grant<BR> ($/Sh)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-weight: bold; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Grant
    Date Fair <BR> Value of Stock <BR> and Option <BR> Awards ($) (6)(7)</FONT></TD><TD STYLE="padding-bottom: 1pt; font-weight: bold"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; text-align: left; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">Dr. Johnston</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 12%; text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,076
                                         </FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-size: 8pt">242,000</FONT></TD><TD STYLE="width: 1%; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,835</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(2)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">5,076</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">242,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">1,835</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(4)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">88,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">24,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">307,334</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">Mr. Schlenker</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,398</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">210,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,398</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">210,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/12/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">16,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.26</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">204,890</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">Dr. Corrigan</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,189</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">4,189</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">200,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">07/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">07/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">24,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">50.81</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">50.81</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">324,946</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">Dr. Murray</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,770</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">180,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">3,770</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">180,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">Dr. Kytomaa</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,723</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(1)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">130,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">03/11/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">02/29/2016</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">2,723
                                         </FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">(3)</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">47.75</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">130,000</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Amounts represent the number of fully vested restricted
stock units granted under our 2008 Equity Incentive Plan.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Our 2008 Equity Incentive Plan authorizes the grant of
performance awards to our executive officers. Performance awards are payable only to the extent certain performance targets, based
on objective business criteria specified by the Committee, are achieved in the relevant measurement period. Performance awards
are payable in cash or restricted stock units, at the discretion of the Committee. Amounts represent the number of fully vested
restricted stock units granted by the Committee to settle the equity component of Dr. Johnston&rsquo;s 2015 performance award.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Amounts represent the number of unvested restricted stock
units granted under our 2008 Equity Incentive Plan. These awards cliff vest four years from the date of grant. All unvested restricted
stock units will continue to vest in the case of retirement at 59 &frac12; years or older, provided that the named executive officer
does all consulting work through the Company and does not become an employee for a past or present client (direct or indirect)
or competitor of the Company.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Our 2008 Equity Incentive Plan authorizes the grant of
performance awards to our executive officers. Performance awards are payable only to the extent certain performance targets, based
on objective business criteria specified by the Committee, are achieved in the relevant measurement period. Performance awards
are payable in cash or restricted stock units, at the discretion of the Committee. Amounts represent the number of unvested restricted
stock units granted by the Committee to settle the equity component of Dr. Johnston&rsquo;s 2015 performance award. These awards
cliff vest four years from the date of grant. All unvested restricted stock units will continue to vest in the case of retirement
at 59 &frac12; years or older, provided that the named executive officer does all consulting work through the Company and does
not become an employee for a past or present client (direct or indirect) or competitor of the Company.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Amounts represent options granted under our 2008 Equity
Incentive Plan. These options become exercisable over a period of four years at a rate of 25% per year, subject to continued employment,
and expire 10 years from the date of grant. All stock options will continue to vest in the case of retirement at 59 &frac12; years
or older, provided that the named executive officer does all consulting work through the Company and does not become an employee
for a past or present client (direct or indirect) or competitor of the Company.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">The amounts shown in this column represent the Black-Scholes
value calculated for stock options granted.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0; text-align: justify"></TD><TD STYLE="width: 0.25in; text-align: justify">(7)</TD><TD STYLE="text-align: justify">The values of equity-based awards for this column represent
the grant date fair value of the awards in accordance with ASC 718. All equity-based awards have dividend equivalent rights (&ldquo;DER&rdquo;),
which entitle the holder of the award to the same dividend value per share as holders of common stock. DER are subject to the
same vesting and other terms and conditions as the corresponding stock award or option award. DER are accumulated and paid when
the underlying stock awards or option awards vest and are forfeited if the underlying stock awards or option awards are forfeited.
See the notes to our consolidated financial statements in our Annual Report on Form 10-K for the year ended December 30, 2016
regarding assumptions underlying the valuation of equity awards.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Restricted Stock
Unit Awards. </B>Each of the named executive officers were awarded the number of vested and unvested restricted stock unit awards
as shown in the table above. The number of fully vested restricted stock unit awards granted was determined by dividing the portion
of each named executive officer&rsquo;s 2015 bonus designated for settlement in fully vested restricted stock units by the closing
price of our common stock on the day of the grant. An equal number of matching unvested restricted stock unit awards were also
granted to each named executive officer. For financial statement reporting purposes the value of these awards is amortized over
the shorter of the four-year vesting period or the period between the grant date and the date the award recipient turns 59 &frac12;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Stock Options.
</B>Certain of the named executive officers were awarded stock options as shown in the table above. The exercise price of these
stock options was equal to the closing price of our common stock on the date of grant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="a_047"></A>OUTSTANDING EQUITY
AWARDS AT FISCAL 2016 YEAR-END </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information regarding each named executive officer&rsquo;s outstanding equity awards as of December 30, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="14" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Awards</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="5" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Stock Awards</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Securities <BR> Underlying <BR> Unexercised <BR> Options (#) <BR> Exercisable</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Securities <BR> Underlying <BR> Unexercised Options <BR> (#) Unexercisable</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option <BR> Exercise <BR> Price ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option <BR> Expiration <BR> Date</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of <BR> Shares or Units <BR> of Stock That <BR> Have Not Vested <BR> (#)</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Market Value <BR> of Shares or <BR> Units of Stock <BR> That Have Not <BR> Vested ($) (1)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 14%; text-align: left; padding-left: 0.7pt">Dr. Johnston</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right">&nbsp;</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 12%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,000 </FONT></TD><TD STYLE="width: 1%; text-align: left">(2)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">47.26</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/12/2026</FONT></TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 13%; text-align: right; padding-left: 0.7pt">6,911</TD><TD STYLE="width: 1%"> (7)</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 11%; text-align: right">416,733</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">6,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,000</FONT></TD><TD STYLE="text-align: left">(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44.20</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/13/2025</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">8,222</TD><TD> (8)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">495,787</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">13,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">13,500</FONT></TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/07/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">9,632 </TD><TD> (9)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">580,810</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24,750</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,250</FONT></TD><TD STYLE="text-align: left">(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2023</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">12,656</TD><TD> (10)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">763,157</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">30,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24.14</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/09/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.86</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Mr. Schlenker</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">16,000</FONT></TD><TD STYLE="text-align: left">(2)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">47.26</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/12/2026</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">4,398</TD><TD> (7)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">265,199</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">12,000</FONT></TD><TD STYLE="text-align: left">(3)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">44.20</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/13/2025</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">5,026</TD><TD> (8)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">303,068</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">9,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">9,000</FONT></TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35.40</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/07/2024</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">5,886</TD><TD> (9)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">354,926</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">16,500</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,500</FONT></TD><TD STYLE="text-align: left">(5)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25.02</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/15/2023</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">8,190</TD><TD> (10)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">493,857</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">20,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">24.14</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/09/2022</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">25,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18.86</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/2021</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">35,000</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">12.98</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">02/11/2020</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Corrigan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">24,000</FONT></TD><TD STYLE="text-align: left">(6)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">50.81</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">07/29/2026</FONT></TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">4,189</TD><TD> (7)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">252,597</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">4,798</TD><TD> (8)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">289,319</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">5,352</TD><TD> (9)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">322,726</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt"> </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">5,584</TD><TD> (10)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">336,715</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Murray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">3,770</TD><TD> (7)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">227,331</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">3,656 </TD><TD> (8)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">220,457</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">2,810</TD><TD> (9)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">169,443</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">3,630</TD><TD> (10)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">218,889</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Kytomaa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">2,723</TD><TD> (7)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">164,197</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">2,514</TD><TD> (8)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">151,594</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">3,478</TD><TD> (9)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">209,723</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right; padding-left: 0.7pt">4,096</TD><TD> (10)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">246,989</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Value is determined based on the closing price of our common
stock on December 30, 2016 of $60.30 per share.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">Four-year vesting at a rate of 25% per year, subject to
continued employment. Options fully vest on February 12, 2020.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify">Four-year vesting at a rate of 25% per year, subject to
continued employment. Options fully vest on February 13, 2019.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify">Four-year vesting at a rate of 25% per year, subject to
continued employment. Options fully vest on February 7, 2018</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Four-year vesting at a rate of 25% per year, subject to
continued employment. Options fully vest on February 15, 2017.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">Four-year vesting at a rate of 25% per year, subject to
continued employment. Options fully vest on July 29, 2020.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(7)</TD><TD>Stock awards cliff vest on March 11, 2020.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(8)</TD><TD>Stock awards cliff vest on March 13, 2019.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(9)</TD><TD>Stock awards cliff vest on March 14, 2018.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left">(10)</TD><TD>Stock awards cliff vest on March 15, 2017.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="a_048"></A>OPTION EXERCISES AND
STOCK VESTED IN FISCAL 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information for each named executive officer regarding options exercised and restricted stock units vested during fiscal
2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20pt; text-align: justify; text-indent: -20pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="6" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Option Awards </TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="4" STYLE="text-align: center; border-bottom: Black 1pt solid"><B>Stock Awards</B></TD><TD STYLE="text-align: center; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Shares <BR> Acquired on <BR> Exercise (#)</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value Realized on <BR> Exercise ($)</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of Shares <BR> Acquired on Vesting <BR> (#)</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Value Realized <BR> on Vesting ($)</TD><TD STYLE="font-weight: bold; text-align: center; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 20%; text-align: left">Dr. Johnston</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; text-align: right">30,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; text-align: right">999,422</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 19%; text-align: right">6,911 </TD><TD STYLE="width: 1%">(1)</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 17%; text-align: right">330,000</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">26,021</TD><TD>(2)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">1,245,885</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD></TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Mr. Schlenker</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">4,398</TD><TD>(1)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">210,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">17,347</TD><TD>(2)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">830,574</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Corrigan</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">4,189</TD><TD>(1)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">200,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">10,410 </TD><TD>(2)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">498,431</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Murray</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">3,770 </TD><TD>(1)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">180,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">7,158 </TD><TD>(2)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">342,725</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left">Dr. Kytomaa</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">2,723</TD><TD>(1)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">130,000</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: right">13,878</TD><TD>(2)</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">664,479</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">The amounts shown represent fully vested restricted stock
units granted on March 11, 2016 to settle a portion of each named executive officer's 2015 bonus.</TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify">The amounts shown represent unvested restricted stock unit
awards granted on March 9, 2012 that vested and were settled on March 9, 2016.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>


<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><B><A NAME="a_049"></A>NONQUALIFIED DEFERRED
COMPENSATION IN FISCAL 2016</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth information regarding activity in our nonqualified deferred compensation plan for each named executive officer during
fiscal 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Name</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Executive <BR> Contributions in <BR> 2016 ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Registrant <BR> Contributions in <BR> 2016 ($) (1)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate <BR> Earnings in <BR> 2016 ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate <BR> Withdrawals/ <BR> Distributions in <BR> 2016 ($)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Aggregate <BR> Balance at <BR> 12/30/16 ($) (2)</TD><TD STYLE="padding-bottom: 1pt; font-weight: bold">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: right">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 35%; text-align: left; padding-left: 0.7pt">Dr. Johnston </TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">478,124</FONT></TD><TD STYLE="width: 1%; text-align: left">(3)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">28,229</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">231,048</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">-</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,864,778</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Mr. Schlenker </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">11,604</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">4,633</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">40,502</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Corrigan </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif">50,000</FONT></TD><TD STYLE="text-align: left">(4)</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">17,607</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">64,280</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">945,135</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Murray </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">5,694</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">18,875</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">213,729</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-left: 0.7pt">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-left: 0.7pt">Dr. Kytomaa </TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">7,619</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">247</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">-</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">221,369</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
Company provides a defined contribution retirement plan for all of it employees whereby the Company contributes to each eligible
employee&rsquo;s account 7% of the employee&rsquo;s eligible base salary plus overtime. These contributions are made to the 401(k)
plan up to the statutory maximum. Any portion of the 7% contribution in excess of the statutory maximum is made to the Company&rsquo;s
nonqualified deferred compensation plan. Amounts represent Company contributions to the nonqualified deferred compensation plan
associated with the defined contribution retirement plan.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
aggregate balance at December 30, 2016 was fully vested for all named executive officers. Each named executive officer who participates
in the nonqualified deferred compensation plan chooses from a number of investment vehicles available under the plan. Earnings
are credited based on earnings of the investment options selected by the participant.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount
represents the portion of Dr. Johnston&rsquo;s 2015 bonus, disclosed in the Summary Compensation Table, that the employee elected
to contribute to the deferred compensation plan.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Amount
represents the portion of Dr. Corrigan&rsquo;s 2016 salary, disclosed in the Summary Compensation Table, that the employee elected
to contribute to the deferred compensation plan.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 19.5pt; text-align: justify; text-indent: -19.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_050"></A>EQUITY COMPENSATION PLAN INFORMATION
IN FISCAL 2016</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
sets forth certain information regarding securities authorized for issuance under the Company&rsquo;s equity compensation plans
during the fiscal year ended December 30, 2016. The equity compensation plans of the Company include the 2008 Equity Incentive
Plan and the 2008 Employee Stock Purchase Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The 2008 Equity Incentive
Plan and the 2008 Employee Stock Purchase Plan were both approved by the Company&rsquo;s stockholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The following table
summarizes the Company&rsquo;s equity compensation plans as of December 30, 2016:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Plan category</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of securities <BR> to be issued upon <BR> exercise of <BR> outstanding options, <BR> warrants and rights</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Weighted-average <BR> exercise price of <BR> outstanding <BR> options, warrants <BR> and rights</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1pt solid">Number of securities <BR> remaining available for <BR> future issuance under <BR> equity compensation plans <BR> (excluding securities <BR> reflected in the first <BR> column)</TD><TD STYLE="font-weight: bold; padding-bottom: 1pt">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD NOWRAP STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD>
    <TD NOWRAP COLSPAN="2" STYLE="text-align: center">&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 61%; text-align: left; text-indent: -0.1in; padding-left: 0.1in">Equity compensation plans approved by security holders</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">1,687,889</TD><TD STYLE="width: 1%; text-align: left">(1)</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">$</TD><TD STYLE="width: 10%; text-align: right">31.58</TD><TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 1%">&nbsp;</TD>
    <TD STYLE="width: 1%; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; text-align: right">753,041</TD><TD STYLE="width: 1%; text-align: left">(2)</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; text-indent: -0.1in; padding-left: 0.1in">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD><TD>&nbsp;</TD>
    <TD STYLE="text-align: left">&nbsp;</TD><TD STYLE="text-align: right">&nbsp;</TD><TD STYLE="text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-align: left; padding-bottom: 1pt; text-indent: -0.1in; padding-left: 0.1in">Equity compensation plans not approved by security holders</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; text-align: right">-</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
<TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: left; padding-bottom: 2.5pt; padding-left: 0.25in">Total</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">1,687,889</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 2.5pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">31.58</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 2.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 2.5pt double; text-align: right">753,041</TD><TD STYLE="padding-bottom: 2.5pt; text-align: left">&nbsp;</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-weight: normal">(1)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Includes 695,314 shares
of common stock issuable to settle unvested restricted stock unit awards. Includes 673,575 shares of common stock issuable to
settle fully vested restricted stock unit awards. No weighted average exercise price has been assumed for these shares in the
table above.</FONT></TD>
</TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-weight: normal">(2)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-weight: normal">Includes 43,123 shares
which are reserved for issuance under the 2008 Employee Stock Purchase Plan.</FONT></TD>
</TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: center"><A NAME="a_051"></A>REPORT OF THE HUMAN RESOURCES
COMMITTEE OF THE BOARD OF DIRECTORS</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>The following report
of the Human Resources Committee of the Board of Directors does not constitute soliciting material and should not be considered
filed or incorporated by reference into any other Company filing under the Securities Act of 1933 or the Securities Exchange Act
of 1934, except to the extent the Company specifically incorporates this Report by reference therein.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Human Resources
Committee of the Board of Directors oversees the general compensation policies for all employees and the specific compensation
plans for officers of the Company, including the Chief Executive Officer. The Committee is composed of five independent non-employee
directors. No executive officers of the Company are included on the Human Resources Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The Committee has
reviewed and discussed with management the Compensation Discussion and Analysis, and based on the review and discussion, the Committee
recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-size: 10pt">Members of the Human Resources Committee</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">&nbsp;</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Debra L. Zumwalt, Chairperson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Carol Lindstrom</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Karen A. Richardson</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">Stephen C. Riggins</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-size: 10pt">John B. Shoven, Ph.D.</FONT></TD></TR>
</TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 250pt; text-indent: -10pt"></P>


<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_052"></A>CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Indemnification Agreements </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">We are a party to
indemnification agreements with our directors and executive officers for the indemnification of and advancement of expenses to
these persons to the fullest extent permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Exponent Engineering </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;In January 2006,
we entered into a services agreement with Exponent Engineering, P.C., a California professional corporation that is qualified to
do business in the States of New York, Michigan, and North Carolina, in order to facilitate the provision of professional engineering
services in these states. Pursuant to the agreement, we provide all professional and administrative services required by Exponent
Engineering. In exchange for these services, Exponent Engineering will deliver to us all amounts or other consideration received
by Exponent Engineering resulting from the provision of these professional services. The shareholders of Exponent Engineering are
Paul Johnston, Ph.D., Robert Caligiuri, Ph.D., and John Osteraas, Ph.D. Drs. Johnston, Caligiuri, and Osteraas are all officers
of Exponent. However, none of these officers receive any compensation for their participation in Exponent Engineering and have
no financial interest in the securities of Exponent Engineering. During fiscal 2016 we received $9,163,000 of consideration from
Exponent Engineering under this services agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Audit Committee Approval Procedures</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;The Audit Committee
of the Board of Directors is responsible for reviewing and approving all related party transactions in accordance with its charter
and based on the facts and circumstances of each particular situation. Related party transactions subject to review and approval
of the Audit Committee include, without limitation, those that are required to be disclosed under applicable SEC and NASDAQ rules.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_053"></A>OTHER MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;The Company knows
of no other matters that will be brought before the Annual Meeting. However, if any such matters are properly presented before
the Annual Meeting, it is the intention of the persons named in the Notice to vote the shares they represent as the Board of Directors
may recommend. It is important that your shares be represented at the Annual Meeting, regardless of the number of shares that you
hold. You are therefore urged to vote by phone, vote via the internet or submit your proxy by mail if you elected to receive printed
proxy materials at your earliest convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;<B>Notice Regarding
the Internet Availability of Proxy Materials for the 2017 Annual Meeting.</B> This proxy statement and our 2016 Annual Report on
Form 10-K for the fiscal year ended December 30, 2016, as filed with the SEC, will be available at: www.edocumentview.com/EXPO
on or about April 18, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>&#9;Stockholder
Proposals and Nominations for the 2018 Annual Meeting. </B>Stockholders are entitled to present proposals for action at a forthcoming
meeting if they comply with the requirements of the proxy rules promulgated by the Securities and Exchange Commission and our Bylaws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><I>&#9;Stockholder-Initiated
Proposals and Nominations for 2018 Annual Meeting </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;<U>Proposals Submitted
under SEC Rules</U>. Stockholder-initiated proposals (other than director nominations) may be eligible for inclusion in our Proxy
Statement for next year&rsquo;s 2018 Annual Meeting (in accordance with SEC Rule 14a-8) and for consideration at the 2018 Annual
Meeting. Our Secretary must receive a stockholder proposal no later than the close of business on December 19, 2017 for the proposal
to be eligible for inclusion. Any stockholder interested in submitting a proposal or nomination is advised to contact legal counsel
familiar with the detailed securities law requirements for submitting proposals or nominations for inclusion in a company&rsquo;s
proxy statement. Proposals should be sent to us at: Exponent, Inc., 149 Commonwealth Drive, Menlo Park, CA 94025, Attention: Corporate
Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;<U>Proposals and
Nominations under Company Bylaws</U>. Stockholders may also submit proposals for consideration, and nominations of director candidates
for election, at the 2018 Annual Meeting by following certain requirements set forth in our Bylaws. The current applicable provisions
of our Bylaws are described below. Proposals will not be eligible for inclusion in the 2018 Proxy Statement unless they are submitted
in compliance with then applicable SEC rules as referenced above; however, they will be presented for discussion at our 2018 Annual
Meeting if the requirements established by our Bylaws for stockholder proposals and nominations have been satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;For nominations
and proposals which are intended to be presented at the 2018 Annual Meeting but not intended to be included in our 2018 Proxy Statement,
the stockholder must provide the information required by our Bylaws and give timely notice to our Corporate Secretary in accordance
with our Bylaws, which, in general, require that the notice be received by our Corporate Secretary:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">not earlier than the close of business
on January 18, 2018; and</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">not later than the close of business on
February 17, 2018.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&#9;For a full description
of the requirements for submitting a proposal or nomination, see our Bylaws. Submissions or questions should be sent to us at:
Exponent, Inc., 149 Commonwealth Drive, Menlo Park, CA 94025, Attention: Corporate Secretary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"><B>Proxy Solicitation
Costs. </B>The cost of soliciting proxies will be borne by the Company. The Company may reimburse brokerage firms and other persons
representing beneficial owners of shares for their expenses in forwarding solicitation materials to such beneficial owners. Proxies
may be solicited by certain Company directors, officers and regular employees, without additional compensation, by personal conversation,
telephone, telegram, letter, electronically, or by facsimile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">&nbsp;</TD>
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif">FOR THE BOARD OF DIRECTORS</FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><IMG SRC="pg59img1-.jpg" ALT="">&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif">Richard L. Schlenker, <I>Corporate Secretary</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Menlo Park, California</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">April 18, 2017</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="a_054"></A>APPENDIX A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">FORM OF AMENDMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXPONENT INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">AMENDED AND RESTATED 2008 EQUITY INCENTIVE
PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In accordance with
Section&nbsp;15 of the 2008 Plan, the 2008 Plan is hereby amended effective June 1, 2017 to include the following changes and additions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">1.&nbsp;&nbsp;&nbsp;&nbsp;By
substituting the following for the first sentence of subsection 3(a) of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 2.25pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;Subject to the provisions
of Section 14 of the Plan, the maximum aggregate number of Shares that may be sold or issued under the Plan is 5,928,150 shares
of Common Stock.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">2.&nbsp;&nbsp;&nbsp;&nbsp;By
adding the following after the second sentence of the second paragraph of subsection 3(a) of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;In addition, Shares which
are not issued under a net settled Stock Appreciation Right shall not become available for re-issuance thereafter under the Plan.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">3.&nbsp;&nbsp;&nbsp;&nbsp;By
adding the following as the last sentence of the second paragraph of subsection 3(a) of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;For the avoidance of doubt,
any Shares purchased by the Company on the open market using the proceeds from the payment of the exercise price during an Option
exercise shall not increase the maximum number of Shares that may be sold or issued under the Plan.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">4.&nbsp;&nbsp;&nbsp;&nbsp;By
adding the following paragraph to the end of section 13 of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;(h) <I>Dividend and Dividend
Equivalents</I>.&nbsp;&nbsp;&nbsp;&nbsp;In no event will any dividend or dividend equivalent payments be paid or delivered to a
Participant prior to the vesting of the underlying Award. For the avoidance of doubt, the Administrator may provide in an Award
Agreement that dividend or dividend equivalents on an underlying Award may be credited to a Participant prior to the vesting date,
but not paid or delivered prior to such vesting date. In such case, the dividend or dividend equivalents shall be subject to the
same vesting conditions as the underlying Award.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 37.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPONENT, INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>AMENDED AND RESTATED 2008 EQUITY INCENTIVE
PLAN (AS PROPOSED TO BE AMENDED)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>1.</B></TD><TD><B>Purposes of the Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The purpose of this
Plan is to encourage ownership in Exponent, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), by key personnel whose
long-term employment or other service relationship with the Company is considered essential to the Company&rsquo;s continued progress
and, thereby, encourage recipients to act in the stockholders&rsquo; interest and share in the Company&rsquo;s success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>2.</B></TD><TD><B>Definitions.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">As used herein, the following
definitions shall apply:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&ldquo;<B>Administrator&rdquo;</B>&nbsp;means
the Committee or delegate as shall be administering the Plan in accordance with Section&nbsp;4 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&ldquo;<B>Affiliate&rdquo;</B>&nbsp;means
any entity that is directly or indirectly controlled by the Company or any entity in which the Company has a significant ownership
interest as determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;<B>&ldquo;Applicable
Laws&rdquo;</B>&nbsp;means the requirements relating to the administration of stock option and stock award plans under U.S. federal
and state laws, any stock exchange or quotation system on which the Company has listed or submitted for quotation the Common Stock
to the extent provided under the terms of the Company's agreement with such exchange or quotation system and, with respect to Awards
subject to the laws of any foreign jurisdiction where Awards are, or will be, granted under the Plan, the laws of such jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;<B>&ldquo;Award&rdquo;</B>&nbsp;means
a Cash Award, Stock Award or Option granted in accordance with the terms of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(e)&nbsp;&nbsp;&nbsp;<B>&ldquo;Awardee&rdquo;</B>&nbsp;means
an Employee, Consultant or Director of the Company or any Affiliate who has been granted an Award under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(f)&nbsp;&nbsp;&nbsp;<B>&ldquo;Award
Agreement&rdquo;</B>&nbsp;means a Cash Award Agreement, Stock Award Agreement and/or Option Agreement, which may be in written
or electronic format, in such form and with such terms and conditions as may be specified by the Administrator, evidencing the
terms and conditions of an individual Award. Each Award Agreement is subject to the terms and conditions of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(g)&nbsp;&nbsp;&nbsp;<B>&ldquo;Board&rdquo;</B>&nbsp;means
the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(h)&nbsp;&nbsp;&nbsp;&ldquo;<B>Cash
Award</B>&rdquo; means a bonus opportunity awarded under Section 12 pursuant to which an Awardee may become entitled to receive
an amount based on the satisfaction of such performance criteria as are specified in the agreement or other documents evidencing
the Award (the &ldquo;<B>Cash Award Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(i)&nbsp;&nbsp;&nbsp;<B>&ldquo;Cause&rdquo;
</B>means, unless such term or an equivalent term is otherwise defined with respect to an Award by the Participant&rsquo;s Cash
Award Agreement, Option Agreement, Stock Award Agreement or written contract of employment or service, any of the following: (i)
the Participant&rsquo;s theft, dishonesty, willful misconduct, breach of fiduciary duty for personal profit, or falsification of
any Company or Affiliate documents or records; (ii) the Participant&rsquo;s material failure to abide by a Company&rsquo;s or Affiliate&rsquo;s
code of conduct or other policies (including without limitation, policies relating to confidentiality and reasonable workplace
conduct); (iii)&nbsp;the Participant&rsquo;s unauthorized use, misappropriation, destruction or diversion of any tangible or intangible
asset or corporate opportunity of the Company or an Affiliate (including, without limitation, the Participant&rsquo;s improper
use or disclosure of confidential or proprietary information); (iv)&nbsp;the Participant&rsquo;s violation of any noncompetition
agreement with the Company or an Affiliate; (v)&nbsp;any intentional act by the Participant which has a material detrimental effect
on the Company or an Affiliate&rsquo;s reputation or business; (vi)&nbsp;the Participant&rsquo;s repeated failure or inability
to perform any reasonable assigned duties after written notice from the Company or an Affiliate, and a reasonable opportunity to
cure, such failure or inability; (vii)&nbsp;any material breach by the Participant of any employment or service agreement between
the Participant and the Company or an Affiliate, which breach is not cured pursuant to the terms of such agreement; or (vii) the
Participant&rsquo;s conviction (including any plea of guilty or nolo contendere) of any criminal act involving fraud, dishonesty,
misappropriation or moral turpitude, or which impairs the Participant&rsquo;s ability to perform his or her duties with the Company
or an Affiliate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 61; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(j)&nbsp;&nbsp;&nbsp;&nbsp;<B>&ldquo;Change
in Control&rdquo;</B>&nbsp;means, unless such term or an equivalent term is otherwise defined with respect to an Award by the Participant&rsquo;s
Cash Award Agreement, Option Agreement, Stock Award Agreement or written contract of employment or service, the consummation of
any of the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;an
Ownership Change Event or a series of related Ownership Change Events (collectively, a &ldquo;<B>Transaction</B>&rdquo;) in which
the stockholders of the Company immediately before the Transaction do not retain immediately after the Transaction, in substantially
the same proportions as their ownership of shares of the Company&rsquo;s voting stock immediately before the Transaction, direct
or indirect beneficial ownership of more than fifty percent (50%) of the total combined voting power of the outstanding voting
securities of the Company or such surviving entity immediately outstanding after the Transaction, or, in the case of an Ownership
Change Event described in Section 2(ee)(iii), the entity to which the assets of the Company were transferred (the &ldquo;<B>Transferee</B>&rdquo;),
as the case may be; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;the
liquidation or dissolution of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">For purposes of the preceding
sentence, indirect beneficial ownership shall include, without limitation, an interest resulting from ownership of the voting securities
of one or more corporations or other business entities which own the Company or the Transferee, as the case may be, either directly
or through one or more subsidiary corporations or other business entities. The Board shall have the right to determine whether
multiple sales or exchanges of the voting securities in the Company or multiple Ownership Change Events are related, and its determination
shall be final, binding and conclusive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(k)&nbsp;&nbsp;&nbsp;<B>&ldquo;Code&rdquo;</B>&nbsp;means
the United States Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(l)&nbsp;&nbsp;&nbsp;<B>&ldquo;Committee&rdquo;</B>&nbsp;mean
the Human Resources Committee of the Board or a committee of Directors appointed by the Board in accordance with Section&nbsp;4
of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(m)&nbsp;&nbsp;&nbsp;<B>&ldquo;Common
Stock&rdquo;</B>&nbsp;means the common stock of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(n)&nbsp;&nbsp;&nbsp;<B>&ldquo;Company&rdquo;</B>&nbsp;means
Exponent, Inc., a Delaware corporation, or its successor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(o)&nbsp;&nbsp;&nbsp;<B>&ldquo;Consultant&rdquo;</B>
means any person engaged by the Company or any Affiliate to render services to such entity as an advisor or consultant.<B>&nbsp;&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(p)&nbsp;&nbsp;&nbsp;<B>&ldquo;Conversion
Award&rdquo;&nbsp;</B>has the meaning set forth in Section&nbsp;4(b)(xi)&nbsp;of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(q)&nbsp;&nbsp;&nbsp;<B>&ldquo;Director&rdquo;</B>&nbsp;means
a member of the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(r)&nbsp;&nbsp;&nbsp;<B>&ldquo;Effective
Date&rdquo; </B>means the date of approval of the Plan by the stockholders of the Company in the manner and to the extent required
by Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(s)&nbsp;&nbsp;&nbsp;<B>&ldquo;Employee&rdquo;</B>&nbsp;means
a regular, active employee of the Company or any Affiliate, including an Officer and/or Inside Director. The Administrator shall
determine whether or not the Chairman of the Board qualifies as an &ldquo;Employee.&rdquo; Within the limitations of Applicable
Law, the Administrator shall have the discretion to determine the effect upon an Award and upon an individual's status as an Employee
in the case of (i)&nbsp;any individual who is classified by the Company or its Affiliate as leased from or otherwise employed by
a third party or as intermittent or temporary, even if any such classification is changed retroactively as a result of an audit,
litigation or otherwise, (ii)&nbsp;any leave of absence approved by the Company or an Affiliate, (iii)&nbsp;any transfer between
locations of employment with the Company or an Affiliate or between the Company and any Affiliate or between any Affiliates, (iv)&nbsp;any
change in the Awardee's status from an Employee to a Consultant or Director, and (v)&nbsp;at the request of the Company or an Affiliate
an Employee becomes employed by any partnership, joint venture or corporation not meeting the requirements of an Affiliate in which
the Company or an Affiliate is a party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 62; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(t)&nbsp;&nbsp;&nbsp;<B>&ldquo;Exchange
Act&rdquo;</B>&nbsp;means the Securities Exchange Act of 1934, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(u)&nbsp;&nbsp;&nbsp;<B>&ldquo;Fair
Market Value&rdquo;</B>&nbsp;means, as of any date, the value of a share of Common Stock determined as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;If
the Common Stock is listed on any established stock exchange or a national market system, including without limitation the Nasdaq
Global Market or The Nasdaq Global Select Market, its Fair Market Value shall be the closing price for the Common Stock as quoted
on such exchange or system on the date of determination, or if the Shares are not trading on such date, then the closing price
for the Common Stock on the last preceding trading day on which sales of the Shares are reported as having occurred, as reported
in The Wall Street Journal or such other source as the Administrator deems reliable;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;If
the Common Stock is regularly quoted by a recognized securities dealer but selling prices are not reported, the Fair Market Value
of a Share of Common Stock shall be the mean between the closing high bid and low asked prices for the Common Stock on the date
of determination, or if no prices are quoted for such date, then the mean between the closing high bid and low asked prices on
the last preceding trading day on which any bid and asked prices were quoted, as reported in The Wall Street Journal or such other
source as the Administrator deems reliable; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;In
the absence of an established market for the Common Stock, the Fair Market Value shall be determined in good faith by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(v)&nbsp;&nbsp;&nbsp;<B>&ldquo;Grant
Date&rdquo;</B>&nbsp;means, for all purposes, the date on which the Administrator approves the grant of an Award, or such later
date as is determined by the Administrator, provided that in the case of any Incentive Stock Option, the grant date shall be the
later of the date on which the Administrator makes the determination granting such Incentive Stock Option or the date of commencement
of the Awardee's employment relationship with the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(w)&nbsp;&nbsp;&nbsp;<B>&ldquo;Incentive
Stock Option&rdquo;</B>&nbsp;means an Option intended to qualify as an incentive stock option within the meaning of Section&nbsp;422
of the Code and the regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(x)&nbsp;&nbsp;&nbsp;<B>&ldquo;Insider
Director&rdquo; </B>means a Director who is an Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(y)&nbsp;&nbsp;&nbsp;<B>&ldquo;Nasdaq&rdquo;</B>
means the Nasdaq Global Market or its successor.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(z)&nbsp;&nbsp;&nbsp;<B>&ldquo;Nonstatutory
Stock Option&rdquo;</B>&nbsp;means an Option not intended to qualify as an Incentive Stock Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(aa)&nbsp;&nbsp;<B>&ldquo;Officer&rdquo;</B>&nbsp;means
a person who is an officer of the Company within the meaning of Section&nbsp;16 of the Exchange Act and the rules and regulations
promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(bb)&nbsp;&nbsp;&nbsp;&nbsp;<B>&ldquo;Option&rdquo;</B>&nbsp;means
a right granted under Section&nbsp;8 to purchase a number of Shares at such exercise price, at such times, and on such other terms
and conditions as are specified in the agreement or other documents evidencing the Option (the &ldquo;<B>Option Agreement</B>&rdquo;).
Both Options intended to qualify as Incentive Stock Options and Nonstatutory Stock Options may be granted under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(cc)&nbsp;&nbsp;<B>&ldquo;Outside
Director&rdquo;</B> means a Director who is not an Employee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(dd)&nbsp;&nbsp;&ldquo;<B>Ownership
Change Event</B>&rdquo; means the consummation of any of the following with respect to the Company: (i) the direct or indirect
sale or exchange in a single or series of related transactions by the stockholders of the Company of more than fifty percent (50%)
of the voting stock of the Company; (ii) a merger or consolidation in which the Company is a party; or (iii)&nbsp;the sale, exchange,
or transfer of all or substantially all of the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 63; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(ee)&nbsp;&nbsp;<B>&ldquo;Participant&rdquo;</B>&nbsp;means
the Awardee or any person (including any estate) to whom an Award has been assigned or transferred as permitted hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(ff)&nbsp;&nbsp;<B>&ldquo;Plan&rdquo;</B>&nbsp;means
this Exponent, Inc. 2008 Equity Incentive Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(gg)&nbsp;&nbsp;<B>&ldquo;Qualifying
Performance Criteria&rdquo;</B>&nbsp;shall have the meaning set forth in Section&nbsp;12(b) of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(hh)&nbsp;<B>&ldquo;Share&rdquo;</B>&nbsp;means
a share of the Common Stock, as adjusted in accordance with Section&nbsp;14 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(ii)&nbsp;&nbsp;<B>&ldquo;Stock
Appreciation Right&rdquo;</B>&nbsp;means a right to receive cash and/or shares of Common Stock based on a change in the Fair Market
Value of a specific number of shares of Common Stock between the grant date and the exercise date granted under Section 11.<B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(jj)&nbsp;&nbsp;<B>&ldquo;Stock
Award&rdquo;</B>&nbsp;means an award or issuance of Shares, Stock Units, Stock Appreciation Rights or other similar awards made
under Section&nbsp;11 of the Plan, the grant, issuance, retention, vesting, settlement, and/or transferability of which is subject
during specified periods of time to such conditions (including continued employment or performance conditions) and terms as are
expressed in the agreement or other documents evidencing the Award (the &ldquo;<B>Stock Award Agreement</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(kk)&nbsp;&nbsp;<B>&ldquo;Stock
Unit&rdquo;</B>&nbsp;means a bookkeeping entry representing an amount equivalent to the Fair Market Value of one Share (or a fraction
or multiple of such value), payable in cash, property or Shares. Stock Units represent an unfunded and unsecured obligation of
the Company, except as otherwise provided for by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(ll)&nbsp;&nbsp;&nbsp;<B>&ldquo;Subsidiary&rdquo;</B>&nbsp;means
any company (other than the Company) in an unbroken chain of companies beginning with the Company, provided each company in the
unbroken chain (other than the Company) owns, at the time of determination, stock possessing 50% or more of the total combined
voting power of all classes of stock in one of the other companies in such chain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(mm)&nbsp;&nbsp;&nbsp;<B>&ldquo;Termination
of Employment&rdquo;</B>&nbsp;shall mean ceasing to be an Employee, Consultant or Director, as determined in the sole discretion
of the Administrator. However, for Incentive Stock Option purposes, Termination of Employment will occur when the Awardee ceases
to be an employee (as determined in accordance with Section&nbsp;3401(c) of the Code and the regulations promulgated thereunder)
of the Company or one of its Subsidiaries. The Administrator shall determine whether any corporate transaction, such as a sale
or spin-off of a division or business unit, or a joint venture, shall be deemed to result in a Termination of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(nn)&nbsp;&nbsp;&nbsp;<B>&ldquo;Total
and Permanent Disability&rdquo;</B>&nbsp;shall have the meaning set forth in Section&nbsp;22(e)(3) of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>3.</B></TD><TD><B>Stock Subject to the Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;<I>Aggregate
Limits.</I>&nbsp;&nbsp;&nbsp;Subject to the provisions of Section&nbsp;14 of the Plan, the maximum aggregate number of Shares that
may be sold or issued under the Plan is 5,928,150 shares of Common Stock. The maximum number of shares that may be issued as Incentive
Stock options is 3,739,440.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">Shares subject to Awards granted
under the Plan that are cancelled, expire or are forfeited shall be available for re-grant under the Plan. If an Awardee pays the
exercise or purchase price of an Award granted under the Plan through the tender or withholding of Shares, or if Shares are tendered
or withheld to satisfy any Company withholding obligations<B>,</B> the number of Shares so tendered or withheld shall not become
available for re-issuance thereafter under the Plan. In addition, Shares which are not issued under net settled Stock Appreciation
Rights shall not become available for re-issuance thereafter under the Plan. The Shares subject to the Plan may be either Shares
reacquired by the Company, including Shares purchased in the open market, or authorized but unissued Shares. For the avoidance
of doubt, any Shares purchased by the Company on the open market using the proceeds from the payment of the exercise price during
an Option exercise shall not increase the maximum number of Shares that may be sold or issued under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 64; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;<I>Code
Section&nbsp;162(m) Share Limits.</I>&nbsp;&nbsp;&nbsp;Subject to the provisions of Section&nbsp;14 of the Plan, the aggregate
number of Shares subject to non-cash Awards granted under this Plan during any calendar year to any one Awardee shall not exceed
400,000 Shares, except that in connection with his or her first commencing service with the Company or an Affiliate, an Awardee
may be granted Awards covering up to an additional 800,000 Shares during the year in which such service commences. Notwithstanding
anything to the contrary in the Plan, the limitations set forth in this Section&nbsp;3(b) shall be subject to adjustment under
Section&nbsp;14(a) of the Plan only to the extent that such adjustment will not affect the status of any Award intended to qualify
as &ldquo;performance based compensation&rdquo; under Code Section&nbsp;162(m).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>4.</B></TD><TD><B>Administration of the Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(a)&nbsp;&nbsp;&nbsp;<I>Procedure</I>.&nbsp;&nbsp;&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;<I>Multiple
Administrative Bodies.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall be administered by a Committee and/or their delegates; provided
however that any delegation of authority to any Committee or delegate does not diminish the authority of the Board to administer
the Plan should it deem it appropriate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;<I>Section&nbsp;162.</I>&nbsp;&nbsp;&nbsp;&nbsp;To
the extent that the Administrator determines it to be desirable to qualify Awards granted hereunder as &ldquo;performance-based
compensation&rdquo; within the meaning of Section&nbsp;162(m) of the Code, Awards to &ldquo;covered employees&rdquo; within the
meaning of Section&nbsp;162(m) of the Code or Employees that the Committee determines may be &ldquo;covered employees&rdquo; in
the future shall be made by a Committee of two or more &ldquo;outside directors&rdquo; within the meaning of Section&nbsp;162(m)
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;<I>Rule&nbsp;16b-3.</I>&nbsp;&nbsp;&nbsp;&nbsp;To
the extent desirable to qualify transactions hereunder as exempt under Rule&nbsp;16b-3 promulgated under the Exchange Act (&ldquo;Rule&nbsp;16b-3&rdquo;),
Awards to Officers and Directors shall be made by the entire Board or a Committee of two or more &ldquo;non-employee directors&rdquo;
within the meaning of Rule&nbsp;16b-3.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iv.&nbsp;&nbsp;&nbsp;<I>Other
Administration.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Board or a Committee may delegate to an authorized officer or officers of the Company
the power to approve Awards to persons eligible to receive Awards under the Plan who are not (A)&nbsp;subject to Section&nbsp;16
of the Exchange Act or (B)&nbsp;at the time of such approval, &ldquo;covered employees&rdquo; under Section&nbsp;162(m) of the
Code or (C) any other executive officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">v.&nbsp;&nbsp;&nbsp;<I>Delegation
of Authority for the Day-to-Day Administration of the Plan.</I>&nbsp;&nbsp;&nbsp;&nbsp;Except to the extent prohibited by Applicable
Law, the Administrator may delegate to one or more individuals the day-to-day administration of the Plan and any of the functions
assigned to it in this Plan. Such delegation may be revoked at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vi.&nbsp;&nbsp;&nbsp;<I>Nasdaq</I>.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The
Plan will be administered in a manner that complies with any applicable Nasdaq or stock exchange listing requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;<I>Powers
of the Administrator.</I>&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of the Plan and, in the case of a Committee or delegates
acting as the Administrator, subject to the specific duties delegated to such Committee or delegates, the Administrator shall have
the authority, in its discretion:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;to
select the Employees, Consultants and Directors of the Company or its Affiliates to whom Awards are to be granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;to
determine the number of shares of Common Stock or amount of cash to be covered by each Award granted hereunder;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;to
determine the type of Award to be granted to the selected Employees, Consultants and Directors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iv.&nbsp;&nbsp;&nbsp;to
approve forms of Award Agreements for use under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 65; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">v.&nbsp;&nbsp;&nbsp;to
determine the terms and conditions, not inconsistent with the terms of the Plan, of any Award granted hereunder. Such terms and
conditions include, but are not limited to, the exercise and/or purchase price (if applicable), the time or times when an Award
may be exercised (which may or may not be based on performance criteria), the vesting schedule, any vesting and/or exercisability
acceleration or waiver of forfeiture restrictions, the acceptable forms of consideration, the term, and any restriction or limitation
regarding any Award or the Shares relating thereto, based in each case on such factors as the Administrator, in its sole discretion,
shall determine and may be established at the time an Award is granted or thereafter;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
correct administrative errors;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
construe and interpret the terms of the Plan (including sub-plans and Plan addenda) and Awards granted pursuant to the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">viii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
adopt rules and procedures relating to the operation and administration of the Plan to accommodate the specific requirements of
local laws and procedures. Without limiting the generality of the foregoing, the Administrator is specifically authorized (A)&nbsp;to
adopt the rules and procedures regarding the conversion of local currency, withholding procedures and handling of stock certificates
which vary with local requirements and (B)&nbsp;to adopt sub-plans and Plan addenda as the Administrator deems desirable, to accommodate
foreign laws, regulations and practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ix.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
prescribe, amend and rescind rules and regulations relating to the Plan, including rules and regulations relating to sub-plans
and Plan addenda;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">x.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
modify or amend each Award, including, but not limited to, the acceleration of vesting and/or exercisability, provided, however,
that any such amendment is subject to Section&nbsp;15 of the Plan and except as set forth in that Section, may not impair any outstanding
Award unless agreed to in writing by the Participant;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
allow Participants to satisfy withholding tax amounts by electing to have the Company withhold from the Shares to be issued upon
exercise of an Option or vesting of a Stock Award that number of Shares having a Fair Market Value equal to the amount required
to be withheld. The Fair Market Value of the Shares to be withheld shall be determined in such manner and on such date that the
Administrator shall determine or, in the absence of provision otherwise, on the date that the amount of tax to be withheld is to
be determined. All elections by a Participant to have Shares withheld for this purpose shall be made in such form and under such
conditions as the Administrator may provide;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
authorize conversion or substitution under the Plan of any or all stock options, stock appreciation rights or other stock awards
held by service providers of an entity acquired by the Company (the &ldquo;Conversion Awards&rdquo;). Any conversion or substitution
shall be effective as of the close of the merger, acquisition or other transaction. The Conversion Awards may be Nonstatutory Stock
Options or Incentive Stock Options, as determined by the Administrator, with respect to options granted by the acquired entity;
provided, however, that with respect to the conversion of stock appreciation rights in the acquired entity, the Conversion Awards
shall be Nonstatutory Stock Options. Unless otherwise determined by the Administrator at the time of conversion or substitution,
all Conversion Awards shall have the same terms and conditions as Awards generally granted by the Company under the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xiii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
authorize any person to execute on behalf of the Company any instrument required to effect the grant of an Award previously granted
by the Administrator;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"></P>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xiv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
impose such restrictions, conditions or limitations as it determines appropriate as to the timing and manner of any resales by
a Participant or other subsequent transfers by the Participant of any Shares issued as a result of or under an Award, including
without limitation, (A)&nbsp;restrictions under an insider trading policy or under any other Company policy relating to Company
stock and stock ownership and (B)&nbsp;restrictions as to the use of a specified brokerage firm for such resales or other transfers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
provide, either at the time an Award is granted or by subsequent action, that an Award shall contain as a term thereof, a right,
either in tandem with the other rights under the Award or as an alternative thereto, of the Participant to receive, without payment
to the Company, a number of Shares, cash or a combination thereof, the amount of which is determined by reference to the value
of the Award; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">xvi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;to
make all other determinations deemed necessary or advisable for administering the Plan and any Award granted hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Effect
of Administrator's Decision.</I>&nbsp;&nbsp;&nbsp;&nbsp;All decisions, determinations and interpretations by the Administrator
regarding the Plan, any rules and regulations under the Plan and the terms and conditions of any Award granted hereunder, shall
be final and binding on all Participants and on all other persons. The Administrator shall consider such factors as it deems relevant,
in its sole and absolute discretion, to making such decisions, determinations and interpretations including, without limitation,
the recommendations or advice of any officer or other employee of the Company and such attorneys, consultants and accountants as
it may select.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>5.</B></TD><TD><B>Eligibility.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Awards may be granted
to Employees, Consultants and Directors of the Company or any of its Affiliates; provided that Incentive Stock Options may be granted
only to Employees of the Company or of a Subsidiary of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>6.</B></TD><TD><B>Term of Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Plan shall become
effective on the Effective Date. It shall continue in effect for a term of ten (10)&nbsp;years from the later of the Effective
Date or the date any amendment to add shares to the Plan is approved by stockholders of the Company unless terminated earlier under
Section&nbsp;15 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#9;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>7.</B></TD><TD><B>Term of Award.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The term of each Award
shall be determined by the Administrator and stated in the Award Agreement. In the case of an Option, the term shall be ten (10)&nbsp;years
from the Grant Date or such shorter term as may be provided in the Award Agreement; provided that an Incentive Stock Option granted
to an Employee who on the Grant Date owns stock representing more than ten percent (10%) of the voting power of all classes of
stock of the Company or any Subsidiary shall have a term of no more than five (5) years from the Grant Date; and provided further
that the term may be ten and one-half (10<SUP>1/2</SUP>) years (or a shorter period) in the case of Options granted to Employees
in certain jurisdictions outside the United States as determined by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>8.</B></TD><TD><B>Options.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Administrator may
grant an Option or provide for the grant of an Option, either from time to time in the discretion of the Administrator or automatically
upon the occurrence of specified events, including, without limitation, the achievement of performance goals, the satisfaction
of an event or condition within the control of the Awardee or within the control of others.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Option
Agreement.</I>&nbsp;&nbsp;&nbsp;&nbsp;Each Option Agreement shall contain provisions regarding (i)&nbsp;the number of Shares that
may be issued upon exercise of the Option, (ii)&nbsp;the type of Option, (iii)&nbsp;the exercise price of the Shares and the means
of payment for the Shares, (iv)&nbsp;the term of the Option, (v)&nbsp;such terms and conditions on the vesting and/or exercisability
of an Option as may be determined from time to time by the Administrator, (vi)&nbsp;restrictions on the transfer of the Option
or the Shares issued upon exercise of the Option and forfeiture provisions, and (vii)&nbsp;such further terms and conditions, in
each case not inconsistent with this Plan as may be determined from time to time by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 67; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exercise
Price.</I>&nbsp;&nbsp;&nbsp;&nbsp;The per share exercise price for the Shares to be issued pursuant to exercise of an Option shall
be determined by the Administrator, subject to the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the case of an Incentive Stock Option, the per Share exercise price shall be no less than one hundred percent (100%) of the Fair
Market Value per Share on the Grant Date; provided however, that in the case of an Incentive Stock Option granted to an Employee
who on the Grant Date owns stock representing more than ten percent (10%) of the voting power of all classes of stock of the Company
or any Subsidiary, the per Share exercise price shall be no less than one hundred ten percent (110%) of the Fair Market Value per
Share on the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
the case of a Nonstatutory Stock Option, the per Share exercise price shall be no less than one hundred percent (100%) of the Fair
Market Value per Share on the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding
the foregoing, at the Administrator's discretion, Conversion Awards may be granted in substitution and/or conversion of options
of an acquired entity, with a per Share exercise price of less than 100% of the Fair Market Value per Share on the date of such
substitution and/or conversion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Vesting
Period and Exercise Dates.</I>&nbsp;&nbsp;&nbsp;&nbsp;Options granted under this Plan shall vest and/or be exercisable at such
time and in such installments during the period prior to the expiration of the Option's term as determined by the Administrator.
The Administrator shall have the right to make the timing of the ability to exercise any Option granted under this Plan subject
to continued employment, the passage of time and/or such performance requirements as deemed appropriate by the Administrator, or
to grant fully vested Options. At any time after the grant of an Option, the Administrator may reduce or eliminate any restrictions
surrounding any Participant's right to exercise all or part of the Option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Form
of Consideration.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Administrator shall determine the acceptable form of consideration for exercising
an Option, including the method of payment, either through the terms of the Option Agreement or at the time of exercise of an Option.
Acceptable forms of consideration may include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cash;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;check
or wire transfer (denominated in U.S. Dollars);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;subject
to the Company's discretion to refuse for any reason and at any time to accept such consideration and subject to any conditions
or limitations established by the Administrator, other Shares held by the Participant which&nbsp;have a Fair Market Value on the
date of surrender equal to the aggregate exercise price of the Shares as to which said Option shall be exercised;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;consideration
received by the Company under a broker-assisted sale and remittance program acceptable to the Administrator;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;cashless
&ldquo;net exercise&rdquo; arrangement pursuant to which the Company will reduce the number of Shares issued upon exercise by the
largest whole number of Shares having an aggregate Fair Market Value that does not exceed the aggregate exercise price; provided
that the Company shall accept a cash or other payment from the Participant to the extent of any remaining balance of the exercise
price not satisfied by such reduction in the number of whole Shares to be issued;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;such
other consideration and method of payment for the issuance of Shares to the extent permitted by Applicable Laws; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;any
combination of the foregoing methods of payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Effect
of Termination on Options</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Generally</I>.&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise provided for by the Administrator, upon an Awardee's Termination of Employment other than as a result of circumstances
described in Sections 8(f)(ii), (iii) and (iv)&nbsp;below, all outstanding Options granted to such Awardee that were vested and
exercisable as of the date of the Awardee&rsquo;s Termination of Employment may be exercised by the Awardee until the earlier of
(A) three (3) months following Awardee&rsquo;s Termination of Employment or (B)&nbsp;the expiration of the term of such Option;
provided, however, that the Administrator may in the Option Agreement specify a period of time (but not beyond the expiration date
of the Option) following Termination of Employment during which the Awardee may exercise the Option as to Shares that were vested
and exercisable as of the date of Termination of Employment. To the extent such a period following Termination of Employment is
specified, the Option shall automatically terminate at the end of such period to the extent the Awardee has not exercised it within
such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Disability
of Awardee.</I>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided for by the Administrator, upon an Awardee's Termination of Employment
as a result of the Awardee's disability, including Total and Permanent Disability, all outstanding Options granted to such Awardee
that were vested and exercisable as of the date of the Awardee&rsquo;s Termination of Employment may be exercised by the Awardee
until the earlier of (A) twelve (12) months following Awardee&rsquo;s Termination of Employment as a result of Awardee&rsquo;s
disability, including Total and Permanent Disability or (B)&nbsp;the expiration of the term of such Option. If the Participant
does not exercise such Option within the time specified, the Option (to the extent not exercised) shall automatically terminate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Death
of Awardee.</I>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided for by the Administrator, upon an Awardee's Termination of Employment
as a result of the Awardee's death, all outstanding Options granted to such Awardee that were vested and exercisable as of the
date of the Awardee&rsquo;s death may be exercised until the earlier of (A)&nbsp;twelve (12) months following the Awardee's death
or (B)&nbsp;the expiration of the term of such Option. If an Option is held by the Awardee when he or she dies, such Option may
be exercised, to the extent the Option is vested and exercisable, by the beneficiary designated by the Awardee (as provided in
Section&nbsp;16 of the Plan), the executor or administrator of the Awardee's estate or, if none, by the person(s) entitled to exercise
the Option under the Awardee's will or the laws of descent or distribution; provided that the Company need not accept exercise
of an Option by such beneficiary, executor or administrator unless the Company has satisfactory evidence of such person's authority
to act as such. If the Option is not so exercised within the time specified, such Option (to the extent not exercised) shall automatically
terminate. The Awardee&rsquo;s service shall be deemed to have terminated on account of death if the Awardee dies within three
(3) months (or such longer period as determined by the Administrator, in its discretion) after the Awardee&rsquo;s Termination
of Employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iv.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination
for Cause.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Administrator has the authority to cause all outstanding Awards held by an Awardee to
terminate immediately in their entirety (including as to vested Options) upon first notification to the Awardee of the Awardee&rsquo;s
Termination of Employment for Cause. If an Awardee&rsquo;s employment or consulting relationship with the Company is suspended
pending an investigation of whether the Awardee shall be terminated for Cause, the Administrator has the authority to cause all
the Awardee&rsquo;s rights under all outstanding Awards to be suspended during the investigation period in which event the Awardee
shall have no right to exercise any outstanding Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">v.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Other
Terminations of Employment.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Administrator may provide in the applicable Option Agreement for different
treatment of Options upon Termination of Employment of the Awardee than that specified above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vi.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Extension
of Exercise Period</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Administrator shall have full power and authority to extend the period of time
for which an Option is to remain exercisable following an Awardee&rsquo;s Termination of Employment from the periods set forth
in Sections 8(f)(i), (ii) and (iii) above or in the Option Agreement to such greater time as the Board shall deem appropriate,
provided that in no event shall such Option be exercisable later than the date of expiration of the term of such Option as set
forth in the Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 69; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">vii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Extension
if Exercise Prevented by Law.</I>&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, other than a termination for Cause, if
a sale within the applicable time periods set forth in Section 8(f) above or in the Option Agreement is prevented by Section 18
below, the Option shall remain exercisable until thirty (30) days after the date the Awardee is notified by the Company that the
Option is exercisable, but in any event no later than the Option expiration date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">viii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Extension
if Subject to Section 16(b).</I>&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the foregoing, other than a termination for Cause, if a
sale within the applicable time periods set forth in Section 8(f) above or in the Option Agreement would subject the Awardee to
a suit under Section 16(b) of the Exchange Act, the Option shall remain exercisable until the earliest to occur of (i)&nbsp;the
tenth (10<SUP>th</SUP>) day following the date on which a sale of shares by the Awardee would no longer be subject to suit, (ii)&nbsp;the
one hundred ninetieth (190<SUP>th</SUP>) day after Awardee&rsquo;s Termination of Employment, or (iii)&nbsp;the Option expiration
date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Leave
of Absence.&nbsp;&nbsp;&nbsp;&nbsp;</I>The Administrator shall have the discretion to determine whether and to what extent the
vesting of Options shall be tolled during any unpaid leave of absence; provided, however, that in the absence of such determination,
vesting of Options shall be tolled during any leave that is not a leave required to be provided to the Awardee under Applicable
Law. In the event of military leave, vesting shall toll during any unpaid portion of such leave, provided that, upon an Awardee&rsquo;s
returning from military leave (under conditions that would entitle him or her to protection upon such return under the Uniform
Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Options to the same extent
as would have applied had the Awardee continued to provide services to the Company throughout the leave on the same terms as he
or she was providing services immediately prior to such leave.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>9.</B></TD><TD><B>Incentive Stock Option Limitations/Terms.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Eligibility.</I>&nbsp;&nbsp;&nbsp;&nbsp;Only
employees (as determined in accordance with Section&nbsp;3401(c) of the Code and the regulations promulgated thereunder) of the
Company or any of its Subsidiaries may be granted Incentive Stock Options.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>$100,000
Limitation.</I>&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding the designation &ldquo;Incentive Stock Option&rdquo; in an Option Agreement,
if and to the extent that the aggregate Fair Market Value of the Shares with respect to which Incentive Stock Options are exercisable
for the first time by the Awardee during any calendar year (under all plans of the Company and any of its Subsidiaries) exceeds
U.S. $100,000, such Options shall be treated as Nonstatutory Stock Options. For purposes of this Section&nbsp;9(b), Incentive Stock
Options shall be taken into account in the order in which they were granted. The Fair Market Value of the Shares shall be determined
as of the Grant Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Transferability.</I>&nbsp;&nbsp;&nbsp;&nbsp;An
Incentive Stock Option may not be sold, pledged, assigned, hypothecated, transferred or disposed of in any manner by the Awardee
otherwise than by will or the laws of descent and distribution, and, during the lifetime of such Awardee, may only be exercised
by the Awardee. If the terms of an Incentive Stock Option are amended to permit transferability, the Option will be treated for
tax purposes as a Nonstatutory Stock Option. The designation of a beneficiary by an Awardee will not constitute a transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exercise
Price.</I>&nbsp;&nbsp;&nbsp;&nbsp;The per Share exercise price of an Incentive Stock Option shall be determined by the Administrator
in accordance with Section&nbsp;8(b)(i)&nbsp;of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Other
Terms.</I>&nbsp;&nbsp;&nbsp;&nbsp;Option Agreements evidencing Incentive Stock Options shall contain such other terms and conditions
as may be necessary to qualify, to the extent determined desirable by the Administrator, with the applicable provisions of Section&nbsp;422
of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 70; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: -0.25in"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>10.</B></TD><TD><B>Exercise of Option.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Procedure
for Exercise</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any
Option granted hereunder shall be exercisable according to the terms of the Plan and at such times and under such conditions as
determined by the Administrator and set forth in the respective Option Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Option shall be deemed exercised when the Company receives (A)&nbsp;written or electronic notice of exercise (in accordance with
the Option Agreement) from the person entitled to exercise the Option; (B)&nbsp;full payment for the Shares with respect to which
the related Option is exercised; and (C)&nbsp;payment of all applicable withholding taxes (if any).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An
Option may not be exercised for a fraction of a Share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Rights
as a Stockholder</I>. The Company shall issue (or cause to be issued) such Shares as administratively practicable after the Option
is exercised. Shares issued upon exercise of an Option shall be issued in the name of the Participant or, if requested by the Participant,
in the name of the Participant and his or her spouse. Unless provided otherwise by the Administrator or pursuant to this Plan,
until the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer
agent of the Company), no right to vote or receive dividends or any other rights as a stockholder shall exist with respect to the
Shares subject to an Option, notwithstanding the exercise of the Option. &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>11.</B></TD><TD><B>Stock Awards.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock
Award Agreement.</I>&nbsp;&nbsp;&nbsp;&nbsp;Each Stock Award Agreement shall contain provisions regarding (i)&nbsp;the number of
Shares subject to such Stock Award or a formula for determining such number, (ii)&nbsp;the purchase price of the Shares, if any,
and the means of payment for the Shares, (iii)&nbsp;the performance criteria (including Qualifying Performance Criteria), if any,
and level of achievement versus these criteria that shall determine the number of Shares granted, issued, retainable and/or vested,
(iv)&nbsp;such terms and conditions on the grant, issuance, vesting, settlement and/or forfeiture of the Shares as may be determined
from time to time by the Administrator, (v)&nbsp;restrictions on the transferability of the Stock Award and (vi)&nbsp;such further
terms and conditions in each case not inconsistent with this Plan as may be determined from time to time by the Administrator.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Restrictions
and Performance Criteria.</I>&nbsp;&nbsp;&nbsp;&nbsp;The grant, issuance, retention, settlement and/or vesting of each Stock Award
or the Shares subject thereto may be subject to such performance criteria (including Qualifying Performance Criteria) and level
of achievement versus these criteria as the Administrator shall determine, which criteria may be based on financial performance,
personal performance evaluations and/or completion of service by the Awardee. Unless otherwise permitted in compliance with the
requirements of Code Section 162(m) with respect to an Award intended to comply as &ldquo;performance-based compensation&rdquo;
thereunder, the Committee shall establish the Qualifying Performance Criteria applicable to, and the formula for calculating the
amount payable under, the Award no later than the earlier of (a) the date ninety (90) days after the commencement of the applicable
performance period, or (b) the date on which 25% of the performance period has elapsed, and in any event at a time when the achievement
of the applicable Qualifying Performance Criteria remains substantially uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Forfeiture.</I>&nbsp;&nbsp;&nbsp;&nbsp;Unless
otherwise provided for by the Administrator, upon the Awardee's Termination of Employment, the Stock Award and the Shares subject
thereto shall be forfeited, provided that to the extent that the Participant purchased or earned any Shares, the Company shall
have a right to repurchase the unvested Shares at such price and on such terms and conditions as the Administrator determines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Rights
as a Stockholder.</I>&nbsp;&nbsp;&nbsp;&nbsp;Unless otherwise provided by the Administrator in the Award Agreement, the Participant
shall have the rights equivalent to those of a stockholder and shall be a stockholder only after Shares are issued (as evidenced
by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) to the Participant.
Unless otherwise provided by the Administrator, a Participant holding Stock Units shall not be entitled to receive dividend payments
or any credit therefor as if he or she was an actual stockholder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 71; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Stock
Appreciation Rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>General.&nbsp;&nbsp;&nbsp;&nbsp;</I>Stock
Appreciation Rights may be granted either alone, in addition to, or in tandem with other Awards granted under the Plan. The Board
may grant Stock Appreciation Rights to eligible Participants subject to terms and conditions not inconsistent with this Plan and
determined by the Board. The specific terms and conditions applicable to the Participant shall be provided for in the Stock Award
Agreement. Stock Appreciation Rights shall be exercisable, in whole or in part, at such times as the Board shall specify in the
Stock Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Exercise
of Stock Appreciation Right</I>.&nbsp;&nbsp;&nbsp;&nbsp;Upon the exercise of a Stock Appreciation Right, in whole or in part, the
Participant shall be entitled to a payment in an amount equal to the excess of the Fair Market Value on the date of exercise of
a fixed number of Shares covered by the exercised portion of the Stock Appreciation Right, over the Fair Market Value on the Grant
Date of the Shares covered by the exercised portion of the Stock Appreciation Right (or such other amount calculated with respect
to Shares subject to the Award as the Board may determine). The amount due to the Participant upon the exercise of a Stock Appreciation
Right shall be paid in such form of consideration as determined by the Board and may be in cash, Shares or a combination thereof,
over the period or periods specified in the Stock Award Agreement. A Stock Award Agreement may place limits on the amount that
may be paid over any specified period or periods upon the exercise of a Stock Appreciation Right, on an aggregate basis or as to
any Participant. A Stock Appreciation Right shall be considered exercised when the Company receives written notice of exercise
in accordance with the terms of the Stock Award Agreement from the person entitled to exercise the Stock Appreciation Right.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Nonassignability
of Stock Appreciation Rights.</I>&nbsp;&nbsp;&nbsp;&nbsp;Except as determined by the Administrator, no Stock Appreciation Right
shall be assignable or otherwise transferable by the Participant except by will or by the laws of descent and distribution.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>12.</B></TD><TD><B>Cash Awards.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Cash
Award</I>.&nbsp;&nbsp;&nbsp;&nbsp;Each Cash Award shall contain provisions regarding (i) the target and maximum amount payable
to the Awardee as a Cash Award, (ii) the performance criteria and level of achievement versus these criteria which shall determine
the amount of such payment, (iii) the period as to which performance shall be measured for establishing the amount of any payment,
(iv) the timing of any payment earned by virtue of performance, (v) restrictions on the alienation or transfer of the Cash Award
prior to actual payment, (vi) forfeiture provisions, and (vii) such further terms and conditions, in each case not inconsistent
with the Plan, as may be determined from time to time by the Administrator. The maximum amount payable as a Cash Award may be a
multiple of the target amount payable, but the maximum amount payable pursuant to that portion of a Cash Award granted under this
Plan for any fiscal year to any Awardee that is intended to satisfy the requirements for &ldquo;performance based compensation&rdquo;
under Section 162(m) of the Code shall not exceed U.S. $1,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Performance
Criteria</I>. The Administrator shall establish the performance criteria and level of achievement versus these criteria which shall
determine the target and the minimum and maximum amount payable under a Cash Award, which criteria may be based on financial performance
and/or personal performance evaluations. The Committee may specify the percentage of the target Cash Award that is intended to
satisfy the requirements for &ldquo;performance-based compensation&rdquo; under Section 162(m) of the Code. Notwithstanding anything
to the contrary herein, the performance criteria for any portion of a Cash Award that is intended to satisfy the requirements for
&ldquo;performance-based compensation&rdquo; under Section 162(m) of the Code shall be a measure established by the Committee based
on one or more Qualifying Performance Criteria selected by the Committee and specified in writing not later than the earlier of
(a) the date ninety (90) days after the commencement of the applicable performance period, or (b) the date on which 25% of the
performance period has elapsed, and in any event at a time when the achievement of the applicable Qualifying Performance Criteria
remains substantially uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 72; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Timing
and Form of Payment</I>. The Administrator shall determine the timing of payment of any Cash Award. The Administrator may provide
for or, subject to such terms and conditions as the Administrator may specify, may permit an Awardee to elect for the payment of
any Cash Award to be deferred to a specified date or event. The Administrator may specify the form of payment of Cash Awards, which
may be cash or other property, or may provide for an Awardee to have the option for his or her Cash Award, or such portion thereof
as the Administrator may specify, to be paid in whole or in part in cash or other property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination
of Employment</I>. The Administrator shall have the discretion to determine the effect a Termination of Employment due to (i) disability,
(ii) death or (iii)&nbsp;otherwise shall have on any Cash Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>13.</B></TD><TD><B>Other Provisions Applicable to Awards.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Non-Transferability
of Awards.</I>&nbsp;&nbsp;&nbsp;&nbsp;Unless determined otherwise by the Administrator, an Award may not be sold, pledged, assigned,
hypothecated, transferred, or disposed of in any manner for value other than by beneficiary designation, will or by the laws of
descent or distribution. Subject to Section 9(c), the Administrator may in its discretion make an Award transferable to an Awardee's
family member or any other person or entity as it deems appropriate. If the Administrator makes an Award transferable, either at
the time of grant or thereafter, such Award shall contain such additional terms and conditions as the Administrator deems appropriate,
and any transferee shall be deemed to be bound by such terms upon acceptance of such transfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Qualifying
Performance Criteria.</I>&nbsp;&nbsp;&nbsp;&nbsp;For purposes of this Plan, the term &ldquo;Qualifying Performance Criteria&rdquo;
shall mean any one or more of the following performance criteria, either individually, alternatively or in any combination, applied
to either the Company as a whole or to a business unit, Affiliate or business segment, either individually, alternatively or in
any combination, and measured either annually or cumulatively over a period of years, on an absolute basis or relative to a pre-established
target, to previous years' results or to a designated comparison group, in each case as specified by the Administrator in the Award:
(i)&nbsp;cash flow; (ii)&nbsp;earnings (including gross margin; earnings before interest, taxes, depreciation, amortization and
stock-based compensation; earnings before taxes; and net earnings); (iii)&nbsp;earnings per share; (iv)&nbsp;stock price; (v)&nbsp;return
on equity or average stockholders' equity; (vi)&nbsp;total stockholder return; (vii)&nbsp;return on assets or net assets; (viii)&nbsp;return
on investment; (ix)&nbsp;revenue before reimbursements; (x)&nbsp;income or net income; (xi)&nbsp;operating income or net operating
income, in aggregate or per share; (xii)&nbsp;operating profit or net operating profit; (xiii)&nbsp;operating margin; (xiv)&nbsp;return
on operating revenue; (xv)&nbsp;contract awards or backlog; (xvi)&nbsp;overhead or other expense reduction; (xvii)&nbsp;growth
in stockholder value relative to the moving average of the S&amp;P 500 Index or S&amp;P SmallCap 600 Index; and (xviii)&nbsp;objective
strategic plan development and implementation (including individual objective performance goals that relate to achievement of the
Company&rsquo;s or any business unit&rsquo;s strategic plan). The Committee may appropriately adjust any evaluation of performance
under a Qualifying Performance Criteria to exclude any of the following events that occurs during a performance period: (A)&nbsp;asset
write-downs; (B)&nbsp;litigation or claim judgments or settlements; (C)&nbsp;the effect of changes in tax law, accounting principles
or other such laws or provisions affecting reported results; (D)&nbsp;accruals for reorganization and restructuring programs; and
(E)&nbsp;any gains or losses classified as extraordinary or as discontinued operations in the Company&rsquo;s financial statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certification.</I>&nbsp;&nbsp;&nbsp;&nbsp;Prior
to the payment of any compensation under an Award intended to qualify as &ldquo;performance-based compensation&rdquo; under Section&nbsp;162(m)
of the Code, the Committee shall certify the extent to which any Qualifying Performance Criteria and any other material terms under
such Award have been satisfied (other than in cases where such relate solely to the increase in the value of the Common Stock).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Discretionary
Adjustments Pursuant to Section&nbsp;162(m).</I>&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding satisfaction of any completion of any Qualifying
Performance Criteria, to the extent specified at the time of grant of an Award to &ldquo;covered employees&rdquo; within the meaning
of Section&nbsp;162(m) of the Code, the number of Shares, Options or other benefits granted, issued, retainable and/or vested under
an Award on account of satisfaction of such Qualifying Performance Criteria may be reduced by the Committee on the basis of such
further considerations as the Committee in its sole discretion shall determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Tax
Withholding Obligation</I>.&nbsp;&nbsp;&nbsp;&nbsp;As a condition of the grant, issuance, vesting, exercise or settlement of an
Award granted under the Plan, the Participant shall make such arrangements as the Administrator may require for the satisfaction
of any applicable federal, state, local or foreign withholding tax obligations that may arise in connection with such grant, issuance,
vesting, exercise or settlement of the Award. The Company shall not be required to issue any Shares under the Plan until such obligations
are satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 73; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance
with Section 409A</I>.&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding anything to the contrary contained herein, to the extent that the
Administrator determines that any Award granted under the Plan is subject to Code Section 409A and unless otherwise specified in
the applicable Award Agreement, the Award Agreement evidencing such Award shall incorporate the terms and conditions necessary
for such Award to avoid the consequences described in Code Section 409A(a)(1), and to the maximum extent permitted under Applicable
Law (and unless otherwise stated in the applicable Award Agreement), the Plan and the Award Agreements shall be interpreted in
a manner that results in their conforming to the requirements of Code Section 409A(a)(2), (3) and (4) and any Department of Treasury
or Internal Revenue Service regulations or other interpretive guidance issued under Section 409A (whenever issued, the &ldquo;<B>Guidance</B>&rdquo;).
Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement provides otherwise, with specific reference
to this sentence), to the extent that a Participant holding an Award that constitutes &ldquo;deferred compensation&rdquo; under
Section 409A and the Guidance is a &ldquo;specified employee&rdquo; (also as defined thereunder), no distribution or payment of
any amount shall be made before a date that is six (6) months following the date of such Participant's &ldquo;separation from service&rdquo;
(as defined in Section 409A and the Guidance) or, if earlier, the date of the Participant's death.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(g)&nbsp;&nbsp;&nbsp;<I>&nbsp;&nbsp;Deferral
of Award Benefits</I>.&nbsp;&nbsp;&nbsp;&nbsp;The Administrator may in its discretion and upon such terms and conditions as it
determines appropriate permit one or more Participants whom it selects to (a) defer compensation payable pursuant to the terms
of an Award, or (b) defer compensation arising outside the terms of this Plan pursuant to a program that provides for deferred
payment in satisfaction of such other compensation amounts through the issuance of one or more Awards. Any such deferral arrangement
shall be evidenced by an Award Agreement in such form as the Administrator shall from time to time establish, and no such deferral
arrangement shall be a valid and binding obligation unless evidenced by a fully executed Award Agreement, the form of which the
Administrator has approved, including through the Administrator's establishing a written program (the &ldquo;<B>Program</B>&rdquo;)
under this Plan to govern the form of Award Agreements participating in such Program. Any such Award Agreement or Program shall
specify the treatment of dividends or dividend equivalent rights (if any) that apply to Awards governed thereby, and shall further
provide that any elections governing payment of amounts pursuant to such Program shall be in writing, shall be delivered to the
Company or its agent in a form and manner that complies with Code Section 409A and the Guidance, and shall specify the amount to
be distributed in settlement of the deferral arrangement, as well as the time and form of such distribution in a manner that complies
with Code Section 409A and the Guidance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Dividend
and Dividend Equivalents</I>.&nbsp;&nbsp;&nbsp;&nbsp;In no event will any dividend or dividend equivalent payments be paid or delivered
to a Participant prior to the vesting of the underlying Award. For the avoidance of doubt, the Administrator may provide in an
Award Agreement that dividend or dividend equivalents on an underlying Award may be credited to a Participant prior to the vesting
date, but not paid or delivered prior to such vesting date. In such case, the dividend or dividend equivalents shall be subject
to the same vesting conditions as the underlying Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>14.</B></TD><TD><B>Adjustments upon Changes in Capitalization, Dissolution,
or Change In Control</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Changes
in Capitalization.</I>&nbsp;&nbsp;&nbsp;&nbsp;Subject to any required action by the stockholders of the Company, the number of
shares of Common Stock covered by each outstanding Award, the number of shares of Common Stock which have been authorized for issuance
under the Plan, but as to which no Awards have yet been granted or which have been returned to the Plan upon cancellation, forfeiture
or expiration of an Award, the price per Share subject to each such outstanding Award and each of the share limits set forth in
Section 3(b), shall be proportionately adjusted for any increase or decrease in the number of issued shares of Common Stock resulting
from a stock split, reverse stock split, stock dividend, combination or reclassification of the Common Stock, payment of a dividend
or distribution in a form other than stock (excepting normal cash dividends) that has a material effect on the Fair Market Value
of the shares of Common Stock, or any other increase or decrease in the number of issued shares of Common Stock effected without
receipt of consideration by the Company; provided, however, that conversion of any convertible securities of the Company shall
not be deemed to have been &ldquo;effected without receipt of consideration.&rdquo; Such adjustment shall be made by the Administrator,
whose determination in that respect shall be final, binding and conclusive. Except as expressly provided herein, no issuance by
the Company of shares of stock of any class, or securities convertible into shares of stock of any class, shall affect, and no
adjustment by reason thereof shall be made with respect to, the number or price of shares of Common Stock subject to an Award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 74; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Dissolution
or Liquidation.</I>&nbsp;&nbsp;&nbsp;&nbsp;In the event of the proposed dissolution or liquidation of the Company, the Administrator
shall notify each Participant as soon as practicable prior to the effective date of such proposed transaction. To the extent it
has not been previously exercised or the Shares subject thereto issued to the Awardee and unless otherwise determined by the Administrator,
an Award will terminate immediately prior to the consummation of such proposed transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Change
in Control.</I>&nbsp;&nbsp;&nbsp;&nbsp;In the event there is a Change in Control of the Company, as determined by the Board or
a Committee, the Board or Committee may, in its discretion, (i) provide for the assumption or substitution of, or adjustment (including
to the number and type of Shares and exercise or purchase price applicable) to, each outstanding Award; (ii) accelerate the vesting
of Options and terminate any restrictions on Stock Awards; and/or (iii) provide for termination of Awards as a result of the Change
in Control on such terms and conditions as it deems appropriate, including providing for the cancellation of Awards for a cash
or other payment to the Participant.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">For purposes of this Section
14(c), an Award shall be considered assumed, without limitation, if, at the time of issuance of the stock or other consideration
upon a Change in Control, as the case may be, each holder of an Award would be entitled to receive upon exercise of the Award the
same number and kind of shares of stock or the same amount of property, cash or securities as such holder would have been entitled
to receive upon the occurrence of the transaction if the holder had been, immediately prior to such transaction, the holder of
the number of Shares covered by the Award at such time (after giving effect to any adjustments in the number of Shares covered
by the Award as provided for in Section 14(a)); provided that if such consideration received in the transaction is not solely common
stock of the successor corporation, the Administrator may, with the consent of the successor corporation, provide for the consideration
to be received upon exercise of the Award to be solely common stock of the successor corporation equal to the Fair Market Value
of the per Share consideration received by holders of Common Stock in the transaction. The treatment of Cash Awards in a transaction
governed by this Section 14(c) shall be governed by the applicable Award Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>15.</B></TD><TD><B>Amendment and Termination of the Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;<I>Amendment
and Termination.</I>&nbsp;&nbsp;&nbsp;&nbsp;The Administrator may amend, alter or discontinue the Plan or any Award Agreement,
but any such amendment shall be subject to approval of the stockholders of the Company in the manner and to the extent required
by Applicable Law. To the extent required to comply with Section 162(m), the Company shall seek re-approval of the Plan from time
to time by the stockholders. In addition, without limiting the foregoing, unless approved by the stockholders of the Company, no
such amendment shall be made that would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">i.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;increase
the maximum number of Shares for which Awards may be granted under the Plan, other than an increase pursuant to Section&nbsp;14
of the Plan;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">ii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;increase
the share limits set forth in Section 3(b) or the cash limit set forth in Section 12(a);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iii.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;reprice
or otherwise reduce the exercise price of Options outstanding under the Plan, other than an adjustment provided for under Section
14 of the Plan; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">iv.&nbsp;&nbsp;&nbsp;change
the class of persons eligible to receive Awards under the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;<I>Effect
of Amendment or Termination.</I>&nbsp;&nbsp;&nbsp;&nbsp;No amendment, suspension or termination of the Plan shall impair the rights
of any Award, unless mutually agreed otherwise between the Participant and the Administrator, which agreement must be in writing
and signed by the Participant and the Company; provided further that the Administrator may amend an outstanding Award in order
to conform it to the Administrator&rsquo;s intent (in its sole discretion) that such Award not be subject to Code Section 409A(a)(1)(B).
Termination of the Plan shall not affect the Administrator's ability to exercise the powers granted to it hereunder with respect
to Awards granted under the Plan prior to the date of such termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 75; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;<I>Effect
of the Plan on Other Arrangements.</I>&nbsp;&nbsp;&nbsp;&nbsp;Neither the adoption of the Plan by the Board or a Committee nor
the submission of the Plan to the stockholders of the Company for approval shall be construed as creating any limitations on the
power of the Board or any Committee to adopt such other incentive arrangements as it or they may deem desirable, including without
limitation, the granting of restricted stock, stock options or cash bonuses otherwise than under the Plan, and such arrangements
may be either generally applicable or applicable only in specific cases. The value of Awards granted pursuant to the Plan will
not be included as compensation, earnings, salaries or other similar terms used when calculating an Awardee&rsquo;s benefits under
any employee benefit plan sponsored by the Company or any Subsidiary except as such plan otherwise expressly provides.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>16.</B></TD><TD><B>Designation of Beneficiary.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;An
Awardee may file&nbsp;a written designation of a beneficiary who is to receive the Awardee's rights pursuant to Awardee's Award
or the Awardee may include his or her Awards in an omnibus beneficiary designation for all benefits under the Plan. To the extent
that Awardee has completed a designation of beneficiary while employed with the Company, such beneficiary designation shall remain
in effect with respect to any Award hereunder until changed by the Awardee to the extent enforceable under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;Such
designation of beneficiary may be changed by the Awardee at any time by written notice. In the event of the death of an Awardee
and in the absence of a beneficiary validly designated under the Plan who is living at the time of such Awardee's death, the Company
shall allow the executor or administrator of the estate of the Awardee to exercise the Award, or if no such executor or administrator
has been appointed (to the knowledge of the Company), the Company, in its discretion, may allow the spouse or one or more dependents
or relatives of the Awardee to exercise the Award to the extent permissible under Applicable Law or if no spouse, dependent or
relative is known to the Company, then to such other person as the Company may designate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>17.</B></TD><TD><B>No Right to Awards or to Employment.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">No person shall have
any claim or right to be granted an Award and the grant of any Award shall not be construed as giving an Awardee the right to continue
in the employ or service of the Company or its Affiliates. Further, the Company and its Affiliates expressly reserve the right,
at any time, to dismiss any Employee, Consultant or Awardee at any time without liability or any claim under the Plan, except as
provided herein or in any Award Agreement entered into hereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>18.</B></TD><TD><B>Legal Compliance.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to Section
22, Shares shall not be issued pursuant to the exercise of an Option or Stock Award unless the exercise of such Option or Stock
Award and the issuance and delivery of such Shares shall comply with Applicable Laws and shall be further subject to the approval
of counsel for the Company with respect to such compliance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>19.</B></TD><TD><B>Reservation of Shares</B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company, during
the term of this Plan, will at all times reserve and keep available such number of Shares as shall be sufficient to satisfy the
requirements of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>20.</B></TD><TD><B>Notice</B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt">Any written
notice to the Company required by any provisions of this Plan shall be addressed to the Secretary of the Company and shall be effective
when received.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 76; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>21.</B></TD><TD><B>Governing Law; Interpretation of Plan and Awards.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;This
Plan and all determinations made and actions taken pursuant hereto shall be governed by the substantive laws, but not the choice
of law rules, of the state of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;In
the event that any provision of the Plan or any Award granted under the Plan is declared to be illegal, invalid or otherwise unenforceable
by a court of competent jurisdiction, such provision shall be reformed, if possible, to the extent necessary to render it legal,
valid and enforceable, or otherwise deleted, and the remainder of the terms of the Plan and/or Award shall not be affected except
to the extent necessary to reform or delete such illegal, invalid or unenforceable provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;The
headings preceding the text of the sections hereof are inserted solely for convenience of reference, and shall not constitute a
part of the Plan, nor shall they affect its meaning, construction or effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(d)&nbsp;&nbsp;&nbsp;The
terms of the Plan and any Award shall inure to the benefit of and be binding upon the parties hereto and their respective permitted
heirs, beneficiaries, successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(e)&nbsp;&nbsp;&nbsp;All
questions arising under the Plan or under any Award shall be decided by the Administrator in its total and absolute discretion.
In the event the Participant believes that a decision by the Administrator with respect to such person was arbitrary or capricious,
the Participant may request arbitration with respect to such decision. The review by the arbitrator shall be limited to determining
whether the Administrator's decision was arbitrary or capricious. This arbitration shall be the sole and exclusive review permitted
of the Administrator's decision, and the Awardee shall as a condition to the receipt of an Award be deemed to explicitly waive
any right to judicial review.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(f)&nbsp;&nbsp;&nbsp;Notice
of demand for arbitration shall be made in writing to the Administrator within thirty (30)&nbsp;days after the applicable decision
by the Administrator. The arbitrator shall be selected from amongst those members of the Board who are neither Administrators nor
Employees. If there are no such members of the Board, the arbitrator shall be selected by the Board. The arbitrator shall be an
individual who is an attorney licensed to practice law in the State of Delaware. Such arbitrator shall be neutral within the meaning
of the Commercial Rules of Dispute Resolution of the American Arbitration Association; provided, however, that the arbitration
shall not be administered by the American Arbitration Association. Any challenge to the neutrality of the arbitrator shall be resolved
by the arbitrator whose decision shall be final and conclusive. The arbitration shall be administered and conducted by the arbitrator
pursuant to the Commercial Rules of Dispute Resolution of the American Arbitration Association. The decision of the arbitrator
on the issue(s) presented for arbitration shall be final and conclusive and may be enforced in any court of competent jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>22.</B></TD><TD><B>Limitation on Liability</B>.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and any
Affiliate which is in existence or hereafter comes into existence shall not be liable to a Participant, an Employee, an Awardee
or any other persons as to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(a)&nbsp;&nbsp;&nbsp;<I>The
Non-Issuance of Shares.</I>&nbsp;&nbsp;&nbsp;&nbsp;The non-issuance or sale of Shares (including under Section 18 above) as to
which the Company has been unable, or the Arbitration deems it infeasible, to obtain from any regulatory body having jurisdiction
the authority deemed by the Company's counsel to be necessary to the lawful issuance and sale of any shares hereunder; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;<I>Tax
Consequences.</I>&nbsp;&nbsp;&nbsp;&nbsp;Any tax consequence realized by any Participant, Employee, Awardee or other person due
to the receipt, vesting, exercise or settlement of any Option or other Award granted hereunder or due to the transfer of any Shares
issued hereunder. The Participant is responsible for, and by accepting an Award under the Plan agrees to bear, all taxes of any
nature that are legally imposed upon the Participant in connection with an Award, and the Company does not assume, and will not
be liable to any party for, any cost or liability arising in connection with such tax liability legally imposed on the Participant.
In particular, Awards issued under the Plan may be characterized by the Internal Revenue Service (the &ldquo;IRS&rdquo;) as &ldquo;deferred
compensation&rdquo; under the Code resulting in additional taxes, including in some cases interest and penalties. In the event
the IRS determines that an Award constitutes deferred compensation under the Code or challenges any good faith characterization
made by the Company or any other party of the tax treatment applicable to an Award, the Participant will be responsible for the
additional taxes, and interest and penalties, if any, that are determined to apply if such challenge succeeds, and the Company
will not reimburse the Participant for the amount of any additional taxes, penalties or interest that result.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>


<!-- Field: Page; Sequence: 77; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(c)&nbsp;&nbsp;&nbsp;<I>Forfeiture</I>.
The requirement that Participant forfeit an Award, or the benefits received or to be received under an Award, pursuant to any Applicable
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>23.</B></TD><TD><B>Indemnification.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition to such
other rights of indemnification as they may have as members of the Board or officers or employees of the Company or an Affiliate,
members of the Board and any officers or employees of the Company or an Affiliate to whom authority to act for the Board or the
Company is delegated shall be indemnified by the Company against all reasonable expenses, including attorneys&rsquo; fees, actually
and necessarily incurred in connection with the defense of any action, suit or proceeding, or in connection with any appeal therein,
to which they or any of them may be a party by reason of any action taken or failure to act under or in connection with the Plan,
or any right granted hereunder, and against all amounts paid by them in settlement thereof (provided such settlement is approved
by independent legal counsel selected by the Company) or paid by them in satisfaction of a judgment in any such action, suit or
proceeding, except in relation to matters as to which it shall be adjudged in any such action, suit or proceeding that such person
is liable for gross negligence, bad faith or intentional misconduct in duties; provided, however, that within sixty (60) days after
the institution of such action, suit or proceeding, such person shall offer to the Company, in writing, the opportunity at its
own expense to handle and defend the same.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.25in; text-align: left"><B>24.</B></TD><TD><B>Unfunded Plan.</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt">Insofar
as it provides for Awards, the Plan shall be unfunded. Although bookkeeping accounts may be established with respect to Awardees
who are granted Stock Awards under this Plan, any such accounts will be used merely as a bookkeeping convenience. The Company shall
not be required to segregate any assets which may at any time be represented by Awards, nor shall this Plan be construed as providing
for such segregation, nor shall the Company nor the Administrator be deemed to be a trustee of stock or cash to be awarded under
the Plan. Any liability of the Company to any Participant with respect to an Award shall be based solely upon any contractual obligations
which may be created by the Plan; no such obligation of the Company shall be deemed to be secured by any pledge or other encumbrance
on any property of the Company. Neither the Company nor the Administrator shall be required to give any security or bond for the
performance of any obligation which may be created by this Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 4.5pt; text-align: justify; text-indent: 31.5pt">&nbsp;</P>


<!-- Field: Page; Sequence: 78; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><A NAME="a_055"></A>APPENDIX B </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">FORM OF AMENDMENT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">TO</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">EXPONENT INC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">2008 EMPLOYEE STOCK PURCHASE PLAN</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 24.5pt">In accordance with
Section&nbsp;24 of the 2008 Employee Stock Purchase Plan, the 2008 Employee Stock Purchase Plan is hereby amended effective June
1, 2017 to include the following changes and additions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
substituting the following for the second to last sentence of section 1 of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;A total of 600,000 Shares
of Common Stock may be issued under the Plan.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24.45pt; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.25in">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By
substituting the following for the first sentence of section 24 of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&ldquo;The Plan shall continue
until the earlier to occur of termination by the Board, issuance of all of the Shares of Common Stock reserved for issuance under
the Plan, or June 1, 2027.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 79; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPONENT, INC.</B><BR>
<B>AMENDED AND RESTATED 2008 EMPLOYEE STOCK PURCHASE PLAN (AS PROPOSED TO BE AMENDED)</B></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">1.</TD><TD>ESTABLISHMENT OF PLAN</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Exponent, Inc. (the &ldquo;Company&rdquo;)
adopted this plan in 2008 to grant options for the purchase of shares (&ldquo;Shares&rdquo;) of the Company&rsquo;s Common Stock
to eligible employees of the Company and Subsidiaries (as hereinafter defined) pursuant to this Employee Stock Purchase Plan (the
&ldquo;Plan&rdquo;). For purposes of this Plan, &ldquo;parent corporation&rdquo; and &ldquo;Subsidiary&rdquo; (collectively, &ldquo;Subsidiaries&rdquo;)
shall have the same meanings as &ldquo;parent corporation&rdquo; and &ldquo;subsidiary corporation&rdquo; in Section&nbsp;424,
of the Internal Revenue Code of 1986, as amended (the &ldquo;Code&rdquo;). The Company intends that the Plan shall qualify as an
&ldquo;employee stock purchase plan&rdquo; under Section&nbsp;423 of the Code (including any amendments or replacements of such
section), and the Plan shall be so construed. Any term not expressly defined in the Plan but defined for purposes of Section&nbsp;423
of the Code shall have the same definition in this Plan. A total of 600,000 Shares of Common Stock may be issued under the Plan.
Such number shall be subject to adjustments effected in accordance with Section&nbsp;14 of the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">2.</TD><TD>PURPOSES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The purpose of the Plan is to provide employees
of the Company and any Subsidiary designated by the Company&rsquo;s Board of Directors (the &ldquo;Board&rdquo;) as one whose employees
are eligible to participate in the Plan with a convenient means to acquire an equity interest in the Company through payroll deductions,
to enhance such employees&rsquo; sense of participation in the affairs of the Company and Subsidiaries, and to provide an incentive
for continued employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">3.</TD><TD>ADMINISTRATION</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)&nbsp;&nbsp;&nbsp;&nbsp;The
Plan is administered by the Board or by a committee designated by the Board (in which event all references herein to the Board
shall be to the committee). Subject to the provisions of the Plan and the limitations of Section&nbsp;423 of the Code or any successor
provision in the Code, all questions of interpretation or application of the Plan shall be determined by the Board and its decisions
shall be final and binding upon all participants. Members of the Board shall receive no compensation for their services in connection
with the administration of the Plan, other than standard fees as established from time to time by the Board of Directors of the
Company for services rendered by Board members serving on Board committees. All expenses incurred in connection with the administration
of the Plan shall be paid by the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-align: justify; text-indent: 0.25in">(b)&nbsp;&nbsp;&nbsp;The
Board (or the committee) shall have the power, subject to, and within the limitations of, the express provisions of the Plan:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)&nbsp;&nbsp;&nbsp;To
determine when and how options to purchase Shares shall be granted and the provisions of each Offering Period (which need not be
identical);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)&nbsp;&nbsp;&nbsp;To
designate from time to time a Subsidiary as one whose employees shall be eligible to participate in the Plan (any such designated
Subsidiary, a &ldquo;Designated Corporation&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)&nbsp;&nbsp;&nbsp;To
construe and interpret the Plan and rights to purchase (options on) Shares, and to establish, amend and revoke rules and procedures
for its administration, including that the Board, in the exercise of this power, may correct any defect, omission or inconsistency
in the Plan, in a manner and to the extent it shall deem necessary or expedient to make the Plan fully effective;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)&nbsp;&nbsp;&nbsp;To
amend or terminate the Plan as provided in Section&nbsp;24 below;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)&nbsp;&nbsp;&nbsp;To
adopt rules and procedures (including sub-plans and/or special provisions)&nbsp;relating to the operation and administration of
the Plan to permit participation in the Plan by employees who are foreign nationals or employed outside the United States; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 80; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi)&nbsp;&nbsp;&nbsp;Generally,
to exercise such powers and to perform such acts it deems necessary, desirable, convenient or expedient to promote the best interests
of the Company and its Subsidiaries and to carry out that intent that the Plan be treated as an &ldquo;employee stock purchase
plan&rdquo; under Section&nbsp;423 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">4.</TD><TD>ELIGIBILITY</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Any employee of the Company or any of its
Subsidiaries whom the Board designates as a participating Subsidiary (a &ldquo;Designated Subsidiary&rdquo;) is eligible to participate
in an Offering Period (as hereinafter defined) under the Plan except the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;employees
who are not employed by the Company or a Designated Subsidiary on a date specified by the Board before the beginning of such Offering
Period; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;employees
who are customarily employed for less than 20 hours per week; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c)&nbsp;&nbsp;&nbsp;employees
who are customarily employed for less than 5&nbsp;months in a calendar year; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d)&nbsp;&nbsp;&nbsp;employees
who, together with any other person whose stock would be attributed to such employee pursuant to Section 425(d) of the Code, own
stock or hold options to purchase stock or who, as a result of being granted an option under the Plan with respect to such Offering
Period, would own stock or hold options to purchase stock possessing 5&nbsp;percent or more of the total combined voting power
or value of all classes of stock of the Company or any of its Subsidiaries; and </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(e)&nbsp;&nbsp;&nbsp;individuals
who provide services to the Company or a Designated Subsidiary as independent contractors who are reclassified as common law employees
for any reason except for federal income and employment tax purposes. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">5.</TD><TD>OFFERING PERIODS; OFFERING DATES; AND PURCHASE DATES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;Each
Offering Period under the Plan (each an &ldquo;Offering Period&rdquo;) shall be of the duration provided for or permitted herein.
The first trading day (a day on which the Common Stock trades on the principal exchange or system on which the Common Stock is
listed) of each Offering Period is referred to as the &ldquo;Offering Date.&rdquo; The Board may but need not provide for multiple
purchases within a single Offering Period. The Board shall have the power to change the duration of Offering Periods without stockholder
approval. The last trading day of each Offering Period (or in the case of an Offering Period encompassing multiple purchases, each
such purchase period) is hereinafter referred to as the &ldquo;Purchase Date.&rdquo; </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;Subject
to Section 5(c) below, each Offering Period shall be of three months&rsquo; duration commencing on the first business day of each
fiscal quarter and ending on the last business day of the fiscal quarter, and shall have a single Purchase Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c)&nbsp;&nbsp;&nbsp;Notwithstanding
5(b) above and the other provisions of the Plan, the Board of Directors may, but need not, vary the terms and structure of the
Offering Periods under this Plan, on such basis as it shall determine in its sole discretion (including without limitation, the
length of each Offering Period and Offering Periods during which more than one Purchase Date shall occur; provided however that
no Offering Period may have a duration in excess of twenty-seven (27) months (or such longer period as may be permitted under Code
Section 423). </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">6.</TD><TD>PARTICIPATION IN THE PLAN</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">An eligible employee may become a participant
in an Offering Period under the Plan if (a) as of the Offering Date with respect to the Offering Period he or she satisfies the
eligibility requirements set forth above, and (b) prior to such Offering Date (at such time and in such manner as may be specified
with respect to such Offering Period) he or she delivers to the Company or its authorized representative a subscription agreement
indicating his or her desire to enroll in the Offering Period and authorizing payroll deductions in a manner consistent with Section
9 below. An eligible employee who does not timely deliver a subscription agreement by the date specified in advance of the applicable
Offering Date shall not participate in that Offering Period and shall not participate in any subsequent Offering Period unless
such employee enrolls in the Plan by timely delivering a subscription agreement to the Company or its representative prior the
Offering Date of the applicable, subsequent Offering Period. Once an employee becomes a participant in an Offering Period, such
employee will automatically participate in the Offering Period commencing immediately following the last day of that Offering Period
unless the employee withdraws from the Plan or terminates further participation in the Offering Period as set forth in Section&nbsp;11
below. Such participant is not required to file any additional subscription agreements in order to continue participation in the
Plan with respect to subsequent Offering Periods. Any participant who has not withdrawn from the Plan pursuant to Section&nbsp;11
below will automatically be re-enrolled in the Plan and granted a new option on the Offering Date of the next Offering Period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 81; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">7.</TD><TD>GRANT OF OPTION</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;Each
employee enrolled in an Offering Period will be granted on the Offering Date an option to purchase on each Purchase Date up to
that number of Shares determined by dividing the amount accumulated in such employee&rsquo;s payroll deduction account during such
Offering Period by the Purchase Price (as defined in Section 8 below) applicable to that Offering Period. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;In
no event, however, shall the number of Shares of the Company&rsquo;s Common Stock subject to any option granted pursuant to this
Plan exceed the limitations set forth in Section&nbsp;10 below. The Purchase Price and fair market value of a Share shall be determined
as provided in Section&nbsp;8 hereof. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">8.</TD><TD>PURCHASE PRICE</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The &ldquo;Purchase Price&rdquo; per Share
at which a Share will be sold in any Offering Period shall be ninety-five percent (95%) of the fair market value on the applicable
Purchase Date. For purposes of the Plan, the term &ldquo;fair market value&rdquo; on a given date shall mean: (a) the closing price
on the Purchase Date of a Share as reported on the Nasdaq Stock Market (or any other exchange or market quotation system that is
then the primary exchange or market on which the Common Stock trades), (b) if the relevant date does not fall on a trading day,
the closing price of a Share as of the last preceding day on which the Common Stock traded, or (c) such other value as the Board
determines in its good faith judgment to be a reasonable valuation for a Share as of such date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in">9.</TD><TD STYLE="text-align: justify">PAYMENT OF PURCHASE PRICE; CHANGES IN PAYROLL DEDUCTIONS; ISSUANCE OF SHARES</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;The
aggregate purchase price of the Shares is accumulated by regular payroll deductions made during each Offering Period. The deductions
are made as a percentage of the employee&rsquo;s compensation in one percent (1%) increments not less than one percent (1%) nor
greater than fifteen percent (15%). Compensation shall mean all base straight-time gross earnings including commissions, overtime
and paid-time off but exclusive of shift premiums, incentive compensation, bonuses, any amounts relating to Company equity awards,
and other compensation not listed above; provided, however, that for purposes of determining a participant&rsquo;s compensation,
any election by such participant to reduce his or her regular cash remuneration under Sections&nbsp;125 or 401(k) of the Code shall
be treated as if the participant did not make such election. Payroll deductions shall commence on the first payroll date following
the Offering Date and shall continue until the last payroll date immediately preceding the Purchase Date unless sooner altered
or terminated as provided in the Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;Except
pursuant to a withdrawal from the Plan under Section 11 below (in which case all payroll deductions shall cease), a participant
may not change his or her rate of payroll deductions during an Offering Period. A participant may increase or decrease the rate
of payroll deductions for any subsequent Offering Period by filing with the Administrator a new authorization for payroll deductions
on a date specified by the Board prior to the beginning of such Offering Period.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c)&nbsp;&nbsp;&nbsp;All
payroll deductions made for a participant are credited to his or her account under the Plan and are deposited with the general
funds of the Company. No interest accrues on the payroll deductions. All payroll deductions received or held by the Company may
be used by the Company for any corporate purpose, and the Company shall not be obligated to segregate such payroll deductions.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>


<!-- Field: Page; Sequence: 82; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d)&nbsp;&nbsp;&nbsp;On
each Purchase Date, so long as the Plan remains in effect and provided that the participant has not withdrawn from that Offering
Period under the Plan in accordance with the provisions of Section 11 below before that date, the Company shall apply the funds
then in the participant&rsquo;s account to the purchase of whole Shares reserved under the option granted to such participant with
respect to the Offering Period to the extent that such option is exercisable on the Purchase Date. The Purchase Price per Share
shall be as specified in Section&nbsp;8 of the Plan. Any cash remaining in a participant&rsquo;s account after such purchase of
Shares shall be refunded (without interest) to such participant in cash; provided, however, that any amount remaining in such participant&rsquo;s
account on a Purchase Date which is less than the amount necessary to purchase a full Share of Common Stock of the Company shall
be carried forward, without interest, into the next Offering Period (or in the event of an Offering Period during which multiple
purchase will occur, into the next applicable purchase period within the Offering Period). In the event that the Plan has been
oversubscribed as provided in Section 10(c), all funds not used to purchase Shares on the Purchase Date shall be returned to the
participant (without interest). No Shares shall be purchased on a Purchase Date on behalf of any employee whose participation in
the Plan has terminated prior to such Purchase Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(e)&nbsp;&nbsp;&nbsp;&nbsp;As
promptly as practicable after the Purchase Date, the Company shall arrange the delivery to each participant, as appropriate, of
a certificate representing the Shares purchased upon exercise of his option; provided that the Company may deliver certificates
to a broker or brokers that hold such certificate in street name for the benefit of each such participant.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(f)&nbsp;&nbsp;&nbsp;&nbsp;During
a participant&rsquo;s lifetime, such participant&rsquo;s option to purchase Shares hereunder is exercisable only by him or her.
The participant will have no interest or voting right in Shares covered by his or her option until such option has been exercised.
Shares to be delivered to a participant under the Plan will be registered in the name of the participant or in the name of the
participant and his or her spouse provided that shares may be registered to a broker or brokers that hold such shares in street
name for the benefit of each participant.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">10.</TD><TD>LIMITATIONS ON SHARES TO BE PURCHASED</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;No
employee shall be entitled to purchase Shares under the Plan at a rate which, when aggregated with his or her rights to purchase
Shares of Common Stock under all other employee stock purchase plans of the Company or any Subsidiary, exceeds $25,000 in fair
market value, determined as of the date such right is granted (or such other limit as may be imposed by the Code) for each calendar
year in which the employee participates in the Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;Subject
to Sections 9(a), 10(a) and 14(a) of the Plan, the maximum number of Shares that a participant may purchase on any single Purchase
Date shall not exceed 5,000 Shares (the &ldquo;Maximum Share Amount&rdquo;); provided that prior to the commencement of any Offering
Period, the Board may, in its sole discretion and without stockholder approval, change the Maximum Share Amount with respect to
that Offering Period. If a new Maximum Share Amount is set, then all participants must be notified of such Maximum Share Amount
prior to the commencement of the next Offering Period. Once a Maximum Share Amount is set, it shall continue to apply in respect
of all succeeding Purchase Dates and Offering Periods unless revised by the Board as set forth above. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(c)&nbsp;&nbsp;&nbsp;If
the number of Shares to be purchased on a Purchase Date by all employees participating in the Plan exceeds the number of Shares
then available for issuance under the Plan, the Company will make a pro rata allocation of the remaining Shares in as uniform a
manner as shall be practicable and as the Board shall determine to be equitable. In such event, the Company shall give written
notice of such reduction of the number of Shares to be purchased under a participant&rsquo;s option to each employee affected thereby.
</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(d)&nbsp;&nbsp;&nbsp;Any
payroll deductions accumulated in a participant&rsquo;s account which are not used to purchase stock due to the limitations in
this Section&nbsp;10 shall be returned to the participant (without interest) as soon as practicable after the end of the Offering
Period in the manner set forth in Section 9(d). </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 83; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">11.</TD><TD>WITHDRAWAL</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;&nbsp;Each
participant may withdraw from an Offering Period under the Plan by signing and delivering to the Administrator notice on a form
provided for such purpose. Such withdrawal may be elected at any time prior to the end of an Offering Period at such time and in
such manner as the Board specifies. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;&nbsp;Upon
withdrawal from the Plan, the accumulated payroll deductions shall be returned (without interest) to the withdrawn employee and
his or her interest in the Plan shall terminate. In the event an employee voluntarily elects to withdraw from the Plan, he or she
may not resume his or her participation in the Plan during the same Offering Period, but he or she may participate in any Offering
Period under the Plan which commences on a date subsequent to such withdrawal by filing a new authorization for payroll deductions
in the same manner as set forth in Section 6 above for initial participation in the Plan. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">12.</TD><TD>TERMINATION OF EMPLOYMENT</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Termination of a participant&rsquo;s employment
for any reason, including retirement or death, or the failure of a participant to remain an eligible employee as set forth in Section
4 terminates his or her participation in the Plan immediately. In such event, the payroll deductions credited to the participant&rsquo;s
account will be returned to him or her or, in the case of his or her death, to his or her legal representative. For this purpose,
an employee will not be deemed to have terminated employment or failed to remain in the continuous employ of the Company in the
case of sick leave, military leave, or any other leave of absence approved by the Board of Directors of the Company; provided that
such leave is for a period of not more than ninety (90)&nbsp;days or, if such leave is longer than nintey (90) days, reemployment
upon the expiration of such leave is guaranteed by contract or statute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">13.</TD><TD>RETURN OF PAYROLL DEDUCTIONS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event an employee&rsquo;s interest
in the Plan is terminated by withdrawal, termination of employment or otherwise, or in the event the Plan is terminated by the
Board, the Company shall promptly deliver to the employee all payroll deductions credited to his or her account. No interest shall
accrue on the payroll deductions of a participant in the Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">14.</TD><TD>CAPITAL CHANGES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Subject to any required action by the stockholders
of the Company, the number of Shares covered by each option under the Plan which has not yet been exercised, the Maximum Share
Amount set forth in Section 10(b) above, and the number of Shares which have been authorized for issuance under the Plan but have
not yet been placed under option (collectively, the &ldquo;Reserves&rdquo;), as well as the price per Share covered by each option
under the Plan which has not yet been exercised, shall be proportionately adjusted for any increase or decrease in the number of
issued Shares resulting from a stock split or the payment of a stock dividend (but only on the Common Stock) or any other increase
or decrease in the number of Shares effected without receipt of consideration by the Company; provided, however, that conversion
of any convertible securities of the Company shall not be deemed to have been &ldquo;effected without receipt of consideration.&rdquo;
Such adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive. Except
as expressly provided herein, no issue by the Company of shares of stock of any class, or securities convertible into shares of
stock of any class, shall affect, and no adjustment by reason thereof shall be made with respect to, the number or price of Shares
subject to an option.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In the event of the proposed dissolution
or liquidation of the Company, each Offering Period will terminate immediately prior to the consummation of such proposed action,
unless otherwise provided by the Board. In such event, the Board may, in the exercise of its sole discretion in such instances,
declare that the options under the Plan shall terminate as of a date fixed by the Board and give each participant the right to
exercise his or her option as to all of the optioned stock. In the event of a proposed sale of all or substantially all of the
assets of the Company, or the merger of the Company with or into another corporation, each option under the Plan shall be assumed
or an equivalent option shall be substituted by such successor corporation or a parent or subsidiary of such successor corporation,
unless the Board determines, in the exercise of its sole discretion and in lieu of such assumption or substitution, that the participant
shall have the right to exercise the option as to all of the optioned Shares. If the Board makes an option exercisable in lieu
of assumption or substitution in the event of a merger or sale of assets, the Board shall notify the participant that the option
shall be fully exercisable on a date specified in such notice, and the option will terminate upon the expiration of such period.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 84; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Board may, if it so determines in the
exercise of its sole discretion, also make provision for adjusting the Reserves, as well as the price per Share covered by each
outstanding option, in the event that the Company effects one or more reorganizations, recapitalizations, rights offerings or other
increases or reductions of Shares of its outstanding Common Stock, and in the event of the Company being consolidated with or merged
into any other corporation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">15.</TD><TD>NONASSIGNABILITY</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither payroll deductions credited to
a participant&rsquo;s account nor any rights with regard to the exercise of an option or to receive Shares under the Plan may be
assigned, transferred, pledged or otherwise disposed of in any way (other than by will, the laws of descent and distribution or
as provided in Section&nbsp;22 hereof) by the participant. Any such attempt at assignment, transfer, pledge or other disposition
shall be without effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">16.</TD><TD>REPORTS</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Individual accounts will be maintained
for each participant in the Plan. Each participant shall receive any reports required to be delivered by applicable law as well
as, after the end of each Offering Period, a report of his account setting forth the total payroll deductions accumulated, the
number of Shares purchased, the per Share price thereof and the remaining cash balance, if any, carried forward to the next Offering
Period or Offering Period, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">17.</TD><TD>NOTICE OF DISPOSITION</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Each participant shall notify the Company
if the participant disposes of any of the Shares purchased in any Offering Period pursuant to this Plan if such disposition occurs
within two years from the Offering Date or within one (1) year from the Purchase Date on which such Shares were purchased (the
&ldquo;Notice Period&rdquo;). Unless such participant is disposing of any of such Shares during the Notice Period, such participant
shall keep the certificates representing such Shares in his or her name (and not in the name of a nominee) during the Notice Period.
The Company may, at any time during the Notice Period, place a legend or legends on any certificate representing Shares acquired
pursuant to the Plan requesting the Company&rsquo;s transfer agent to notify the Company of any transfer of the Shares. The obligation
of the participant to provide such notice shall continue notwithstanding the placement of any such legend on certificates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">18.</TD><TD>NO RIGHTS TO CONTINUED EMPLOYMENT</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Neither this Plan nor the grant of any
option hereunder shall confer any right on any employee to remain in the employ of the Company or any Subsidiary or restrict the
right of the Company or any Subsidiary to terminate such employee&rsquo;s employment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">19.</TD><TD>EQUAL RIGHTS AND PRIVILEGES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All participants in an Offering Period
shall have the same rights and privileges with respect to their participation in the Plan for that Offering Period, in accordance
with Section&nbsp;423 of the Code and the related regulations (and any successor provisions). Any provision of the Plan, a specific
Offering Period or an option granted under the Plan which is inconsistent with this Section&nbsp;19 shall without further act or
amendment by the Company or the Board be reformed, if possible, to the extent necessary to render such provision in compliance
with the requirements of Section&nbsp;423 of the Code, or shall otherwise be deleted, and the remainder of the terms of the Plan,
an Offering Period and/or an option shall not be affected.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


<!-- Field: Page; Sequence: 85; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">20.</TD><TD>NOTICES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All notices or other communications by
a participant to the Company under or in connection with the Plan shall be deemed to have been duly given when received in the
form specified by the Company at the location, or by the person, designated by the Company for the receipt thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">21.</TD><TD>DESIGNATION OF BENEFICIARY</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A
participant may file a written designation of a beneficiary who is to receive any Shares and cash, if any, from the participant&rsquo;s
account under the Plan in the event of such participant&rsquo;s death subsequent to the end of an Offering Period but prior to
delivery to him of such Shares and cash. In addition, a participant may file a written designation of a beneficiary who is to receive
any cash from the participant&rsquo;s account under the Plan in the event of such participant&rsquo;s death prior to a Purchase
Date. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Such
designation of beneficiary may be changed by the participant at any time by written notice. In the event of the death of a participant
and in the absence of a beneficiary validly designated under the Plan who is living at the time of such participant&rsquo;s death,
the Company shall deliver such Shares or cash to the executor or administrator of the estate of the participant, or if no such
executor or administrator has been appointed (to the knowledge of the Company), the Company, in its discretion, may deliver such
Shares or cash to the spouse or to any one or more dependents or relatives of the participant, or if no spouse, dependent or relative
is known to the Company, then to such other person as the Company may designate. </FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">22.</TD><TD>CONDITIONS UPON ISSUANCE OF SHARES</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Shares shall not be issued with respect
to an option unless the exercise of such option and the issuance and delivery of such Shares pursuant thereto shall comply with
all applicable provisions of law, domestic or foreign, including, without limitation, the Securities Act of 1933, as amended, the
Exchange Act, the rules and regulations promulgated thereunder, and the requirements of any stock exchange upon which the Shares
may then be listed, and shall be further subject to the approval of counsel for the Company with respect to such compliance. The
Company shall have no liability for failure to issue any Shares under this Plan in the event that such issuance cannot be accomplished
in compliance with all applicable laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">23.</TD><TD>APPLICABLE LAW</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan shall be governed by the substantive
laws (excluding the conflict of laws rules) of the State of Delaware.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0%"></TD><TD STYLE="width: 0.5in; text-align: left">24.</TD><TD>AMENDMENT OR TERMINATION OF THE PLAN</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Plan shall continue until the earlier
to occur of termination by the Board, issuance of all of the Shares of Common Stock reserved for issuance under the Plan, or June
1, 2027. The Board of Directors of the Company may at any time amend or terminate the Plan, except that any such termination cannot
affect options previously granted under the Plan, nor may any amendment make any change in an option previously granted which would
adversely affect the right of any participant; provided that if the Board determines that a change in applicable accounting rules
or a change in applicable laws, renders an amendment or termination desirable, then the Board may approve such an amendment or
termination. The Board may not amend the Plan without approval of the stockholders of the Company obtained in accordance with Section&nbsp;21
hereof within 12&nbsp;months of the adoption of such amendment (or earlier if required by Section&nbsp;21) if such amendment would:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(a)&nbsp;&nbsp;&nbsp;Increase
the number of Shares that may be issued under the Plan; or </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-weight: normal">(b)&nbsp;&nbsp;&nbsp;Expand
the designation of the employees (or class of employees) eligible for participation in the Plan. </FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 86; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>



<P STYLE="margin: 0"><IMG SRC="def14a_proxy1.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 87 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"><IMG SRC="def14a_proxy2.jpg" ALT=""></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 88; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="width: 33%">&nbsp;</TD><TD STYLE="width: 34%; text-align: center">&nbsp;</TD><TD STYLE="width: 33%; text-align: right">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>def14a_logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14a_logo.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ 3 $M P$1  (1 0,1 ?_$ )4   (" @,  P
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M8'\1>-T684XJ6SCD*-0$8Z/*P3.I$8UIKEP0KLU3K"KE4RBY@3-(O3G7,0I
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M.>YS)4;=,G8MM<O5&M*PWDG([!PR<H2->2]KEJ979:-CG1Y,>T$5U4S]OSA
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MCY)@)Q*/3KY?708>Q=LBV9X0E0GL-;3=MN*IT%!5+-X\PAC6GS!%!#H)TY2
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'0&@- :#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>pg03mg1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg03mg1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ )P$+ P$1  (1 0,1 ?_$ '4   $#!0$!
M      D'" H  00%!@," 0$                     $   !@(!! $"! 0%
M!0     ! @,$!08'"!$ (1()$S$405$B(V$R%1:!0B47&'%2,R0*$0$
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MPX^G0:F6?,HQL\?OGK6/9,6CA[(.G3A)H@W:MTP4<.G+MP)6[9JW0*)CG,(
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MT'(6J\U*CQ+^P7"WUVKQ,:W,XDY.Q3<="1C!N % 7#I9ZX+]MP!R]S=@_'H
M8[<>ZN!82U5UZT*QQ=-E=C\W6)QC?#5Y90ZS? [2T$,/]S61]<'1D#VB#H,8
MFL\>'BF[E$ATTTU%"?('($6T4TDI^H%)EW+MT-]S[E9PE<-@LWS13/+7DN^O
M1^XD57$DN==1K7XMPJ*$>P2,1N@@F40)Y=P!]X$(7N4I2_AV* =A'D0[!^8\
M]!]=!705T @O9+L%,NI&NZ8XQNZ5%M62ZM/90V!R* %,IB+4VG%\LA3,:H(
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M6C(QJ[!]FK*L@]H^&X%X<OV[>;&.6?2=RGB)B*C:ITB*2._>KB !XI@0!\C
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MMAJ+//WN34B9ES7W;BT-/'[2C12$TQ.@L]DCHD0(/R&#QZ .F>L:;D>RS?\
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M!A$3_?\ S$^0%2F\13#QXY'D'*.#& I!Y#CR,)B"D*ACI@4?,A3>102,)?\
M,/;H!+YLB/8MAS<2<S5KFVJ.SNON1<=Q%=M&N5POK+'LWB:X0!U0C[E09D8B
M03=1UD1$HR+=T4XF5$?B$G #T%Y?%WL9VAB7*6P.4:1H]B0[1JK-477*PNL@
M98GHCXU%9UG/9LM$#7(NE J@!4^(N,46(!C"5V @ @$>S3VV[B:5GW:UK]4>
MK>MNZL*^RY<)_#FTF/MDM?+O;(2%LCAL63B\V.XZ[#9Y.;JEA^<Q&<BLF<7
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HM+^[_A_V#M/W/VO]6_I']%^#X_D_NOS_ '_Z5Q]]]I^]\?AWZ#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>pg59img1-.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 pg59img1-.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@ *@$+ P$1  (1 0,1 ?_$ (    (!! ,!
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M/?&.48L^4W/&HPC5RO'IY,Q];)60+VIQC&SRN**:PD*RU @ 0KAM&QK:05V
M!.9[N.XB.@8(7M[0[1W*/4!_;OUW_GOH*=4=C&[O<$FQ3"/H1,2ATV!,/</W
M#ZAZ:"TR\RPK\8]G9N5CXB*8-Q<2,E+/6T5$,&Q?5X\>/5 39)E 0W,<Q2!]
MN@1WS,\V6*L8N(O"/$&L6KE5RBRA9BXQPVE2HA=]AQ3([PXIO?U!D4ITXR0C
MZ>S(J]?A%D>>RFB!5!3[P$0FOP(X/0?%2NV*\7=\3(W*K-RB%OY$YKEBJ.YZ
MUVIW_P!RI7XMTY.N,32JP=7Y5@P;F31*1(#B43#N ,+*0A>I2%*/7J!0 >H]
MP]0#[1ZZ#EH#0&@5-Y'>05LC24[B+A6V,*IF7/L?8)ZWW1T5-1/#7&BGMC.L
MOY0$3[)EEOR4#M(HBG59V<_8 F(&@[?&#AJN5K'5AS+ U4*C6\G!"P6'XI=,
M_P"9I<>Z&5XA0W<HHHFDX5DKM,2<G9EE%/Q%%)GN/\8F'0-!W7$QS^[VI@5/
M8J8"8Z?:/>L90#;]VZ8  ;!ZCH->GR_<H+?G2SM/%)Q8N;V#S9GAK%065;[5
M)% \CC2F6!T0SF#5!#9\W>2T")W$J9LHF[CXHP+$,4=!)_+^35^!^%N*OC^X
M@UR,LW).[UJ#Q-AZ(=(**P%%K-7B6S&X9TR,FV]QQ^FH)-,SI05CIJ/WZI2F
M4W$^@C-C#B%1N067:U4(0[J[X^P#F"*RCR8Y:V5FB:]\E.35,,1U%X[I4LNF
M1U'XYH4N^([5%D<6"!B),TC'-\P(AL.(B4W<?M IQ$0.7IW%, ]2F$ #?81Z
M?QT'?H+3/2T= 0DM.R\@WB(F&CGDK*2KM1-)K&1L>@H[?/W2JOX:;9FU2.HH
M(^A"CH-41.TO/.%S0Q,:.GK9$\3^/65#Y:94=,%V$%<:)0Y([:GY!M:S8YD9
M&>RED*-*>$CS*BBW@HYZHHF8ZB8E#;"1;(M4TV[=NFB@@BDDU2*'P%*B4"I%
M OH7V2E "_L#TT%?H(<<Y>3E5X?\0N0')*V.T6<3C'&5IL#-LZ6*U6DIXS!=
M&O1C4YQ Q7LK)J)I(I?>,8>F@1KX;N-/,W/'!?%ENRSFB<XUX3S(:S9B-0\*
MHMHO->3W64YIY:IJ\WC+KM-=W -+<O)F<,6;!)0Q&"A$U3%$ V![W&[A!QAX
MJ$D'F&L50<':IU05K)D*64<VG(ME<C[A3N9N[SZCV<<'5*?8Z::J2 _X.@:"
M6 )D ! "% !'N'IZCTZ_QZ:"G4 J $!(!+ML %*.VX;" ?"/50W[ T&L+SBY
M6,\_<Z*QC^H,H[)L'P_M2%<Q-BU-07S;-/.ZSQ+5>-D):-;B<AL;<<*M($D)
M9\J'LHOGAT!'W" &@>7PKXY.N-&'$ZE9K&-ZRI;+#,Y'S1D-1,4UKMD^X*IO
MI^1*F8QCHQT8D1"/9$WV!FT2Z 83:"76@- : T&NID#D94,?^3#GSRNM;;\Y
MK/"'B=C/!U09Q[I1PZL^4,H2(9 7J$,5000/9)%T^2CP:H@=0"[F$ $- RO@
M!AN_8UPFXOF7"-T\]<B;7*9\S2BW4<JH1MFN*34\'2T3+;&.WQS34&,&!P
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MT^]N.@\U0^7TUF'GOD;C)BM:KRF,N->+(N3Y"63L6<RK;*N1WJJF/J57U4W
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HQH#ZEC0'U+&@/J6- ?4L:#F7T_U*WK_>]= ?;_J5?7^7I_N_MT'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>def14a_proxy1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14a_proxy1.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$10,T P$1  (1 0,1 ?_$ +   0 !!0$! 0$!
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MC>]0)B@<VJ%*C76*D>5\X;8\2!HC"%>6<>Y@V-MV5O8P'B"$6]!K_JS^(?\
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M233*&K1R(^5"9MPS3C^:PEWTTI&9\[M+\W[=^SXGMUK6!*[ 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M_G18#]2_G:^_7X]_[CML_P#.BP'ZE_.U]^OQ[_W';9_YT6 _4OYVOOU^/?\
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MG-MV74K3<\ZD$Q>7!^?OIF[EKA;FF(Y>YGJ%8$$2130EI1)O=\-&B0E)R]!
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M.K?+,E7_ $JF\&<$3.G^'U])$>23G<E?Z*B42=3KYPNH J/]L)VU, S^=_/
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MAWL19>_4 0VA8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# IA#TS*@-AB5V;%);T
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MMW7#L_!,)2XVC+JR[X9Z(;)E8<(A#U(I774.\BL(K-@=)6Q)(<W0IRDB>O!
M!MW2,Z,05! '(G1*L 3PA3O''<'2<PLQE1W3<LUMAIM_E)#?9[7+X; XTVUU
M-TM\SRO0L,$%"H7$U:6/JX0E;@*4CJ>YJ352'2P!I8E)X1AN;P&!H>_AZ/\
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M17;V6F.-$4)-_A0@WL'N"_M;"/7KK81:]=AWZ;T+7N +81:_)ZZ]0B#O6_\
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MX+"32?\ /1N&\BN1-Y+#[+ADX&>=,AI1S*-<U+%!;0X"U\5LC*H]E)&62:-
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M\]U9VIT4M3@Q*7)M0KU#([_)?2S.>L2E*#6IS^C5CBW?2#>89LD[Y=0>3\0
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M*M1JB!A&4:4,19@!:$'>];UO WYX# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# \3<VMS0C);FE B:V]/\3Y="W)2$2,CXIHSS?@I4Q91!7Q#C!#%[
M0Z]1"WO?Y=[P/;@,!@,!@,!@,!@,!@,!@,!@,!@,!@,"THG () 0/14%A42A
M9<D?%LGD1<3C;/' /\E<O9](R%Z SHT875\7_"#\=6?\10;[=>X>_36!=N P
M& P& P& P-2LI\$?B'FTGD<SE?!M)/DIE[\\2B2O2Q+)MJW=_?W%2[/+HJV5
M(RR_F%[BK,-'[0A#[A[]-:U^3 H/X?SPT?N^:)_^]93_ )2X#\/YX:/W?-$_
M_>LI_P I<!^'\\-'[OFB?_O64_Y2X$_.8>1^;>+Z\75/RU4,4I6N7*4N4V7Q
M.'E+BFQ5*W=O:6IR?#M."U>H$M5MS$C)%OW^WV)P:UK7I@2,P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MLFP'XEGPA_?MBGU4= ?9-@/Q+/A#^_;%/JHZ ^R; ?B6?"']^V*?51T!]DV
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MOM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I>
M_8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q
M _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL
M6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7
M=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P
M'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^
M('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<M
MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ
M[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I>
M _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /
MQ _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[E
ML6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE
M7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+
MP'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!
M^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<
MMBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^L
MJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I
M> _8!^('[EL6^LJ[OM+P'[ /Q _<MBWUE7=]I> _8!^('[EL6^LJ[OM+P'[
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M3";"R&0I.SDQH*'0=)0I2P$ *UK0=:U^3 A4T5)54!\<'\-I8T0@,0C,]?\
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M; ?A:O++^^ZL'])NE/M6P'X6KRR_ONK!_2;I3[5L!^%J\LO[[JP?TFZ4^U;
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MLF\:W@=:V78TXC40M-2D30YP:(O!8E('F:J57TBE-5)64E>J;TZL@U4626:
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M3NSI&_/,ZZ$KE#'JOYQZ&MV0BE'+%@-E77H4H8JQK&5NJ-IA,Z>4J 3B:2!
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MD24(D73-R$RFBC]O3(?^>S&7PY1%1_/IP)W,TQB]L_AJ]MT!PTD-]4NC?;\
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M??&_TI9G.7%E+2EAM*NSH7YD.O>DK3E-1W"VUS9U<4)95A]W2>#67$;"B\C
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M\TG4_D0DGT8\2TM6HH>^XG=\:9XFSFF1$K_\:;?JSTHE))FRVTKX1FRUINP
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MON"ZRIS92AS-GJ>/\@\ML]!/"ZQ"%+6E:4;A('9J^=2%H5:TOX)HO?LL7\S
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M7]"S!7$9 AK3O635#,X';BB-Q:EY#&F"QJ3E 9:%0UM12%(:S%D)FQ0CVH+
MG"]I5X4>OU-F]>,T174H155Y\D=)U(LE4ZFGZQU%LVQ:?,D'J.O['0Q"64NM
ML3FVPU5D0Q,[SA>RSEWCSLC0I/E&DL_U^$%#GOB'[^MVV3)V^U[RM63*32]S
MP=@8*\L9H;&-B3W%XNW_ )";80[-$;YEB<CGLBB%SJ C<9>\2)40HB1B%,V,
MZ,*$90PEO1OB9N:M[YI:ZGEEI ,B@7<M37A(IDUK3#9R;1D'\3;+QFZ1! _C
MAZ9V4"_7JD4+"682DMO,:S/G1#"H%LC0=%6 P& P& P& P& P& P& P& P&
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M66 .]B%O>M:UKUW@0YWY&/'QK>];[MXUUO6]ZWK?3U)>NMZ_)O6__HX_EUO
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MJMI[)OHI (D"YS^@8K)75U^CT0U)>C3OA?#+V8'0A:]VO4)#X# 8# 8# 8#
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MM;@T1T%;/%3-+]&Y(:G<1KVB5G N9E6)T9B?W"1&"-&(&A$_%")\:\B<6>[
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M,PN.NFF$AR:3ANB!4G/">F6 -2A%:QO&9VQ/K%GS@OD%6.C:FBO3S1$)(NG
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MQ0C1;(,$+0Q"+ $N,!@,!@,#G*H3_I/_ '?_ *LZ@_\ A"AV!T:X'.5YU?\
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MZ1C5 WU6/0L7K>V@1I^B:J<5:_%/#,H,(4.!VT2A0E$I1"4EAV:6G5F^W^7
MZ6L!@<]EW^">=3OL7IOL2A_)UUUR#)NJW: .ME1"BR(\T,JT5;PENA483JUX
MEJ=<[%MZ9,I/)V?KU),7':#^3?Y0M[]B!VG^_P"?)A_X98O\:X%Q4=X*)S N
MR.9.R+X\G'7/7\IY4<;#<*TB-ZD1UV9D'ZS80XPF4IT;AI:I7M!3@F4IE!VR
M-:V<8@)T+\FL#H2P&!S6Z_A];2AUJ]&6+SWY<^W.9V7I3H"S>BYE750E1AAB
MQ$WLY^/=W(P($ZY,-P-0(MIT!:DX/QC$R0KW^N]8%>_8@=I_O^?)A_X98O\
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M, 0GV+1&M+CA;UL7M] W=X# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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M"U9U_P")$Q_\U9#_ /.A9@:"_P"%;_T(/)__ )R=%_\ I&VG@=#V!SC<'_\
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M/VZ5/5CY&E<,>ZTK]XA[@L:G%?$W2&QQPC2UP826M.QKE;$K;3FM2L9D[&B
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M$(,,*$$8@OS 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MIT;;Q [77R;TD^P[G/RH51-VV3.:BSHA;KC#)9R5,83-[>L:CI#TW:[5#F.
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M64 .R(/KZ:]?Y?37K_ZOI^7 _N P& P& P& P& P& P& P& P& P& P& P&
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MOV)?ZSOB_P"<A<?N_:V_YM/YL_/?2'ZW_G_UM_G1_P#%WT?[OS=]W^#^#\/
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M@)AA1@0A?ZE4F1)SE:Q00D2IRQ&J%*DTLA.04#7J,TXXT0"RBP:_+L0MZUK
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MKLHB*MXIMTS,I/'_ **F5BM+*]A4L^D[?L\X;><+10M&AV6/>A?E]/38=U.
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M04]+7M"C/;! VUROJ^$RQ?L2C1Q:M@,2:!Z%[UO80)G/4G4TXAK=>TCG?3U
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M;9(7Z31JT;E52/F+E^RR8?7]TL%%6)!YE.6:S91*=1JMY0T)XW*Q.2QNTM2
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MPKWF^@_:8(.!UOX&$NF#CDW.'0*A,<<F4)Z2M8Y.H3FF$*$YQ4$?AE'$'E"
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M65N,@>8GIP'H]0F#H*X* .]EIPGF!8MH>./K*R55X6."[.>V&Y.JZYO:DKM
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MEY6 !O05!NA!Z'?BWDI^E1LV=^<:<72<^OCZJ-<SH%']>ZO5$34P R+Z1@1
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M-JL)6TR'G!B:SUT%+D*R=MKTAF%Z1Y_:5$7:XRI4C&)((E6#V@2C.,%[,#W
M\E1Q=/71T:X<@='(.?*<AE\S/=I;>N>EY<^(H5VE3"Z,T-@[7=JRQ?IF9O,0
M5)V8#DU("AB$6)28F"/W:#,<7[SI>9W)R[2<912]TD?5_.,FZ@@KL4VMP8_'
M*YCY$'/1)YLI&[:6-<CE/YZ#"WI4Y"H(Q-"_1AA?P0_$#)"3J:L''K!PXX;-
MOKC:['2)][R1:D;BC(?'8W^=\=B#?'71]^;T,$X<S)(2X ;0$C&2UB*4GB+
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MW.1*C7!82G !(4:(:D\HK6MF& "(+,(ZXY54MMC/"7I6A%333^FS=KN2:WH
MH0UK]-+C6MFU.U1+^,B*;=W4@:1+I<(C:A6 1)?N-#L&@IM:=:TC8_/1'49D
MR8H)2IRZ:)A3F>R.+L49)00RQ9#6@G\V3!>U49^@I&]1_9S6H"L$%6F5I]Z]
M##/AZ"OH.IN975WKJ/M?0](.+];[8A>JI9$-J0=6[V2SN>W(+:[05M(?#%LJ
M;7 QF6 (/0@/*-,2F@ +8BQZT%&UV3R(*,RJ::ZEYVW#H,[M3!,Y9JZ:XW&H
ML^OJ=0K9&9_?-2/Z,:G1Y3HSA)$YQH#5/P#=%A%LL>@A=[!T/0,KD#[$XO=]
M1R*41>6H(%)(XQV/#W5]89PZE.YS9#WAI0O!ZYND[B"/N'P$)I8%)NT"D(0;
M$G.T /VDZ#H9?-XY6B&ZZG6V+,4#VZQ*"([$B2F82=MC;D\L\@7L$;)=QN[N
MD976..*94-.28$D]N5@'O0DQ^BP]#_?-'Q2Q62H)/<57QVV)*U*7V/5F^3V+
M-4^?&5(F<EBEU:8BN="'YP0%(V9:=LTI.(&RD2@>M["0;L ?6K[QI:[D+ZYT
MS;E96TVQAT"QR1PK2=QB<H6%Y&B3N1;6\*XRZ.:=N7F-RHH\)1P@#$28$>M;
M#O6\#'.NT>/MQ"16!_G4<ZZ@D1DFX;*)ENZ*Z#%V"7?1RQX!%W9]W(M-B&0'
M-+<H5%(S#0J#4Q!AH "  0M![3^O^3DL4DT\4=-4 3"(5*$$(F$P'<%?ZC$7
MF3JE(7-L5D#]^<'T6T2%>B4@.)1GF@4&$B]X0[#Z[P+I!T/0)EA$5(7=]1&6
MHI93Y(16Q=CP\<\-CZ=D1R8Y[!$@O&W[;2"-N)#C\Q\#X6T!H5&A?!W[\"/L
M5\CW&$J<K("7T-3C/$*[ED0A)5HO=LUDBK.=2681-JEQ35 9=J6F-S^N9$CR
M00X$ZV U,>+7J'9>PCV&7C^N.5$L6(G*GI6A$\+53U55::6G6[ 2XV?9B'?J
MNK\E[&_Z;3)FC+U\0UMT9M863_A!%Z+_ )V!:5P=S\FTBPW0[32^*P-=^?X!
M([+M*OV">0]YLR-16+#3IW54L@I+Z6^)32W%<E1Z"H+)#I6L3E#$$1Q?N#+D
MXO>D:QC\4E=D7!6$ C$Z7M35"I%-)[%HPQRYS?$OSS.@C+J].B)"^JW)#K9Y
M $IAHC"-;,#K8-;%H(QE>0VC"H_W-/G@TYJJO@A\=HQ:T^!(X*[EO<CB4'33
M6=L\?C31*%<D:U<8,7D-( O2=K$Y.VS"4FC $C,P+YJ+N;F6Y)#:T1CML0%N
ME=0/,R3RB-/<]@J=^'"X0F9%KG;B-H2218O!5"E%($QQ+TH+(3;),",>P &
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MT>*CND^L+:F=66+:TNK"'2&/7M(+^<H2M:IDS5C.G'4ABQ5H-YBE*:U@($8
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MI+#F;S#6&30Z8<(UMR<YGNDG)K^<IXU.(K*HNM6)]?1;BG5QY6K3Z-)4*M:
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MEX[UO6]?L=X7_)O6_P#_ *0C?_4P.CK P;T]_P 6KH;_ .H;;7^X%_P-5_\
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M.,F1[(^E#E1J-&80'V?_ !L<=R98\F.]9.IS&^PXR'+8*19-FHJZ*$95J&D
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MG_9#%O83GP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MH"V'U0O<#'6M;!0B84D<JQK)#LM,>J(=6B7$.NU0/BE;:T_L]OQ!>X/K0?D
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M\CBD[KS]7<C<KDC4^BZQ,WN-=*:VCZ9Y>U\Q4*W!'\F2B^:3K4ZY,I)/&E.
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MR4.%KB<K KBXI=.9W#'X"-% MUQ44MJ%4PGHG(!3T]AV:N3Z3A"D3+@WB8#
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M)\5\EQB41IV;WZ.22/<Y4\RO[ ^-*HI>U/+*\-L.3.#4ZMBX@!R=0086<2:
M(P"T+6MX$M<!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@> ET;% 4 T[B@/ Z $-L&2L3FA<0 *V>,: 0#!:5@ 1K
M8][+]VM!UZ_R8%N%6-7JAO>W8B=PTYKC3L8PR-R*E#(8WL#X2:42:S/:P"[:
M=J=BCCP $G/$6<$0PZV'UWK \@[4K M&%P,L>! 0"5FH KAS"/!1B7$%%'GH
M@J=N.B=JR25!8QE^[WA",.]Z]-Z]0NX#HV#; O0'% -F$ATYA=@*TXFP3;LC
MYK3@%?HS:7:':;_"?%]_P_A_SO7T_+@6VAL>O'0AR5-D\ACBF96XUX>%"&4,
M:LAI:" "&>Z.1J=<86A;B0!WL9YNP%!UK>]BP*HCE<6<8X5,&^2L"Z)'M^W8
MB4HWAN51PYK" 1@G(I[(4C;#&\( [WL[1NR]:UO?K@4#5K5<)*H7ALF [0I#
M$I*M9J8QW:5*:N"<-$4H4:<?@DF*P)S-E!%O6S- %L/KZ;] NLIZ9E")O<B'
M9L.;G824+4X%+TIB)R$N]/D0MZH!HB%@EGKKX6BQ"^)Z_P WUP/H8Z-A0%AA
MKB@++;U!21>,Q6G !"J/ F-)3+!",T%,H.+6$B" ?M$()H-ZUZ"#ZA3T4KB[
MD_/$5;I(P+Y/'B42A_CB)X;E3\QIW(OXK<>\,Y"D;@V$KROYQ CBP!-#^4.]
MZP/6>]LJ5K7/:EW:T[*V%.![D[GN"0IK;R6D9X'4Y<X&&A2)"FP:4W2@1@PZ
M)V6+0_3V[] MLVSJU3M[.[GV%!R6J0H=NC YFRQ@+;WQMUH(MN+.M&X:3.:'
M01ZW\8D0R_3>OR_EP*D\36&QZ/ERU_EL98XJ:%",J3/#\U-D?, YC**;1EO*
MU60VC"X&'@"1O1F]&B&'0/7>]8%8$Z-@/G-C<4(--R4M<X>Y6G#\BB-+.-*6
M+/4S7RJ4TI.8()@_: 02Q;UOT#OT"FFRV*IY"WQ$^31\F5N[:H>6J,&O+<7(
M7-H2#^&J=6]E&ITY+6U,/^:8>64(H&_R;%K J!+LUJ H!$.3><%TT9ML$2L3
MF!<=$E".-V@V P6EFBB0"&+X?N]H=;WO\FL#P+Y7%FM\98RYR1@;I)(P+1QZ
M/KWAN1OC\!N*T<X#96E0I+7N@$!.]#.V069HH/Y1>FL"D:LJN=N!S3J?PG;J
MG.6IU#9J5,6W A0W ,,<"#D>E_S)1R !(Q'!$'0BM!WL6M>F\"N.LDCK"2I4
MOC^RLR=&G3JU9[JZ(6XE*E5*!)$JE2:L/) 0G4J@[*+&+>@C,UL.M[W^3 M\
MVT*S(;TCL=8D%):EZA0D0N9LN8"V]:J1_"VK3)%@W#292H2Z/!\0 !;$#WA]
MVM>NL"Y75^8V%M&\/CRU,S07HK9CJZN*-N;2]'B"$G8URPXE*'1PA:T'U%_.
MWO7I@?I$],[D!"8W.S8O+<T0W)M,1+TJH#BW%B("->A$0:8%6B )45K9I?N+
MULP/Y?YVO4*8?-8<E<8^SJ9;&4[O+=+-Q5K/?FHEQDVFXK1SAN/H3%05+SI
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M]>[7J'P2/+.O,))0NK:L.4)3%R<I(N2J##T1*C20U82 DT8C4I2K?PA&!UL
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M61,*;JZ2PGRH<FL<M7/K_;37U] F.1R".=",9<A$6B8%[XE:'1<N3MAC8F=
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M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P/QHL&M
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M!UX6)#*HO*Z!JZ]KEV]K-GN.D2V'V5 J1VOCZQ.:86H*?$FQ^P12L)(6LO\
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M4'*JGBKJS,KX_2*KGA*Y2#:[342G@ML0>?.11^VY*L6?&6-<7.)(]I>P_,&
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M-,9^W4!:557K'J[*GISW,D//T2D-?VLFE]7,*Y$M(B[XC.2-@DI_I\[\9$%
MK_Q2,LLNR)W9V-&* OYU4,/1LTF\=7Q-=(8Y%KZO>X*DFC,HJI',&HX94.KB
MMZO31PIS5B3.SB8G"L&F(^9-)(#;M##)H=&V\RPT<7;Y>(2[Z520QS=GB-E
M"XJPMFV]Q?&EC=#Q&M&B!GZ,2EZ I$8 'O $(Q!=& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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MW)V;RY?W2$T:;CF%M1B"Q9+2EVJ:MVTQ1UCREX=AF.;<)*HV6K+/WL\9GH:
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M+<-A::%/KR\6K(T)*MW7[U%(0-8 E4K*4&E&CULXH(21A" ,'^2;QSWYVOY
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MYHF)&ZO;G(G DA?(7)X>5.E+T\*5&]GJ31:$;O6MZ#K0=!J&YMYXO&*]T_Q
M-A2*KY8SPCI)/ROJAI.M1DEM5K"B')DEA<H!$3M*!#6B8Y4H*0J/>$O03S A
MUO?Y?0-(]3>#ELJ7B+PN7)!>%'N*]]PSO?CB6]:R)&!_,L&+53&[0F;U9<CG
M+.NE*F/-K"V(&MF/6&)DNC"P:*V'6O4>L#.9G-W7U6\]=4M%C>-E'V?S59?F
MW[JN&_\ EZ40QM>;PGW-UF!CXJ6Z"YB,72IF3I75CDJ<X\(R/5U6)C?80)(3
M\RI &QC^'^YGMWG2N^O#W:A[=Y'Y:M+HHJ9\<\EWM,SIC9]-U\5#FQKF:U[
MH>9 KB:*<RXC:I,SJ%9JE)I.,0Q'_$"L5!$5F<?)QXO9%Y!>5.6^!['Z9=NL
MNO+:ZEXLZ;CBN+*Z%@BOI8V/J9"Q])&NSVU+XCJG'UN.'KX_PP/98?30R"1
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MEFL$DB50VN24?_8GD;&7L9(RS!A)C 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
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MS<C)]PA_"2HDA9*9.7[Q;W[0!UKUWO>!^6QF9V4"HIF:FUI+7+U+HN+;$*5
M!8YK1!&L<50$I105"]6(.MFG#]3#-ZU[M[P*E@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@<^%K>&V
MU;"\\-*>6]%<=?-]9U;"T,6<*F5,LC,G3H<DJ:PJ\&I1NY(?S?**&X3(I3KW
M[]=$DC#Z>[>MX'0?@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,
M!@,!@,!@,!@,"WI;+8Q XP_S2:O[3%8E%FE<^R.2/RY.V,S(SMI U2YR<EZH
M9:=*D2D%[$,8A:UK6L#!B+L7EQP55PA27K71JZVC#2( CV_$%*WQ23(SH;M(
M<G-T6<QK3)JG,8RR7#20TY\+&W "):$1&@IDI[<Y.AD;:Y=(;V@B6./%=,MN
MH71&O4O)6ZMDBS2"/6$K*9$CBI;H>^J]& 1N"D!293L@_P"&,6B#MEA](MVO
MRE-!0 $;O6!KS;2(<%5?DFN![:HDZ1M-5D#6($[JE1'!1KU"!04@--"66YFI
MS0(Q'C*&$(7+1G4W//2Z5R5T1;<0LPIH;V1X<"X\M-VK(8Y,6K,C<@T@6D(U
MQ\<D0$"CY!Q++&B6;(-T2:/98]:#/V P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P(4>1
M$"4?(5G:4*#4QVGJHAM!FD92Y .3%7571D32R,HU<W_"A:V3A2$OIX!C.2LQ
MBHXHE086$@P-3R!?8A-MIS9S%*Y<>?UW>[_OI9"SV XLJ:+= +;N;/U!%RAU
M25H_2Z?<YQF7E->F,>D<;)?;44*=O@6EJ3F:4AC#QBE-Y?%W3OZJ5M@JJY.X
MO:";[_7LV*T%MMO3:7GDK:%RJCZ6=W*5/=!/E1*6T+<A6?1\5:AHDPHHK<"E
MKT%O#+MJ:5:0G$$C&.%J^?O#3^M=U<"S2YNP#;^AK#45)^J:/Z--:Y>7+YF8
M8DD'T@YL>HXF*/5HOIQ0:-"2'A\)Q[FLFK :>U63'24?CIY*0*$5F/\ >$R5
MR-!IPE(HE*8DZ=)1J"2B%Q 82W<!+! D;_ @&&[&)X$>4B <'1Q@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!
M@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,!@,#
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>def14a_proxy2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 def14a_proxy2.jpg
M_]C_X  02D9)1@ ! @  9 !D  #_[  11'5C:WD  0 $    9   _^X #D%D
M;V)E &3      ?_; (0  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0(" @(" @(" @(" P,# P,# P,# P$! 0$! 0$" 0$"
M @(! @(# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P,#
M P,# P,# P,#_\  $0@$-P,T P$1  (1 0,1 ?_$ *@  0 " @,! 0$!
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M9IH-Q2IEK?=KE:,(15*O2+58T"-0BL12]EQ%44K7EB(+V6K%H9P=@#[1:WK
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M"(DE'LK>S" VZ>#KO.CZPY"2,%LP.@J%)M3R;3OCZEIER)%;86<Q=9WA,&Q
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MT^DG6>W@NHZA>C*+JFWY"R(3I ^.4OM5]IUPD4BU"T<A=Q)Q>HWI'!6-$FV
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M3R!22GY?](UVX7&SR&3.B%K1LJMA(=$<T2? Z3B4 (-&'<V3U)WFY]H<#R*
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M;OYG[P:K^@9O0@%C<GF_/<L:JBGIZ!;&JT=F.UV"L'-D5.T16EJ4*:3EN_\
M6!:Q$@/$&[BLYI=<DI(J:692S=5]TC;9JH.IA/935.FU,X,SU($<,0BLAC9R
M&Q07,65 WKC#"D0MMVUXB!@,&0+8@T:TO^HDJFTK&\7M<OM,;@CCY"('>,DG
MZQ=9A*TKF644R^6!"MQ)[).A36;,PR*P:M>VP*D>V4Q,!. [T#=#V (8!7_Z
MC?YM4ECW#:/(:FK8Z1X^;"\@= )U%SEO"NZ8?#.AG[GIK@*W1M9L^H9)9*\
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MA.L"UBSQWW8IYX8JHU(:Z^I&WR^G]\J50WJ0C:1U ;W^\]3Z82U>XT):9/\
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MA^;+JV >/+F7H@BGJNF-^6S;=^/JQ,W1JPXG6UL\.\C%SNP;AZEJ2'3*1(K
MC"&Q:7B[6LBB1W5K!;5R%(;[BDDTDL86(G_9'D31]HR2 5S:/%,@YA'QO+_(
M#!%QM'6^LL1ZHQHDR:.1Z &2M-?*.,J9B]DN*=;\\+:2T.B1;#I#[?9O K:R
M>6'R)W;0EG]1T-&N5&FO.'^,>8^CNHX/8D8L95)NA['M7EZ,]9V_ *:D#//4
MB&E8S"JQD9*9D7NJ63'K'PW0#P[2@&+ [J/^=NQ9#T3=M$:A$%90 [ X<@W+
M<D>H_(DI-K\Z7_/>98A?R!6'ZM$2JNBF$'0;8X"&F$0E+3/J,PQ$:6E.&H#;
MIY0NE+<Y,XVFMRT23 C;6(L;GFN8B99S*^2."H5EV="5?32EVD#'&Y#%'MS2
ML[?/#502D[@F&(TD/]+>O:'8:7^D?+UW'S'IXH&VY'R3"^@:T[FJSGBQ.@6:
M@.C+2HYXI2[^2+(Z9KJ>,- 02QW&Z4<^(<X-M@=&Y.[NR<H>MJB]^@/8B@FZ
M4]@>49Z-\=)M(] <#2^+=U2"5UPDF\EX[ZIA@6Z60JN;LN%TF26"3._XE-F>
M,N47K$AH(:7-,2X%. QJQ'C3F )"'<1#S725NNKR7I+-KZ)JJ Y>HN_[JY0D
MD24JD4IO='PPO45?V*VO)ZMX>D!1B:[S$A$?$F2DZ+9SA&F_%:+$=@<>S^Y?
M*+Q]Q[-.L^L6KCN10AS;.-)U$I!4<6ME,;6>[VZ$KF W/3DH@"N726166."5
M9-1N#%*FM4A-7.A.RAM!WO +P+L>/WR+LG=%J=YCASDRK:!YQM&IX;4LO40:
MQ*RE#LR26A(=84\63YAM-''Y C4M$X='$A*:-I:RA-Q)0]!.#O2@P-5S%YT.
MF)AP]Y";]CM0U83==+2BB;8XS@BM-(%C/</'G5MUM%7\[228(")>E=3Y])--
M#\0N&C4H$R98:A%M, .]@-#*W3S)])]"N\-9.-ON#B95T=5\1T%7L@NF 3N=
M:KM+T%Q[?5\W&R69&HK95?N#C8-9V?39L<$G(4-X$AA*DHXLT?NFA"U8/)+T
M,V>*[O?IN6P^I$?6W!#MUA44X0QU'*U]$3&V^:E"D"*71IF<G])-D\!F;0J;
ME^VU2Z:7I!GFIMJ1;+T9L-9IOG*[$1\\W[9#+8W&]O1JO;LX:JV,=@5YS5U$
MW42RO724\?HK>-8R.GG6QW&R[(LJ@X^@;7H\N+.A@QE/*9,:ETK,+*$%HI?W
M9Y*7#GSDVZ:*Z*X.LQKZ"ZQAO)CM)'WBKKNKT!$GM"Q%$,CDH:X)9MXP^=MC
M7"0H30N)"LHS3L9O1B0\HK6O>":5/DFZAB##>+9+6VE7R:4GY8>&_'ZL>&"(
MR]GC;_![];^12K5ER9F7SQU<$$C [7B^&,>QK#2$1!:,"@I6(HT9X4%Y]\Y7
M8=GVM+H^%]Y+M9"R,_D/=K#IVM*3OZ/6ER9%.46ZYMT[;%T6*]V*^UE+(79<
MJKIG95"9$2U*%"R0E!1F^J2<6 +]^+#RV6/WY/*+@DQAL+@DG7\53RTNCH0A
M;'Q%*(#T9!+=J.')VYL+<9 Y ;ZTG];V8DE3,2>%:I,;G9$+2XSW#=#"(;K[
MA\JE&6)Y.BGJ<\-R6O\ @'D59U0U-;90=TM<LFZ>QX)T2_T]$ECTKZ%5M*(^
M'/--)=R%2%'[KNF4& 2@0CWHP 0??7Z@B5KF*[9%RF]U:JB-64MX\7MPG=K\
M]='D@B-H]3]3/M,7$<Z5PO.KFPK!AL*@9*%R:"(^E,.6+=FEDJEH]^@ -BT.
M[RNDKQ.=9]NCLZC^@;,I6M^C9Y 9%".=.@^<:T7K*D@:E[8XW)JJOR2BM,XP
MB0MIP5RTI:E2+4QH-)A V 1H@US4OYQ>H9K7=^,3.Y<M="6^5(>!JMYSFT8J
M+H+FN!M]W]SV)(:X^D[CJRXY8_V8_P )J,MF ^F29@/3M3X29\N3&A5^H,@)
M:OSR"^4"@:J[^A;M)>+WGHSQSP2M>D93/ON8MS[L.A><;CAD_619E88"FNU*
M^U1;48GU:.R%P/4/3TV+&_28TI.4,8]Z"9;2N7S,5I?/#]&FW;X['-9URX6<
MR*W\KEWH$E-%%]35;)+E>UQ*$?48C5J1^C;06VIB=F!&G6>U0,9A8O1"&#5Y
MY/\ MAU+Y][*F;)SF5P-UIV+(.0ZTJ=DC<\!TC7+4Y3RQZEIR\9;8RF9'P>5
M&RZPJ\]1\C29A1;;&AU(V0L-/(4>T*J<@>?/JGH20^+^MY/7M(-UC=&WQ:$(
M[#2L4=F1*&#5LK:HG)^<'RN2%L\7',CK9$6G"=0:<X&.A)WR]1LDHL(M>X$Z
M=Z>87IWF;R$6#S76CYRLZ,L ,X?*@7,DT@MJ._4?6BOIR</47L=FHV51">D1
MME=:Q:&\IPV:NCBY(4$X&U(PE[][829$O)AVLN>JJZ]?67G0SQYWGW\LX5AM
M7ML>G:?I:-1USOF4<NU]T0]6.;+UD'=%;]<L;">Y10J/E:11U:6(I<8J*,%L
M*K>/_P OOD&[ILJ(U'7\ZXFF,RL^J;^DLM0P_G?I!.9PE**VE!335CGT4YNE
MNF12SXO;0TREJ2HV9>Q+S7 05!!@TZ90#8274GEB[I@U/\N=%]7*>7I965_6
MWVA'GJ-TG4]FPN61:!\5TKV%,I6-*[2^XYJW.4DG4QYR0#0C^% 0B;U9Q!@#
M31 /*#AV#Y4/))S+24?N'HEFY'D0NMN!^F.MN6(]64/LQO\ N)M6CJ;8[Y8Z
M8N98_6.L!;\5?:ZD8 J'UKW'#2WEN4%!+TF/3FA"_P!XV?)K)>\[/=XRKBL?
MAB&)<A4/8EDPO:%U3SRL.HWJX>CZ@Z!J63&K70XC35"WREDNVLO:0I28E5:4
MC-,+4%!+#5^R_J ;]C[O5)5J5[4Z&(V_QSUI8*">M+#+$,?A'3M9=%]85=SI
M%Y>H5S)> F!6ZR<X@9_1WLE2?*5Q>BUA!9X" ALE[C[ [5J[QA5MW=SNZ\Y,
MLJ::-K&Y+EB-NUK8,R9I-]XT>@6P,M>;BMHPE7$A-D@E1YHC7 UU]]*6 K6M
M#]INPI?U=YH;Q\?Z[LVC^GY51<CZ,I;A6M+TH-YK+GCH<=:69>\W>NA$[@R2
MQ$SR>Q@06OVY%"(N07M[?F;U3SUQNE^R]^XD#.Z3\I?1UM^2NR>5G>Y^9Z^A
M$!Z;24^R4X?R/U?-;8L.$)J4@-HN;XGZ0B<R4\\P)[7KY.X)DY3VF)&G+;P[
M,)%\2GV:'9]L^4#H>F_).Y<<0FZ>:Z,@C=47.4X8EEK\C=7=*2VPY5<T_LF(
MO3$D?.>9BUQ^NF]G)AR'1"I^2DIQFKQ#]499)WIAAU>^<"TGKHNS>;YY!H#$
MI7 /*1+>>6-;MHD&TUD\0,9_1$:6V/$"QR<S2ZT8#8]$&,S\I+&8WEC6I1?
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M+T!%;.6M*02;X<'K ,#8Y .58+7W4G176#>ZOCE.^D(?0\,DK0Z 9S6",-]
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MQ88E >G$:$WROSB\71BON$KQ3ZL>1\V=]SHJKZ_Z+:&6-IJQJ2QCUNFHN']
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M:P[,;##_ (H2'83O=]('M"]W9/>(KV\6].<>>)OCJ[^8Y3W;<TMY$@M<O=#
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MG75)0:?Q;K+E6'=/U59<-1Q%Z1V!/>4>A[EN:&6+$'*)*$93R]%L*>9Z<TY
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M"=C;B1F:*2A#L)MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P/*SY/*?_4URWLVRWWQO7M 81R(K9J]+KN-OSCS^G<43LE@K"GG
M9II4ZKB0RD/QDV+7&A^(5F V 0?2T$'L#H/(#>5=^<A#YP: AMKVQ"W#RKK8
MS%#*?L),HJ <7;&(4*G1K$4M-;H.EKCWR(PF=RS/BFD\8AF:]_8Q[ +0>I7C
M:D/U9;'U9SX\=<=$5O(^8FRU(HLO9A:G3FLU>[UF2O"*4($Q4;JUJD)AQZ#W
MM!TB4D*=B]GNC#^W>![#\"J/<%07Q??+-LU)S)>ZKF:\IBW1]- KQ1(U:]5
MU;;,(Z].ZHE*@/3*S-N\=;5C=OW!AV'2S8O^C6]8'F\_R8OU!?\ N!);_<F7
M_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\
MN!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _
MR8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)
ME_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_
M +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@
M/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]
MR9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%
M_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O
M8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);
M_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU
M!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\
M;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@2
M6_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+
M]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_
M &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X
M$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)
MB_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7
M_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\
MN!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _
MR8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)
ME_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_
M +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@
M/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]
MR9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%
M_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O
M8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);
M_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU
M!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\
M;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@2
M6_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+
M]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X$EO]R9?_
M &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)B_4%_P"X
M$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7_P!O8#_)
MB_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\ N!);_<F7
M_P!O8#_)B_4%_P"X$EO]R9?_ &]@/\F+]07_ +@26_W)E_\ ;V _R8OU!?\
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M*ZH^HNOFN7VC;$P9(% (N34]ZM9C_*Y&L+;V9J"YO=8MK,W;6K#0@T<K4$$
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M(VF.6)3T9Q:S8B0@SACQ =&M72G07;/E6Z1@/7?1-Z<Z+N1B8K6D*'"Z@A=
MOAY*B5QM*0%HB1[JHDNB/2V$+6BTG"H6&#,5'*_4)"B2;P-^6ZGZHGW /+GE
M8A\)\9U@N<M;B8Y-JM&]=$5Y5]@N2I;,JYB\@2,(Q*F]T(<%!2H222L*=:-0
MH, 0CTK4%C"VW8W@VM1SIKQ;U?XX[W@7.3OXQ9'*Y1 )A;L443U4_2.0(HV<
M.6+FE(T+V!R?WB5-J]T<RU2/X,U0X"],L( Z!H.IL'QC^97J'D/L_E?MGR&<
M\W8U= 53#8I4IL=HQOKMOK^<QZV(=.7.1R13$(.P/+LV.,<C9R$!(1J- /.
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M*(5.PJ4A\D>BDI3[,I2^NBZ1S&9/1:( $Q*^225U4J=$@]X"4D9:< A *#O
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M@?/_  ]T1-)/,U54VA71TCL"A3YT5I'*4%,R4B,24TK1;?["4:E,OCJ@)9)
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M:KZMZL@546._-R)X20DUMF4QDB%G<C#2FYWD377\8E:F*-C@(@>TY[H%&6>
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MV9VL+Q]9)%HO@]G>N<B<=C"'8=;]H5FCW5IW3OZ/+I&/R![1O5C\JPYKY1L
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M@J;"RE"0TXH+=O\ K! &'6@@1R?6#RB>1O@KE/G'Q9,GB^O3C.]*QZXOZP;
M:*FH^X3*/A:F./*AIC<#C<;ADNL%#)U!J-0D&F^9%E'C3G# 0D&J4!"P';-
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M-N,+C#?"8=$X8TD$I6J(QIBC#8F3AT!.G;V!K2M2(@@&@@T DI,D"$.M:U[
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M;,U_XH@N_P"5'AFRN[(3R-&ZQEL(B#ASUWESCU;)5$Y/?B$SQ#*;6R10_L#
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MIDI#R>6:>SJ*I<@N6U!:<I/L9.@#,WLS183>.41HH+0,R1,187_:(+"(;L@
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M3#PK5>T2106:;Z8!>F6,(A>P(M;V'Y(E,95+'IN32)B4.$:$E!(D!#NWG+&
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MS ^()A$C5RUL+E,<,<FU(F7N+>![;!KD"%:I,1(UJU(%5M0E2*UA0B2C# A
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MDZUHR**I7(5ATB VV72E5O+%#E+*[2)AD=\VC#JGA)SXV*'9")K;@ODU3*E
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MMA,%D<I6%5'9;URBD5*VJ?)Y1"%T-7<[#JE;%$3(><:V$:>#D(U 4^BC#1[
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MFC>TN*5>KBLA6Q]EE:1D?B4QA@VMU41F1M[@%.=[INTBT@WW?<-!O8?P,UB
MYF;70),QCGJ>,)YJHAP')**2)X@K=5+$DDQ[.$W:XEC5O*(]*4I$#11IY!@
MBV(L>M!D^ P&!C269Q)=+GF HY(RJYO'&%@E+_$T[BE.D#+')6N?VV,O;JU%
MF"6(&R0+XHYDHSC0! H,0*- V+90_8&2X# P6P[,@E4,;?)+#D:.+L;K,(+
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MLN:WJ'QZ16#%'R0 VH1M[7(*IE;_  >PV]88XD(Q%"BLJB[@C4F;UZ/OI1B
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M3R8=B\#4;8G0DLM/H5UBS!%%KAVER13LKM*"RI?'Y;$N5-I*?O-Y9G*1QY@
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M23;K#IRRH[/8[)FCNNB44";5<G9Y5J8P]H)0+T,H&SD*4:&0.&B5CD2N)..
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M[WO ^L(H^EJR:(LP5O4-7U\PP83V.%,L(@$4BC3#QR8.P20<6;6%I0(X^.0
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M,<QL*0M5<P]O?)W+HPZ%OD:E4R=DC,2OD\CCST4%8A7+C#U*14'1I0P&:T+
MD1"P,38:]GMK*TMYTE<=N\C.0MJ-(:_NVVUO9=NCV8026-U<=L[2E2>N?LPW
MX9,45[WN%@#H($:>6N0EU?/,"8N<^;EE52U44=((8TU#6*BOI,M97]R=B#7F
M.HX\../*IIE"Q8I (\DP:=>:<9KW3A#WL,\)HVD4A\<4)Z>JI,IB3F^.\1/)
MKZ(DGQEXD[!N+R5SCAH&@)C,YR&+!VW+CDVRS5;?KT#1#)_H8&/-_+W,S95[
MS2;5SO13?2\F7&NTAJ1OJ6 )*OD#FI4I%Q[F\P)-'RXHZKCUB$@X1QZ0PP1A
M)8][V( =Z#/6VL*T9D49;6>O(,U-T*>5TCAK>VQ)@0HHE(7-.[)')^C*5*WE
M$,+RX)7]>6>J2A*/-+6GA$+>CC-"" ^F>-:>ZH>:9>;)CD9<C:EL]IGJPEWA
M,6E!=@QIMB-AQ8ZJI>*0-ZL2ROW(^PC7 Y$+U"!+$I8ME[WL6\"<&^GZE:69
M+'&JKJZ;8\A@I]7HF%OA,:1LR.M%00!4UVE:TS86A3P50$L.AM  :;QZ#KVE
M;]FL#*6.-1J*D+B(U'V..)7%P4/+D2QM2!G(7.JHLDI6ZKBT!"<M2X*"4I83
M#S-",&$L.MBWH.O8&#NU64E9<#?(D^5S5D_K"Q59\EDL9=HA$I5 YTO=EA+N
MI?WQF6-Z^/R=6YKRBU0U1Y9XSC@A,V+8M:%@8@XUSS_5$NKRU' $$JTV#P1;
MSS6H33XK XBRQNP9)"W,N"QM%Z+2C+5/+S VDAO;R#/<U\/Z:8C0C!^\'W0\
MJ<NMD]+M5MYNH-OM E]5R@JR$-/5XDGI4E7FJ3ETB+F!$=+D('U:<M.&:KTH
MTH,$:/8A[V(7M#-X#452U0;*3*NK&NJV/G<@52^:C@,+C4.-F4I5^S2Z42D4
M=;6X<AD"GW_ZU:K]92/V_P!(>_;@=JGKV I&^/-*6#P],U1%[,DL3;$\9926
M^,2,WYKLV01Y$6B"F97LS;XM]Y6F"4?OXP_VB_K3/>#!H3':??[-GMZP9[CD
MJF3TPQJE)B_QQ\9'I(VIJG?YH\I(>N-91&_"OC(^V(XB6$*S1J2!&@![I6M>
M[L.L8>=>70FRIZC%%4'H^:ODF7S=V8:QKS1LMDKH6OCLQ62I>WLGOOSXXE&J
MD+F8K&:H."(TD_>];&' S>8T_4EB-<M8[ JVNITR3]O96F=L\QA$9D[7-6J-
MJ%"N.MDM;WML7))(WL*I6::B)6 .+2F&C$5H.Q;WL.8BK"M6V)E0)NKR#((,
M0N3N9$,11-@2Q,ER2/1,E2N!4=(;RV<M<FD28M>6;HG1@%I83];T:'0M!T\\
MH^E;38Y)&;.J"KK&C<R<FEZE\?G< B<N9)4\,*1&WL;M)&J0-+@@?'-E0-R<
MA(>J+--3$D%@+$$( ZT'<,<2K4)#C]-QF#!2G,R.NW?Y&S,&B#8]#MNC4WP5
MQ^ 3>F-FBNW):F);#?:0A]<\L)0/?,UL([2\I<N(JZ'4"+FR@TE2F.+J\#JY
M+3M>)Z[&[OR(]M?'04)*CH(T)Q>6Y280J/VF]5028(!@A!%O6PC:0\PQV3=+
M<^V 98*%IKSEB"O:NI.7(Y$86S1J.V')6.1U>BN(UR2$ZD1+<P58_.L;9F9.
M2E:4@E)RC0AG + 4$^SNFJ@M)SB+U9M4UM8KS7[F>]0-VG<&C$N<X2\*0$EJ
M7:(KY UN"J-N2@M.6$9Z,9)H] #K8M^[KV! 55<.4+5=WVM?B&"05XG<]F,;
MDL(=5U=0LIWH]HCU'UM18H554A(:?G,9B[I'JV(//3I#4Q6Q*C"O<V4$.L#C
M<H<:T!QU7C'6,588&X3-Z8W2.R>QG"&0EALNX6HAX?)#I#,7%L0$NDP1QY-(
M#"2R5!JDM.F_Z@Z%OVA-45YWY\@T43P"$4734/@R!W>9 DA45K*$Q^*(GZ2L
MKC')"]IXVT,B1H3N\@CKNK0+5(2='*T2HX@T0BC!AV'?2*G*BF#0Y1^6U77$
MH87J*-T#>&210>,/;0[09H6#<6F&.3:YM:E&OBC6X&"/3MQH!HR#A;& L(M[
MW@<:(TA2\ F,OL2"5#5\)L"P?0^O9U$8!%(W,9O\+L(DWU?)V9I1/<E^'$#6
MR_C3SO<WK7L]F!F[-'(]'/FOT\PLS%\]>5\C>_DS6A:_G$A=-E[<WYU^!((^
M8/+CLD'KJCO?/.]S7OBW[-8$=LW/U#1V7OUA1^DJB8I]*GXR4R><,U;0ULE\
MDDYK8YLILC?I*B92'IX?C&9Z6)!+%!YBC:56<5L?N&C"(.-"N<>>:V2)6^NJ
M&IF H$+LE?T2*%5="(JD1OJ%>[.J)Z2IF)C0$IW9&Z/RY24I '1Q9ZT\P(M#
M.,V().31Z/HWQTDR1C9TLD?$+4UO4A3-B(A\>&UB,<361N='8H@*]P0LQKPK
M$E)-,&6G$J.V7H.S!^\&/1RM*UASD8ZQ&OX-%G@Y*[)37*.11@8W(U$_21=,
M'U.8L;$"54-*]2]T4NBL&Q; I<E!JDS0CC!#V&-,=14+#I3/'&-UA4,6FMWB
M6N=GKV.%0QCE-O"0$A2.#A/%2!L2NT_$B3O>BCC7 2OTP*]!%O6C?8(.3!*)
MI"K62/QJLJ;JJNHY$GMTDT58()7D1B+)&9(]H%C4]2"/M4?:&]"S/;NV.*A,
MJ5IBRSU!!YA9@Q &+6P[D-65@!.^) 5Q P)9.R.T9DJ8,0CP4\AC;\[/K\^1
M]\)TW:+=F1Y?)2YK5:11HPA2K<51Q@!&*#1##I4U$4>CL1TMY'3=5);8?(^5
M$GJSTU>1$BPW>*D)4Z$F,NDU*: R1?'RD*0HD*(U2-,$HH - ]T(=:#&F_GC
MEZ,2FL75JHVA(]-:W8G./4RXM]9UXTRF!1H!BE:\L=8JTS(G=HNQA->3C5*9
MJ$0GT)6,0P^TT6Q!)C;7T"9MQT3/"(@U"B'SOZ3VVQIF0[B_U*8(V1_3NTJ(
MK;)\_-'L2WX;TOBQ;WLWWMX&"O5)\[))D\7+(JCI9-8+K],DO]K/4"@Y,R<?
MIQR;38<4\3E<U!>UGR)W1HQ-FCE0OA5)1.R/=&$'L#+ONMK+Y8A9?NZ@GR=K
MAKI7+8T_2,?^6-U?/A+>G>H(A0?+_A4D->"&A(!4UE@"A4 2E:,*%HL&M!P(
M13-/5G%5<%K>J*UKZ$+TFD"Z'0B"Q>*158@T@"U:1*X\PM:!H4)--8=)O3&3
ML'P^M%^SW/V8'9O, K=?&6>.R&%0A;#88-G<H^Q/,<85$9B@XD2'Z?7L[8N1
MC:F(<93DZ^#-( 5M$ &O3V#6L#%":-Y_=G^$V0GIZG7.4PZ%AAM<3TFOX4L?
MXK7:]N-1@BL)E);08XL<+6-"T96D* \I"8F.$'W-@'O6P[=^I>G95'11"45/
M6DDB8X9NN!Q=^@D6>(Z.O-F-IVX&)E<&I0VBAFSF9&/Y7LKX'WDA._2]I0/=
M#A1^J*,J_P"GS(M6U3UW\K/3LL5,C\.A\2^7*5[2W1=*TQ\;<W-_PAZUB:$C
M<60F]T1B1*2GT'998 !#D12D*6@DKD<\@]0U?#9Q,7%U=Y=,XI (I'97*79]
M$@&]N<CD30THW=\<7@;4EVJ.5'&F*-IBMF"%Z8/8&,G<N<RJ+"^]Q1SK1)UK
M:>@R7[SCJCK\RPM2( ?= _\ UH./[DGSH ?V:5?$^OK7_E8$A'5S7:N!BJY1
M X6IK V/ABHJZ.B[&= S(KI+I&&-BB(T(H\./Z1:T5I'\/\ #>EKW?<]W]F!
M@2#F+FQIJ=?0K7SU1S;1KH::<YTPWU/ D54.)QZPAP..75VF8"X@K--7I2CQ
M",1BV(XL(]_T@ZWH.Z;X51H"'"#M42J@"9='FV".L/;V&(!(61. I"0-$-<(
M^F2:+41Z%(907I,W&$[3-I+B'0"RPJ->^'73JAN=Y>UM9EETS2\H98/)GFS&
M4<ZKN#/37$)BO7*9!(+!:Q/[.I21^3+7(XY<L=BO15&'C&<8;L6Q"P,WU!J_
M6@.5!AT.5ENLI;;$/4ZC[(H Y35N3MA3/.3CM)!A62E"D:$84SGO8E91:4G0
M#-:+![H=$X4G3+LSE1UUJ.L7./D0ARK,AB<(%%5K.36[R8W'/%?%-BEJ,1%P
MAU-9T@E+3H&D!XDI.QE"V4#W0YD-J2J:Z;8HS5]65>P1H@;.[QZ#M4-AD<C#
M=#&!_6(G%^8XHA9&U"FCK0]N#:F/5ID8225)R<L9@1" '>@Z:54#1,ZF)%B3
M>E*DF-@)H\=$DTYE5<0Z0S%/%%)IIZB,D29W9ECT5'CSSQC&B"?I,(8Q;V#>
M][P.;(&^FJW9$LME2&L8%&X0\O4E12:0)HK%F2(R";J7)%(I E>G("% P/,N
M5RE84M5@,*/<#'$X)HC!*!Z&&(-41Y;Y6CKE)62,4%SA$W5:66\/[4RUW3\=
M<7!V<5SF2!R=4B:.MJQ:YN[BI4!T:8(9RD\TS7M&,6]AVZ"A.>C'N=3UKI>F
M1R.YF8MNLR:(*YA GNUH\I)*V4AG4C3L^U\Z9CTX0>Z4X'*B! T'V:WKV8&3
M-M358S31XLAGK2OVJPY";Z[_ #UMAL<0S1\/^6(&3UGB4I6TI\<C?DS4E2>\
M<>/?PJ8HK_Q"P!T'0+N>Z#<WRNI.Y4?4#A)*?+]&I9"NK2&*WRKB=["+95=.
MRAE,7PDOW@:W[K88FU[=:_\ !@22RL+%&T0VV.LK2PMQB]U=3$#*W(VM$-T?
M7-6]/;D-*A)(($O>7E>>K5';#ZBA2<8:9L0QB%L(UB//5!0!M?&:!T?3\):)
M-+4$_DC5$:TA<;;9#.VIT2/;7-7Q"S,J)*[2UM>D!"Q.Y* F+"51)9H#-& "
M+0?2W(?0[NU)9K?$6J-T8Z](=UR*6VXR0U:U0=,_HP,S\K2OTR2FHXR0](#
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M>JRI-%W-1(8?. -2<UK1K4S4A&>00L/#(4W3_9'-$#,H^Q^IH<[ODJY]\?\
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ME[A8$(@5VQ1KG:5AO6'Q":NRIQ;F^7$/*=,<I. $/H'&E##&H3P*U6%:W?\
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MJ1,;_5#["H76S,W-^XXH;"2DJ01>RQ!4*='!5Z^/&'5A-)J8OS14E;.DZT;
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MU;0HVUHBBEB9(BES&RV;3DO@\V(C,M2-Z<#FUB6C;UNTQ!AI(C2"1EA#\O\
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M/'E,#C9$%=&E[%H2$\E :X^AL1H"]G""O4G\C/9,:M%DY'#S!0CKV.^W?%(
ME2@OV<MW.Q566!S]</0$<MLZ>'TLIL(9C$FHJ2QYU9P1S9PW-$2H2G&)U6@D
MA6>!_J"FJ<ES-_C%;T[:3:^T]T/:E&512%WO=C](-(Z 1FO)3/TY6;96.PUD
M39,/2*WM*:Q'R54TEHC$!R52M&4$092Z^;]:T533JY4_>/0,ZO"R+48()=?X
MS%YO%B^O:@@M=3"4R1TGZ*KUULQ&R_J*S$,5#"7>,(W4I>0I<1F_+RP>H':)
M_-+;D]@CI>U.<PU\]T'4E"<R]#=!/,KO%U;)RE8KRL.UJUF,)IAD9ZQ=8_.W
MZOW*HG1R0NKBXL[3(&[2?T]IQJM;)"]WCLMGH:R(9UR]WOM@D2F#]Q]=U_6)
M<2DRY[<QU_7-J2".1Z(GD2"+PEK9Q,138%"W:TH4%J$^@G*3BC!&8&HVY_,-
MTO8-<7K6%9)N2X_>+/7]'W'%'6@NJU5VI:G:G;KVD*2L:D+VED9JE;%6RV4B
M*S$R4X^,GO+=L G'TC0"3)#U8;:.\[2Z:KU[\>K;3QD#:UMJ]C1RO+H;G:8R
M1I:'2,'\]7Q,W:--CHVP)Z<G-G+<X>)>4:-.W''JVQ"4,("5"G9(:KJ!\M/0
M7+G$7/\ ,.N*IA#FTSGA^!6M0UENG0SXZRRPI0ALF@:%-_%#(957I#;6VY:^
M=!QZ3K'E MDH&MFTXZ/TH5I@!/#;#XZ.]T';S%=#<I54N]36A)XPPZ3S#FZR
MG2W:$G#?,(:TS>,R*OIR^12%O8CTQ#@I:GAL6( *&YU;#M:,.(-),$%+>1J"
MGO6]"5+Y$77K2_*SZAM*S-7.C<R[;L!UYW@]1$6ZO1$\K&\OBFT?I-VKX^IV
M[3 M7*F_4GW(S1O7S+XL "] E/F$N&!5,+J*6\RP??,MQUWU1+>1W!CN!X56
MQ+'SFZMK*MN*LEUQ9;7**,P1%T)7=3/3FS*&5U?QL>RB$S@6,P\0R0[G?DQ[
M4B4\G4>M?DRA(_&:,L7C]/>;Y%.BYA)G,BK^WYJQP&M U@TKJ48B9/:%7/+F
MH/E:9S4-#,J2I2_E:L\Q3L*8.[@OE$Z/7-L5L"P.3Z^:JTO%+UW'^<$L;Z"2
MES1]LWD]'9\@3-%MN5@PJ#5K6<+NV&5&]NC6\_.%A<?)1ATY WZ_O$A$4 \R
MESV&XN=45_67(-ZW6HZ(YTI"+2VA>I95,.8E*+I*L>AIZ@?G>S3J9+D!CE4R
MGG9S ^I&MK<"W%$I(,1'!4#$E+"8&7RWRR.P:PW>[:&8(G,:^H?K&3IFJ&V0
MMDT;L3HGC/I1=S-9M,P5X<X8Q.:AJF4FDD)7QQ<>B X&)Y,84H0@&A$,T,:M
MOMJY>$[AK'G)Y15-*I->B^5]!G.G3724AJAKE[O;EWO9+AR5R99$WB3]74EL
M&EV=8 U&TR)]CI"EN4M:9N2E$J!_ !,OF3O!L@=#U30F^FVGD!^[ N]@IXOH
MAPLUNJ%74<(C,?D5O6--6F?.CLQI&)R,8X 6PIQ[4EC,6/Y!0?;LSV8%=(/Y
M9.AK6H3E:3<VTM3%TS:QN$;:ZPMR43ZZ7>OH*T/?+\R@=4W-"(FIA==V2;)7
M25V,^.*5D6 V2W$:3://'LG8=#"1F#RIW;-YNWRR'\TP0'*;9=/#=-32<R6X
MW9#<XU_>-5\Z3B%/$/KALKASBJQ-53]T:U(Y 6N?THUZ4)AJ'>QE[+$$A-_D
M]ECO47-MBLM#,CH_]!\\=A7:FBBZX&"%L[ Z\NCBI3?'7*PIPUL<39HW*=R4
M1[F^N1B,AC1)3#O15BUHH057I[R13WJWI/FBN-RJE3%-7=P-T*G,PX\O*46S
MSU=$$LS@#K^T(VS[DCQ$8"K>5,0EU?!VX(34JUN^-0HEA!WJ>TI.&?\ 2MWV
MS5'F^YF-*L>8HN<%?,,$K"UZR#('4->"E'2%OWC%:SLU?&-K0QXN3M]GUK&X
M^!S&1M4!(]B)";H M@$&OZF?*[9-%S[JJ3V#9M?JW7L#K*(2KF8/7UWR:K^=
MZ Y_?>9$MRQP"Q]2,$Z7L29VK4N.[1LK(UEB=I%(MJ#1% "I/V$^2[]1=!TD
M:B4JC,>YR:M1JD2+MN^)6?TF=%95,]DV1:=;NE9\;!0UNYH;UDZC=,O#PT.;
MEN/M;JA<6,G^I/<S=H Z\[R/7E4LNZ3MZT8RJMQJJBX_);*.>6&)7K,(BSN=
M94)1=+SJ/5W8,%4UTUQIQ,<FV1HPLZI6):-C<5BX_P!@A"V(T+D'>1SKELLI
MRY.?N:*(1=F2BSZJCE2LC=?4R<Z&'75I5!<UW+IC8LX-IYMFS<]5=%J"D+>Y
MM[8Q+ .KH<W;1G 3JCAI@L36GD"<5'"W0'8U\U$&LGCFI[ZLCMCU7$)F7/MJ
M7GEF>SJ .B"+2Y8Q11.Z"F[G"-B;C#D:8 -+2M&^[[![T&M7MGJON.>0ILXX
MLZIZJI&[+-M3@N5+15#U;<[&Q2GFJ_NH&FHIM6_WPP>J8?:L!L1CG*)#'I,M
M9"@$J(X^F+FM6(\(D6@O!Y.8+<"R)\RI(?".D[=YN@\ND"CJ&C>1+H>:UZ<G
M</10!0TUPZQ>6EV-5M@6!$H/-C"E,@9&Z4M[P];.2'"^,"G.3'!K>AG?$ZYR
M!0TOKFW;+Z1Y/K*CO)K,K'@G19E@5MUY&9-3UH<T,M:\RVHRV+&'N4/MQTH]
MVZV11N>92Y(375JD![BM&;\,C4N 7F?/(WUG7UB(>1;,YLHM#W'9;W3FZ*C\
M4O:8/7/4A@=M,MWO[_,IK/'&HF:>L)E)).=Y,0](4C L&\'B;-H!@ O-^""'
M89Y![XB_D=,YDM*M L'3_0=1<KM<5YO5W)MWI>#,<!L_M(SI#HF*3@#5M.KC
MS]5D-:G5B;PLZ*5R(\UM;UJ-&%$O5-X1)S-Y0.B^;^9(#+^E*F;[)JZ7P?MJ
M04S/D%VO\JOBP9W0=\/[/%(A9K/*H2DC41:+:1R1&WQU2E?GHQG*1%Z7%@"9
MHM.$K7MY ;[K*XJ0KOK*)QVCIU1MQ,/0EEI.<K3EEC5Q;O+TCXT[[E(VH2F2
M1&L'U<^1*Q:!5)%[.XH!-ZI<B;7!.=[#-%I0B*PO)OU%SU=AM[=1UU6%61V9
M\.TH[4Q6*7I:4**+^N.D>JXO!HHY7I+'ZL&%)7,GIYG?B]S)Z;V=[3#: C^6
M&GCWI-@3;5_F(NF^7.L:SY]I+G>\K4<K)Z B%G2NO>AY0Z4$.)<]P&AK;<IE
M2LQ35$LDM@N<^A=X)V=N9E3<W#;I@G,1K5(418U^!;/QG>0B6]XH;!=WV.T"
MT-T<:8:]DM]/7BMGM@5>_2H^2$OE#]+5--H/6]F5'=5<_(R?CAFM9K&Z"4F!
M1*-B2&Z$%3*2[@[R=K2O#GV)5W25O7-*>S.YS*G5V3<\RB->5WS+RZ_5;&7!
M!*UL>IEYD!3T9)K5C;*PI&]O6E'"7KERU25I'HM8$U]6]?S"Y?#M)>MJ-9IE
M ['E$?K%>S0EJF.F&7,%CMW0$*@DSJPN>L^BB"O9,&YQCIKH47I.H2B$=LGT
MC-E8$27=YA[#YM?'#GJ_(5RK3O5VK998JVR*?=$3!@X]*JJ2U$]7&TVDY6LY
MU"@L/3J $=6Q+4?!&@J%<D)"<4H"@'LTL).N[MIVZ,\(_1/8U2C<Z^FAW.U[
M*6L=>SDY6:QV-5KO+((\GUO9K<F8#'B/+I9$5!L??RR$6UK8>F5B*(V8(H 1
MK<?EVN/F;4PJWI>J>9*=O\5L4A"*]?I'T=)TW,"2'WG6-OVHEE=H6BZ5&TRM
ME=:[;*'D34O0-[&K"]/!C:!"<62L-,2!!E?^5Z=6;;WWS5TRL<W?)IS[5_.L
M"I)CN9\<><9#U2_^0"SN;@V1'K')B&P.%3NC>VER ,G)COS93$R $:3?%ATG
M"&ROQPV%T#-G/O[\1[:4U6)!NVW6'IX5&YZ\6)!HXPMW+O,+NVI*K?)0U15<
MD@\L5/![ZD1*$#<-*J=SPG@];U3C U47SYA.E)I5W3U:5PDY3B=W,5"(;QA"
MRC.JA76^4@3'>F*,J"?5%T*]16KW.$,MN!9+=(V6*-+WE"4K3KR/5#HA,K4!
MODZJ;NBW[E>=H:;L*%T?=:V#"&ZV()C<K(;Z^) U"4SISKIM6&P_3]*T",M2
M7'%;J40B)6;(5K$1Q98T1@:%>J^X;*:_&#QU6-=WVL@=WN?#''G5?0MO.D[$
MCL=-6IQ%2M2*/() O<DCZNL3I.P3'!,>XA.,.+C[+(3S=Z/,2[,#GW7U.^5C
MV-.)9)+GZ*3]/)?(AR76-*T0POEHG\XRGQVW2\T96:V7IH*@)-H>31B5&V/(
M7%;-%6CY W3M$B;"5B<):=$>&SCKAK?>C>U^;N*'BP;)KRB7*@;ZZAM]!4MA
MRZI)E<2VMIU2=70&LE-DUX[QJPH_ V];;2YZ>D[,Z(%#D>D0$'&_"^N4<$?)
MI3T[R+)XIPOS4]M'9=ER4J]>@(.Y=8V]+HN*BN7($Y5>RM51S>W43!<-E7'.
M#[$LTIJC3JZI0*RF,SWG,\_;:$Q>%>@>9^]YZP+K8HWD.#RFFX>3Q$BFZ:;7
MVOB5J*IKV^L9X0PP6(,[=5LAB!JBF[1?"$TD<5SHG3JVOWCFXL\[6RM!F"[R
MA=CC<55,1WE>@W7I."._:""WOC.@9PVT:SM_($>YKL#YO"Y,&E5D[D/WHPOI
M9I2HTRMF;QM;P4;ZXS$I>S-A\HYY;N@W0F&1YYY:K5EM3JBNN2K2XGAI-Y/;
MDTN$<ZO>YNV)6WI63%U:1N!/U4QZ +I$\ZC"23IEJ'_@T1@U0=C$'>F^3'L*
M03S\,U?<L46NZQ@H^GTEX(9;T!,&2CHR9S@S<USAE>X/+&RFWJ;RIEN^ =-,
M1[64K9FU4RKQFE+=&%)A&FAQHUYJVU^1<\*U=%'LQU^='\OUX)O5SE.(^ \\
M]2<SU5>,8Z$D:K;$2D-1QV=6^UPU:B ("?:W0U&E8=:T3@0 _P#ZA"/LLA2*
M5\-H.(1.*(*SEMAPJPK_ '&.]%SZ WC+7-57#OS/59%<+T=C.K-1*EAF#NF<
MG%I"K5.XF= ,PY,-4(/OV;Y7;0:3^O.:MIJ ACT]<]>1)BK7=+]3:G76M&RO
MG3G>V[#AME71#(1&!1*L06&T00QR:4:.3C?X^>K;RU9?Q/Q8$884CZ;\BSOU
MM#(A#C:[FAZ?R$733]8124W;/XA ED":O%K"K/"EN73%5KBL51B(O#NDDJ9,
ME3/BY;*716#0DY:<E>8%ZND>K)Y=?A%Z+ZB8T4@H2U'#ER[5"M'#)JO$^5K9
M,$/E4%E&X78+.1'G8PMJED95C:G4HE"K$G]$[99!N]@"%=>C7UZ\/TXK2VJE
MLCI&]:NLVANO7&RN>N@ND[-NY&Z3+G;G=_Z-K^<UY+[A=IY*ZT=%6X&XQQYT
MC4":%B9Z2G&H_B$A1@@F&INZ;BAO5VX/TO3T;K^0V7(^;Z[M%QAW2,XM"I:E
M56W5?45BT9N+1V75O!FIE<GQ359<=E:U(4E(7/SHBV$Q20F(&8%:)3^H0:8V
ML975T@M"0N/L,&JBV[#KZR.@G",]#SNM.@']Z>JL%S/6A=<+4-CRYMH'Y','
MA(Z.#.0>O>@,B$TPTD:S ]*_JE^EZWOZ]+T_5]__ ,GT_=]_W_\ VWN_MP/I
M@:F6;P]<YLD^B]@II58PG.)>0&;^05L1;7,I:'<QFD:):@T^;HAH*/%3<;DS
M:W2%N;_?]<EW;"![-$'6P[#*)GXM*FFM#1B@5]CV,DCL72=OHTCVEU&?G:D'
M=,<O"-SX:GUF0Q#[\.2WHX&,WN%!ULQ&G^)];7J:&&"V-XD8W8B>Y:_.Z?OF
M-<VW INF:*><XP7!&R+1^Y[[K>45W/["3RX$9W.7V-'JYHZ2=/$'%:HCY<L6
MB6F%&DEITA(; X?0L>AMW3R\D+T]*WZ?U#3%.N+,KTA^3HF6E'RV'UB=46R4
MI:WYJ[*+<6 5^H:,GW$I/I@!OW]B"M-3^/>-53T=(^@4UP6))$RZ7=1S&&UH
M\MD'3QJOUG7[S4LMN5"V/#1&V^4/B!9.:H*=$&G)4I-1;<5!&AC*T5H(0M#_
M !-MM8"A[!4'6?0U4U>9#.<8E?%?0WZ#;U%]*>7HU&X; Y,?8&HO]=U0^RZ%
MQ!L8I<.++4 'UE1%)P:2&>HH,"VG5/*;CT2[4E.81=LYYYMZ@)G(I1 ;+@T>
M@4Q/ USJ&NU?V!%7B)V7')3$W1OD<7>!;)/&FTH;W!,G4EB%HLPDT*NP7Q'4
M] : M_GMMM>W'2/7%RY N5GJ4/RF++Y>BBM?S.]9JWR\M<7'DR)=-75QOIQ"
MM./3B2F_"$""2 6S??#B/WB2@,LGY7U7?=POO,K99U_VY'.03DD#25@T2SJ:
MNKAKV]$A\K0Q=-93M%7S5Y2)T9FXUTT&/N#FH^'&(G:<I*'?POQG.Z-%%T-P
M=E=%7X16TRY=>:I23(BNXZSPV*\H6PT6W"69QCL&B<?89I.9D[,:1#)I@XIQ
MOB]N2E$IA(]>MZP8[>GB=9^BYQ.7&U^HKOE=6O.^A7VM:K>6NMW992LYZ4IN
M>4E.7"%6TZ1-7:)M>,<<LQY6,4.4. F-O7J2PC >B2(D:<*-NG#]]RCL> U?
M&X#U'6/.->=NN?5#^6Z3CG9^X_=6<533YD>;3@CXWM2+I85J7'-)4F4GU\O3
MF1N,2)0[N@334PD0QAL(EWBDJ*70"EH.9:%JL2SG[DRM.7:LFL?.B2:51API
MJPJ1M2KKN1F+HVXM0[&BDZH5G5:3FI36582:I3*$AA!VP8!1XWYZL!%;$5=R
M]!&]7QF?S>6$]*#CE4*0IHA94,AU?3>F8Q2+C$%U0P^K5\?K]F7IDJ1O^-(E
M+>%Y-5*3S51:@)YK[A^N8%PF3P(.4S665H&DY71RF:296UJK$<F.6MCVV+9*
MX.25L2-9LO)V^#4@5A2@#\8 )ON>][<"K3!X8>7VI+(T+E)+0?$\KX)K?@IY
M&<^MJ%;M@KMS"]ZO5"L1M(1H[XDCZULRY:Z^Z-,)4Q(AZ3[T 01!^G/Q82.2
M:7V7+^U;NDW7I-BTY/87U,J@-((G"#H:)CEH0^#0-MJ)O@:>KUT.<(_=\P&^
M%GI-J71T?S583D^DZ(E,'3LWAMK5AC_N(.A[V/LQLVX2:'W0[:KIRG48N$_K
MVP.T$%O;2"A1,3>G@BS;(<6Y6UJ&_P"3+XZ<8B,3!T9LS07%Y?Y!+YTKR[HD
M]W%8%VROH:UIO<]G61/D,2;'I=-; AD0ACV2R,D/8V*-L,7;D,.3A:VXM.(*
M%/[I'OF!+T+84FBOACAJ2NF>N['ZLZ(M@%24O */Y-ESZGJQDF7+4?K><UG:
M<;ED.<8] D:":6.18M-150-UD"5>$YJ84S::0808N&L#87S904MI2/SC5G7Y
M9'2EAV7+=RR8SFQ$L<C[0E"GCK+$VF)U]6<,;FF"UW"FME82AB1HDPCESBI5
MK5AZA0I$((450>(]N+K25T&]===%OW-Z>KIC3M%TB/Z!:8[24&FLHC<E.2JW
M5FBJ)YN=Q@Z.+IV6)*):8X[CS(,X  G+#1+L"9;L\=$9MJV)1=S)<]D5C9#_
M &YSW;R!XCC3 GQ$P.="US:%0&,*9HE\8>T2YEL2M;B?FYSV?H2E,-06H1FD
M&%:]H0VR^'2G6F0U8(^VK,>ZTKRM^:X$]U$\-L#/C=B+N8Z6LOGJ*2J1O:>,
MII:B5RBI+2<&UX1HEI*(XP!)Y0"3 >W YC-XI5>Z]4UU/>V.GK#;(-%:LB7+
M2UP^[)@/YK^XR>QJR:BGJ)LCL'0QVV[>B\@A+,E42.5(G YP9$(T!A(0+W(:
MP+=<C\JJ^7V^Y5<@NF?WW8-_6\9=UFV#8+;$614JF2BNJ]K4QOC<>A#(Q,,:
MAR!CKA"%O;BRS1)"_: 1QN_:,04-1^&I(PP=96<,[-Z#AL&F58.?.%R-C-&J
M8^8VIRL3,Y]*(!3RIX45^8;$Y'6K):<CCB"8MA93\I8G<T"H1JHE$J2!L"ZC
MY&KKJ/E6;\E/+E(ZZ@TJBD?C+!(:Y5IVB75L?#'%E>8-(X(XK$ZXEK?8:[QU
M$H0FB+,T6-.'VZWKVX%6KE\6$'L1:Z--<W?:?/U36;1]8\U])5#6[9 %D?O2
MD:@2/#+"8OM[E46>I)63V&%R-QC3@[,"A,I6QU7I/[I:A.D5IPZ5\\6:MML^
M87)1O7%P4/8+M9UMSR$.,>@M+2MJKR-]$-D#U?E7IV&7P1Q02R(3.9UFQ2=K
M&ZZ4+8X]-I?PAPD1BI&H"V4VY!B,YY4C/)SO/;.<8S&2J5#NPY/)?K.TY*LI
M6P8-8[>]R^4R-,L^?/TM?8,5MV4C)!ZFE1VR D_U>@!ADMY?-KKA[J:@JJ&]
M3I]LN*]IRB-H'D]H2.#K.NFI%;UH&1<A4#30V)F]/+[*&W(C#QE[ E++$>;L
M6AF;"FE6>)=Q>Z;@3G>W2]YR3I6'53S#&Z2MAR:Z?32_D]1STM23V-,T7;X]
M"00>R'93/5*@B5N4B2.@Y4U%%(SM@+!Z@PM)7?C\3QV21ZPK,Z0O>Y[4207J
M.$R:?OSTU1)<Y%=4K*0-DAD&;H4WLZ.G6FNV^AVE+%6^.[2%-^SU*LX:E><-
M6(*^(/$-HUU<K3F78-US?J=DW2:>F>H5\(I5GGM9MU #L0N$ZDC(PP1!%[J?
M94T6N_MDO<Y.G5J7QM<!DD?+O9H6@F:J/&= JV<Y'+W6V[*L&S+$J'I6N+=L
M*1I8:@<[(E'4\Z@TYL&S%C1'HZU,,>=&/=>-C.P-;<G(:6UC2$IMDFC+V<,(
M2C_APC$2<&]JBW4EU,%4$6;R3>;S6"",U#[\PN7D!DI*,P9[EEAJ8*HG[E G
MUGH9F,61<M:2@3.(CCTAA!(@I0A"G37BX(@'(%F<V4$V77;DPZD:.4.<FZ:)
M'6O8\5SHFHB4RR4QSI>0OQZV*.;:WP(+VJ7*=,Y#JZ+'$A"C2HP 4GGE!>_R
M#\UR*Q?');'+G/D=<RG917E=5U6S#$G1HC[RQ,L5EL'(1&1IV?#DS.V.,5C3
M()0C,/WLL!B4'] >_86(.)6'CI:XG;\1Z*LR^K+N^_V"XU-KOEDR9AKR*:E*
M!OY]L?FZ!UN*)P2+L,9CL,@T+M!U<B]-Q!"I?(5JE8H-$ _2<H, AGBV50ED
M>:Y8^U^KV"D([![.A/-U6P611*O3.<"[.=R'L+RTSJ*QE#++4<*L4)])(45+
M375$R-9AJ8\E=L?K:#%FCQ,.,?D3A>\>Z_L^/=L/-BODY?NI6*J*(;"'UGDM
M:1.IGZNG:BB(-]TZ^)ND8@S0N-/-2C>C)$WD+QKA%EA28$J*/&!7"VKKZK%X
MN2[I7OH:@* H.=SV;R%JEMB+$=!NED/2">*Y$ZM ].<SFCK9RXYR]4KY>0$L
MDE$F2D%A*"$[59R QUHR=6PD^QIO+:VZELZU+./ASD3&V<VKUEWHE [39(5*
M(VSM4A6-L@DSDM=4QKF<K5MQRK91)OI !K04':_"TR;@6X5,.O+RE@XYRT3R
M/4#@GA=&Q!MI^NHM:51W!6,DCT3BU<M\??+'BLSIEI.<W)T*5)Y #6P')20
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M/+&CPNK85SK$GA\B2ID;9#6JWF=SD3Q!)?73J:TJ3VV2J%\B,$I-/]8/N%Z
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M.'XQV>MA4_@\=DRCK)UD$MN) X0!>]2%>B=XI73(@ILECVJC&R'O4EEJ(8U
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M<+!IU-.++$&VFLK$BMO5M7ULP5<8Z0BT(/$[$ASF:F.1FN,5FK"@DL>7&)%
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M,L*48%CNCNH57/Y<';V/GCH+H:;SQ#+WI! J,C\&6N+)'( UMKK+GZ62VR+
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MH:MT]-?3"2-\T.4_&S+F=\FEQM2.1/B8]K;8VC0JE:9O;RU/L6'!MBP& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
MP& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
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M+6&=)VVGB7#3;TT]OG1CA<C[##6IPK5; IC.:W(D$&2:=#B31DI&I0GTC,+
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MZO\ I"3P#FGL(-* Y^+Z<IY!&HPO^M4U=)D+6U?!L4L7N#46Z($Y:)PVE%H
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MK+>5"T<O$ PDE4%3K1  :![NPV/6-QY.;1[2X%[!D$\BC>OY)JSI:'3R(-+
M[;33F3=$0VMV YSB3@K<QF,#)'76$J#@DK JCSDZ@L'OZ& 0A!-O:'.#9U_R
M5T?R\[.)#*FOFF; K%._*D8G B.N\JCB]N8)*8A 828L#''TU,N](!A8Q[3^
MP(P"WH6@TDL_Z?1H01'PP,"RX&58Y>+Z<2":VDY;C#K[G0JB46)';Q>$A0#'
M@9C85N[(R2Z@^8;6?T31BW_7:"+ [*PO#!TZDE+A:?/G4=106VD'ECZ4\E$&
M>+ J*1S:+,[7?=.,-3)ZU?(\@F#&>\.C"0VJ#S5P%)!!OK ]TL.P;]X,VM+Q
MW>52Q+4Y(ZC)[;Y0;NL.:HOTO7SE,#^7Y>IK*506]U5>":4B& E6B2K;7N,H
MH:> Y4->8%0-07O0-: +WPVN,E47Q+N/W^E^A[,@<VOB;518\ FMH0&#N$+@
M2UXF2"3,S0\M,&5OCRX-R)I9W5( \C:X8CS4Y@PB!HS00AIHY8\.'9\*D/CQ
MCW5'9M,V5S_XT%:.0T/7M.\]NE>3N0R>/URY5M$?KRSGN>OZH]B;&USV>N3I
M$10789>@'!U[0F%A)WC>\>GE X)BM \\J.TN7)SR#3;O(BW&!H>:)8UVL_1*
M32B531P:TMC+++5H4;KJ02@>RU(FX00$ T#W1>SV[#8-Y+>,!=_<8V[S&W3(
M-:3&7!B,CK2SM)5JM16]FUW-(_/8/,4A;:L;W()K:^1TL Q)SRCO0-,T$7MW
M@49FWAS?V7COQXU7S)?:&F>K/&D<U2BD+Z>8,"9Q"63%_B2Z.7XV6'!S7-$M
M50V^#WM>H<?AU>ER4TT PC-]@PF!+')?CEN2N1=JWAU7?T8O+LKN2(,T G$Y
MA$#5P*HZPKR"PJ0P^MJZK6&*WEV=]L;(;)UB]>L5* *W-0:'9@=&%B.."!+'
M\1W0"G@3QB<Q4QT76<*O+QOVG2=ML-JS*LWV7P&7R.GH#.H@029"$DF9G0M
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MQ,*4(=%#@K;W2OF.6F&*H\60408C)5* &^IL8=A"G,L\/,UDO0#Y<X;MBJ5
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M&.W'9/7_ &36]QUIX\Z;D5:\D554U%K*V;D,J>Z=%1C99ELRIYFLC=YJ\1.
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M"*M#,UH!K#UB<(O:(D@*C00DGS)>,_7E8Y&;^;$MA(:K?6:X8%:#+.5S,K?
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M@[H@M1AP )3$Q@S/=, $0PA(M1^1_P CU9W3R_"_(ES!S56===VL$X+YZD=
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M.,,%5*YT92%FD>S$)FM;5*-%>D' [V?^$WI&)]R=!W)1Z!C/H#H?QI]:0<^
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M!@,!@,!@,!@,!@,!@,!@,!@,#^;UK?L]NM;]F_;KV_\ 5O\ Z/;K_P &_9O
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MYY2MX0>?'/R_+B.?F.$-M'4$\O,;=W"1S2--$^4'6U:KT7"F9&L<MKV@L25
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M*"F'HZF7N"E?5T/M*I*KA%.;F [9#(1GR)KD$/@Y8SD)C42/XU2(S9V_3_K
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M-<%-M"XI#$9V@*M:)V'V4][<:H8K7$U<.C:P;8Q;+\]1B!NCF_!;0NS[&79
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MW]_\^]=-ZIIJQU96ZH:& EKZEMQX3#%D9I"QX$!R7.:P1HM)@N#SER9==/\
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M I9.>YE+-G%)?52A(]'83-CV/6@D# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8#
M8# 8# 8# 8# 8# 8'G.H6^^@*4J+C7K&;]-6;=Z'IPGHMOMVG+KD]2Q^MV7<
M$I7H6^(M,X#,P0>)*ZA:8FMI(AE<E;FXN#0!G>AG*BQ'IR#<#E*/+Y<FW1GG
M[I 8*BK*E"^L'&_66$N]G'!M-IKCDVK>A:D45.;:U!U[.=Z6.%E ;%!QS:B0
MJS2/BTAZU(86'07XK'NZ:R?ECK&[Y]46H?,>6HS8,A4HF]!;B.N['31:H$UL
M-J^$.5R512D^6H"C%1C&Y^LQ$ (<V]1LDTTD18\" 4G:_7D&F<8YWB5+UI<C
MRP2>G^=7FXK0O=_A3I++\LCD@WJ=;,G>+QNF9<0T5BS(65P1K=I5)[@(Y4D"
MC1[*+.]P.IB?E%Z4N(^#*Z3Y4JE5&[%7U7 8^Y61T-(8VXH+2M'B!!W!ZCVU
MQVDY2 -;PZ)IW!B5+4YYKJN<MI#B4("!'^D'[UY KMLQRC4GH* -+\]WS1E7
M**YKB=V49#H3 GUOYL<>MKG>W.6-<'ERQTFI,:N6 1ML)"V@2&JMC4*!IR"#
MM#"*ZT\AG1DEA7%LV>6UG;J2B4C@<+Z7M99-B-V?9<\8_&)..J[$)7UV7 P1
MA!7[C)W)NT4O1/8'$3PT#'I&! < 0@EUA\BMK4_7!E;S6JEEH]!4O$'6QKN2
M*YJ8@<E=)1"@*IO2:W(@++B)PM*U#W;.HNULNP:*,=6I43I7O1.!*(_)HO72
MEQC4<J1F=2;&F::&\B/HK#,TU= &,G2B3FRT7I2:CB2WZ89X$M6 E.AIMNOQ
ML7]JD.R]ZUK88VV>061W$BJ:R(-&W"%L$$M?C."WBRJ'OYHF.L'JR42BE;2H
M9T1Z9T@S7GGJ1R:+O@G$LPHY0I$$K:8HK9NC O-9_9_.%-S)? +%G+LQRQK2
MMRQ:VI*VM.1D%)W5*!:A&%VB\)>F8_9R8S0MA+4#$7O?NCT$7[,"-K0ZU@MA
M<E=<V1SM.G,^2U#0UL2)"_GPR7Q51&Y6W5E+)#%G%*GGT792W(Q(N:0GZV64
MH)"(O6C-?MT'8:?ZDZ4ZFJYJK>WI%-^WU/,Z])S<]6,]=AQ&LFF<R"?&L\_F
MMI,-(H(]&HN_N%=/-<LH3'$3F2!+IR WA;%(1#<=!"RC!Y<K2D%1'RU10<&A
M4U>9!57T)J<R+HED@4ECELU]8E@HH['"#^72;DM:X(9]W@FUY9X5$G]O)+<T
MKM\>!O"?Z0?I3YG%#(A3SV942@A5:.W(K5T[#&J33*<M%F6GMPY]:KP4M=/F
M*Z=+J>RT+&^N!T3=&]NDHIDU*$![LJ8RVT/MP+45KWC-W_E7K"]IU2@V::<K
M1VP7\^.M6[6CL"MDF)U&CMAJ' I+=E/5)-RD2DQ:./N"A5&]%(G9"H&7M01Z
M>]A72?>1_I!H<WRCW/GBNF:Y6=MLN1V.OC?0#X&*PZHXYS[%[X1RJ RI=1JY
MQD%H;:I0>R%-JME3MQ+VW 5B4C;S]; $0V'Y1NDTU#V\Y5]4T*CZ=KIGHN+T
MU;4LME3*)^HNVAN.67I[<MGD((IQ'$PQE>S*W!* TE2H-.?&TO9J M"M]X@+
MX=C].7[5%9PV#U#7T,E/05C\[WU;"]6[V*NA\.AC?1M<1=PF"Z,OPJ_D:Z12
MA1-;$9DK"F6-2!&> 1JA::E 3LH8:]YYY8+NBM</]>1-AKR0S\CCFPWJ*VMN
M6REZDK1?5<\+CZC-DUK,S73KM3$63O![6X%$QH4D52?1A*96H:BT"P?PH7"Y
MQ\C,]MOI!KH![I<P<>3/DII^0V=%R;;=RVJXZKK1',K ?GQ>X4K':F0U.\R1
M,YL+*I)E!CX8X)T@E#8G"O\ 32!#TN\C=Q\L2SKV;75 F^Q.;X?TO=U;UF_L
MTX.!:;6^UUQU%^BF6!E5ZFK[;07 'Q3$Y$VDN@GM8ZDNRPHPQ%\&+0PAT"CR
M;W@9)8*]/-2GL;TRCMRM]UNVFV9%:MO*QI>Z\=,%&/#+-[OI&K;":8Q%)9?:
MEHD"[Z<&! >D6FDEK@[3%[#/)GY;I+3BI_B%R4 TH;%A=C1VLY*F@]F*7V'N
M2MHLN$%7I,8D^/$)8G%7%*FYLLMEL0TM6C3+AA$K;#BR=I@K3@VD<[VV?>].
MP^WAQ[Z803S3\]1INVO$Y;60C<G>DD!DHE0D:#W1S*%)4#OLG1>])MKO1T,W
M1>C1A-6 P& P& P& P& P& P-2ODE>>@"I75R&JY)T;JN6. 6I+;/C'$TGI<
MKJ1@DA:R&(*LMQ165MGIU]Q4G#S-/9#I'V$S:U>[*D0#4;F3[4Y80$D\FMF-
MK+;(J5C+!U,^5]43STQ(IC/+!5TE!IG3M6\A<B68^NM1QA!5\P>H+([4E5\%
M'(HT]&K"&=3I>:L="@FID102,L\IUALTCL5;(J*K-AJAI%U-%ZVF+U?HV%R?
MI_R_'XU)G-19!3S6R2,5M7,N12 U,2X%.;PY)%+?O_@#_BB :"%V+RLWW(9:
MRRX=;U\FKRM8CU@SW%$V]_LAC%-9K6<YXA;*ZF,%':-&PJ?-<>#&NH"Q#3.K
M<U[/,,5C!\404@4'A.]U^4R859.[D96BA&&0PSGA#U+,+6D3A9SLUOQ\#YKC
MG.JH@J!1=LK>0_/YU8<KZ,0(4Z)2J1(4"5N4*#%9HQE)]A;;D'IRQ>E8!:*B
M3UFCKNQJWE1L13'Z;[A25=-#G&%L$O89#%%]NU-3%B+F1O5R 30[Z&PE;)<6
MU3Z!AQ8BA;##.)K?L=OYCM.<]6V<CGLNJOH;K:+3J?QV$N#*Q_)*QONP8TVI
M8I!&0<G?44;CK"U$(FY)ZSFXC2IP"/.4*!&#$&6?YD''/[/_ **#_P#M]G_X
M&;T_Z_V:_P#P:8%(_(E;%J)>KJ2JZ#S7N5KB4CY.OFS$D8X6BT#D$Y=[(CUE
M4='(6]34JPXF_M2&+(6V7K2 ;6#2(/BU0/BA:+UO80AUK\E?4O/*1UK*YJ\)
MNWI1N$;,+$BK6FG@FN/M-3\F\4OMI0"NRJ*IVWOCIW.;HNIR^2Z<"T$:*5&G
M^JZ%)]HRQ!.4H\L,X:[DM&M(=SZV6@6QU[=<BK=C@$IL:36,ME])M4">G6)6
M4V,M-N,)9)*YM4T/4*(K&WN43EETUB3*F8:]1\(G#$ ^9%]5!JQ-%:7C5KN:
MN*F3NY"J=>+RGH44;/O"4TJV,U9M[7SN-];[- 7"W1\=H[8B:"*&7X336<:-
M28-0G"Q'0?8DRI?R/<]\YMP53\U=$4T4WQB-NQVF"O&*6H;6"JET[E<U"S.(
MFU]2UBTKD<<9=F:.E#Z:F;TX2_?/5I0JLP^:^322%)I0AYL<$FK<=*R*YN>%
MC;T0=#5K=9CS+0$H+?=4?.!KF3,HY!8D*2&H8&DFZ1:G4_#$JP@3F+AA-L-\
MG5MRQPCCZJYA01"L&)-RLBO%;,)[+XW9T9D_4U\6!SFS%5Y6D@J-F7R:+Q.9
M0U(]"6O1T=6.T9>"3DZ(M46--L)>ZJ[CEE#]#1&C%5?LS- IW7XG)OMJ72V7
M0<R5RUU26$ V%4[(RJJEU/K+)AGTDWJ#6"1R)D?'D#X1MF0N DYA9H5(:O+#
M:T<I]@MM/SXU3*E$%?V#'B)9)+P$3<[Y;=%<0OO5<M!)8XEJ1!%C8W*W:*JX
MT0[IE1"@2LD;H-L*2J"4X RBX/*E==)P6Q SBBZ0;KFJRP)2S2&$H;OLF6,T
MHB;%SI6W3#>"M4D-Y]?;7ELQ51:S4S0ZF?2Q,<CJQ$:M6N6DAZ,!X=C6ODAM
ME*\]6.%@0B,R2*1@GIJX*2(:Y5MM=6RL:%Y9X_N9KK^4$ A)*?3Q)'"_SAGN
M %3E\(?LT =G$ (P.EEOECN!I5KTS+SI QER:Y)345/&KK N&3K7\RI:J16K
M;TGG4>J3G2R)%%&OV2!J8H\!$F=A*ER@]4X"0)""_B M%T!Y!G*DN=*4Z&+H
MF4.2:\*IDTB8*]DSFHA<X:+H/I1?:]1T,]MB^/*C44ELA^95D9&<8 L:!TT5
M["#_ %/<"%,9EY*;9M.65J\<XL*-F:Y=+.>6%D6RV>D"@,MADJZPXJJFXS#F
M%'5T@=DLO0/UW/D.3N!2X1*9,V+SPDZ5C3[3AT%'>0WH3504@W7U%QF/4H7T
MM.H78T$M1$9([&A4@Z0DU1/:2VV1?49#/%SC0H6Q68ULYBW2UL7#3Z<4:I.(
MPP-@O$O8EL]0-LK3V'3D$JR7 HOF[HR!M<8M-ZL-C70'J&)S=ZA+#,GI=6\*
M5,LTB[U7;BE> H$CD@$280:E/.WL8-!K8Y+\C/8*746L#H:/P.?5A(:NX#/M
M%Z8IR>UO<"E?1T'L(Y3)*V@R6J&M!*$CB[-K0ND!"US:0H]*1E-H%.D^]FAL
M-X0[PEG8S1,UTEIU=5Z9/6];6_"'Y"CME1''&'VRBDRQKB3L\VA3U2)E=IP4
MF/%&/9;#I[8C"7-(:C<#@"%[ J#S/Y$NL556\L4U85.UQ+.JN@Z1YOGE22)R
MN1V*A$PC=BU]:,EF4VN]X::B*6068Q]MI-Q<CVIA;7M(O.>4:5*JUZ2LTD+!
MTOY,7^W[YY_H -&M\<E-ZUU)K7VM4V@V+D,,B-+2.:53TF@6$Z84;F_R2#WD
MPL[3&RTB?X:4,;_MVV8ATUN*0L-L^ P& P&!K!\CU[7_ $E]T:NNI;)*;IUT
M2V8X6]T+%>8Y5UH97,DCB"+GU9'IS6\,-42&+5+,A+WH]^E!#>L^ "T$I=J&
MP2T"T(1<F\H0X@W2PM="W[J"=QVOV.W)+'^84D&+@+-5\7Y8H>\+:LNKYW8U
MC1LVT*]5N=RMNHYI46W/KDH=RD9*0PE,8M$$E,WE)@SW-)!'4G/U]F1AO(M9
MIBT]3IZS5-MC653]-L-\R2LXC'B[%U+"W5?7K][4#FYHVYE-<4:E,:K)],)I
M@04F\Q3>^R"$.\>IEU55DQAZQ;.AU3%/:7LI?#9+S[!J"GD;(@TPKRV7B!3=
MJDC/>Z#2LQ"H5FI%8MIC0D&IE.L"QMN>3FLJDL*;P1;5%L2-+5"J\W*WYHS?
M0"2+5O6_.M74+:MFV<ZC?YNT.[NS)FKHI@0M[>VI5;RX..CRRTNBRPFC"0^9
M.V&CL2M+D=*<CC4QVW59HV Z"RVP*_FT6)E4B@J.;5N<ZV+1<ILV)*8X^)W9
M.4Y?+U:AQ:U!"P@Q/ZA)>S@Q3C*];9?]]/M5^VO6EH1'GZ9L\9,Z*BD4(JJO
MU$L0PE,^7Q ] 621\95K-1$M$)N->@J@!)V8:W+Q"<FI>:,+#;['Y$T'8M]4
M<X:#K6Q;%N\:QT'0=:]N][WN3^S6M:P*'>1#K^7TE<W,=?1CI^(\S0&W*HZ(
ML!RL=PY\>>F%4E?ZT<Z(1PF-L$7C#JB7 0N;=93DL,-(]0:OX8DDH81C#L00
ME$_,%(:G@)#EUS6X&FVGE+"'8-4,;K JC<XJQ,G)'/EX7@Z.8[VL.&IM/#;)
M[>"!KBPEI\E&<Y)VS9)@TBM46%C9GY=J,@]@OL1=(#8"R.D4Q.;J@\M:7FK5
MKQ9,;@-.(+U<EC'4@I^3;S!%'F!K#/EDC?&5L8U*U$H+,4$$Z(4'AB4G\T5
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M+7]B57\FGO=JFS&.)5Y;)IAUCQ2KV2P[VDS343=+A&^Q7N+DM!PBP@ $80
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MA0"R]!!H,W_'WPG^=7DK^(ZG?ME@8"HZK\;"JT6FZ#^M^1C+,8X#(:O:Y/\
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M)[-_^WU@<:C/ SX?9-25.2-]X&HUR>W^JJ\>7AQ/1R7UW!T<X@SK7!:?Z<B
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M'HW8O>]NDX?9[/V^T-P?\O[X:/\ 3YHC_DY1]I<!_+^^&C_3YHC_ ).4?:7
M?R_OAH_T^:(_Y.4?:7 ?R_OAH_T^:(_Y.4?:7 ?R_OAH_P!/FB/^3E'VEP'\
MO[X:/]/FB/\ DY1]I<!_+^^&C_3YHC_DY1]I<!_+^^&C_3YHC_DY1]I<!_+^
M^&C_ $^:(_Y.4?:7 ?R_OAH_T^:(_P"3E'VEP'\O[X:/]/FB/^3E'VEP'\O[
MX:/]/FB/^3E'VEP'\O[X:/\ 3YHC_DY1]I<!_+^^&C_3YHC_ ).4?:7 ?R_O
MAH_T^:(_Y.4?:7 ?R_OAH_T^:(_Y.4?:7 ?R_OAH_P!/FB/^3E'VEP'\O[X:
M/]/FB/\ DY1]I<!_+^^&C_3YHC_DY1]I<!_+^^&C_3YHC_DY1]I<!_+^^&C_
M $^:(_Y.4?:7 ?R_OAH_T^:(_P"3E'VEP'\O[X:/]/FB/^3E'VEP'\O[X:/]
M/FB/^3E'VEP'\O[X:/\ 3YHC_DY1]I<!_+^^&C_3YHC_ ).4?:7 ?R_OAH_T
M^:(_Y.4?:7 ?R_OAH_T^:(_Y.4?:7 ?R_OAH_P!/FB/^3E'VEP'\O[X:/]/F
MB/\ DY1]I<#Q%_A-YQ_SA/P?_=%$_P ,W^=G]V?W-^@K^D/H+[H_9]+_  _Q
M?QGROV?L]WUO>]G_ %X'LJ_4L?\ LD+O#_YDJG_]^#J3 VT\W_\ L.]"_P#N
MEZM_^<=BP)HP& P& P& P&!57M_JF)\3<GWIU%,4PG1!4D%<7MEC1(MZ73><
MKADL5=5\T@!O1ASS/IVZMS.D #VBV>M#_P"# A+Q8<L2[E'CR%L-NJ .W2MR
MOTIZ6ZQDV_<$ID/25ZN6YM96CCP:"%0EB2A8GCJ$6M:U\N9D^M:U[,#8O@,!
M@,!@,!@,#7'Y5.I9ERMQ]+W2G$X77IN[Y%%>8^3(T 6OBG[HZ]7'Z,K]005O
M>O52PK2I5)5WM]@=-[*?O>\"=^)N68AQ1RE1?+L*4#<FJH(&UQ]SD1X?=7S2
M9*=G/,_GSMO>M",>9[.'-P>%8M_MVH6CP+2X# 8# 8# 8# 8# 8# 8# \XGZ
M:#_V&COC_P""U]J?_%UO@>CO \X'B7_]G(_J)O\ W<_%7_J?L? ]'^ P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P/.-X,O_8P//M_\%'F__P @
M.F!Z.<#S8^,?_P!GV_J%?_CKQ_?^HI^P/2=@,!@,!@,!@,!@,!@,!@,!@,!@
M,!@,!@,!@,!@,!@,!@,#_.+_ /KA;_ZO9_\ 2DP/5'^I8_\ 9(7>'_S)5/\
M^_!U)@;:>;__ &'>A?\ W2]6_P#SCL6!-& P& P& P& P-(75PP]P>3SF+A]
M#['2DN)$<>\@/7I8-Z/:7>R_C72/<5TT]:![2Q*#)2D=IVL0*0&$*43&B%L.
MM[!O8;O<!@,!@,!@,!@,#2 R#_'=YAWV0;UMTYR\1D540QA'O7JLDN[[Z#BZ
M=5,G H>MB2.9G/=!K$S=L(P[,;GR4FB ()A8M:#=_@,!@,!@,!@,!@,!@,!@
M,!@><3]-!_[#1WQ_\%K[4_\ BZWP/1W@><#Q+_\ LY']1-_[N?BK_P!3]CX'
MH_P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&!YQO!E_P"Q@>?;
M_P""CS?_ .0'3 ]'.!YL?&/_ .S[?U"O_P =>/[_ -13]@>D[ 8# 8# 8# 8
M# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8# 8'^<7_\ 7"W_ -7L_P#I28'JC_4L
M?^R0N\/_ )DJG_\ ?@ZDP-M/-_\ [#O0O_NEZM_^<=BP)HP& P& P& P(NNZ
MXH'SU3MHWK:#P4P5U4$"E5CS1W-V#VHXY$&58^.@DY8Q ^)6FID0BTY(=^^>
M>,!8-;$+6MAKD\.U-3M@YVEW6E[,YC5TYY$;(<^O+C;UFA#<(3'IH@1M]"4P
M$XX!2LMJIZCF]E;0)3@A&F<!K=;U[PA;V&VS 8# 8# 8# 8%/^]^KV3B/D6[
MNE75OV_NE?Q(PJOX:2$PU=85M2E8EB52UVV)4^]K%:Z;6(]MK=H) 1F@+/&9
MH.] W@8%XR.3WGCGCFM*RGC@&0WG+3Y#=W3DU'LLU9.>E+I=U$_N*0+5A7L
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MT<X'FQ\8_P#[/M_4*_\ QUX_O_44_8'I.P& P& P& P& P& P& P& P& P&
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MK8.2K##2FTA(!:>,)JG1IH #T$T_S(7A*_/O7_[OKO\ \+\!_,A>$K\^]?\
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M9"\)7Y]Z_P#W?7?_ (7X#^9"\)7Y]Z__ '?7?_A?@/YD+PE?GWK_ /=]=_\
MA?@/YD+PE?GWK_\ =]=_^%^ _F0O"5^?>O\ ]WUW_P"%^ _F0O"5^?>O_P!W
MUW_X7X#^9"\)7Y]Z_P#W?7?_ (7X#^9"\)7Y]Z__ '?7?_A?@/YD+PE?GWK_
M /=]=_\ A?@/YD+PE?GWK_\ =]=_^%^ _F0O"5^?>O\ ]WUW_P"%^ _F0O"5
M^?>O_P!WUW_X7X#^9"\)7Y]Z_P#W?7?_ (7X#^9"\)7Y]Z__ '?7?_A?@/YD
M+PE?GWK_ /=]=_\ A?@/YD+PE?GWK_\ =]=_^%^ _F0O"5^?>O\ ]WUW_P"%
M^ _F0O"5^?>O_P!WUW_X7X#^9"\)7Y]Z_P#W?7?_ (7X#^9"\)7Y]Z__ '?7
M?_A?@/YD+PE?GWK_ /=]=_\ A?@/YD+PE?GWK_\ =]=_^%^ _F0O"5^?>O\
M]WUW_P"%^ _F0O"5^?>O_P!WUW_X7X#^9"\)7Y]Z_P#W?7?_ (7X#^9"\)7Y
M]Z__ '?7?_A?@/YD+PE?GWK_ /=]=_\ A?@4_P#TZMM5W?-X>;BYZDDZ6:5C
M:'D=?IO Y8A2N*)'(HM(6->X,SNF2.Z-N=$Q*Y&<$80*""C0ZW[!!UO]F!Z?
ML#QM4?Y%^+?'YYXO.JM[#O=@I!+:;CQ$F@!SZP39]U)#XA0XS)(6EU#8S)!)
MA-0)$BV/XC1/O>OKW/>]@O=#;/\ S(7A*_/O7_[OKO\ \+\!_,A>$K\^]?\
M[OKO_P +\!_,A>$K\^]?_N^N_P#POP'\R%X2OS[U_P#N^N__  OP'\R%X2OS
M[U_^[Z[_ /"_ ?S(7A*_/O7_ .[Z[_\ "_ ?S(7A*_/O7_[OKO\ \+\!_,A>
M$K\^]?\ [OKO_P +\!_,A>$K\^]?_N^N_P#POP'\R%X2OS[U_P#N^N__  OP
M'\R%X2OS[U_^[Z[_ /"_ ?S(7A*_/O7_ .[Z[_\ "_ ?S(7A*_/O7_[OKO\
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M_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN
M_"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/R
MX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U
M[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/P
MK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%
M"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_
M9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W
M,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O
M[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=
MP'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN!)T-@4
M&KIJ,8:^A<3@K&<M.<C6:&QUGC#4:XJ"R25"\QN9$:%&-:>4F+",W8-C$$L.
MM[WH.O8&68$/2'GB@)<].$DE=&T])Y$[&A4.K](:SA3T].9X"2TX#G!T<F12
MN6&@3D@!H1A@MZ #0?;[-:U@=-^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=
MP'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!
M^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y
M^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!
M^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?E
MPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?K
MW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A
M6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*
M%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^
MSN _"MS!^7"A?W/U[]G<"1(36E<UHE7(:Y@$)@")T4EK'-'"8JQ15*XK"BM)
MRE2Y.Q($!2M260'0 C,T(6@:]FM^S]F!FV!$,DY\H29/:Z2R^D*AE4C=!%#<
MW^25K#'Q[<1ITY20@:YU<V54N5B)2D *!LPP6PE@"'7LUK6L#H_PK<P?EPH7
M]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.
MX#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@
M_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<
M_7OV=P'X5N8/RX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN
M_"MS!^7"A?W/U[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/R
MX4+^Y^O?L[@/PK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U
M[]G<!^%;F#\N%"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@/P
MK<P?EPH7]S]>_9W ?A6Y@_+A0O[GZ]^SN _"MS!^7"A?W/U[]G<!^%;F#\N%
M"_N?KW[.X#\*W,'Y<*%_<_7OV=P'X5N8/RX4+^Y^O?L[@<K\,?-GP/RS\/='
M_+?C?F7R_P"Z>!? _,?A_A/C_A/D'P_QOPG]5ZON^_Z?]'V^S]F!.& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P& P&
M P&!YA_U.?E ZY\8-(<NSKDB616*2"T;6FD4F!TJ@[!.$ZUF98>E=V\A*F?T
MZ@I 86N.V(1A6@C'KV:WOV>W6P\;W\VUYH__ ,;]/?N KO\ L_ ?S;7FC_\
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M@T^LIHJ""R"PGN#U:V-+W83^Q19"8ZO9$29GQ[CC8ZNZ9I3'* )AK2!'Z*V
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M5=G<3,G>D=:YJ133_P ^*^E$+,[M+2EL $#1PI7.S6]4RI7Y>R%R?Y0B&#1
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MI[$*FK*KJBBPIM:]O6W8"M0CAE;5U%_C6PAWE#\-&>866:I3EZ)3F;]_8M!
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M1F*#1X&VC]1C((W%NE?#6_2_J1XXJCC=>W4!KGU P$,REWJ8HRCVE.2Z(B)
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M.G/N5^@FK\/OW7?=?ZBGY)]SGTG]!>KZG_&?*OHG_N]ZGJ_^<]']OO?^-^W
MC>P?P;_6RW[U?PS?>/\ ]F?,?O!^ZSZV_P#14_R;XWZC_P"W?_0O2^%]_P#]
MQ>Y[G]'V8$O3C[LOHT[[R?H3[OO>9_7^N/I_Z-][XY'\@];Y]_V)[WS/X?X/
MWO\ W/Z?I_T_=P,X,]/TQ^K[GI>X+U/4]GI^G[-^_P"_[W]'W/=_Z?;^SV8$
M%(/PQ_!LORO[A_@/H&7?3GP'W??!_==\2+Z\^2_#_P!3] _&>]\W]#_L[U/;
M\1_2P,GKO[E?BWS[IONN^/\ E\2^I?N[^D_B_E7R37T)\\^FOZ[Y?].>SY1\
M1_5_!?\ H_\ 58'1M_X<?JP'RK[DOKGZQF7N?+_H3ZL^\'Y,3]X/N?#?]L?6
M/T]Z?SGV?\;\%[OQ/]5[,"-(TGX?5OB-+6ZWEING:D+@GCCA7^J6%-D"XYN6
MEGK8Z%$E7*=N*5$(X?L]$X'N!%Z@!E^^'89GRA"*/K7G*H(!S;)&68TC#X>B
M8(!+(_*FB<-LF;6XY0G7OVY:P&FLCZXNSV!4>M/2>X1M:,W0"R@ZT6$)/BWW
M<?.IM]%?1/U%\](^\?Z6^1?.OJ;Y<G^&^MOE/_'?/?E/I>Y\?_Q'P_N>S^A[
MN!&P_P +/W\@]3[@/Q/?*/ZOW_NZ^_GY#\%_Y'O?_1!^4?+?_!_4^A_\+@?.
MZ?PJ?.8)^(K\/GU!\S%]V7WT_=Q\Y^<>NF][Z$^N?^-^9_$^C[?E_P#6^_[G
M_7[N!F=TP0JSJHG<".L695*EDT>5MZNQZ]7Q9LF$20_T%"UT95\UC4QB28S2
M0D99HG!L6)MIQF:&7[-^W0:JC_'#7_P!^U7E.[3^5ZKI >I^(L7B3;=]T.U&
M]-85 3>2?A=U?\7_ .C%C_['T;_XFO>P.NM7QPU20FA7WY^4[L(2(QQ*W7'W
MP6)PTH2Z=O<2^A]":G')!A)3AZ>R/<^7>PSW?3]G[/=P.\N#QOPXB&B'T%Y3
M^X15YMQ0Z%J[+'XL40?YOO9FVS^KG_)1L?"Y_P#C_#[UKU?_ !O<_P"O [MS
M\;R/5?[/>?*?W]]T_P C0BV%TLCCW=:?3&RD_P LUM.LY+W$OI[T=D_#Z]WX
M70?<]S7L]W O9S10#KS]&7UE<NDNA>DRI"Z(WAN?^@Y%7,B=8TB);"$)3)$S
MZVK*L6Q+'C]%:4;+.3J3/6'O83= ]@-!WJS\,OWZM_Q_W$_B9^0C^5?&?=_]
M^OTO\,9[_P O];_O_P#(?@_>]OI_\/Z7M_\ )]N!Q[K_  M?'P;\1GW _-/G
M&_NU^^O[N_C_ )_ZB;WOH;ZZ_P"(^<>KZ/M^ _KO>]S_ *_=P,ZE/W3_ #QI
M^MON[^I/IN6_(_JGZ:^>?2'P27Z[^4_-O^/^F_E_H?-O1_X7T?<^(_H^[@83
MO\+_ ,I%[WW"_(ONE+][V_=[\I^XKX_?I>][?^#^Z7YG[?=_^X_K_P#1_3P)
M;U]+?2VO9\@^BOD'[/9\N^EOI;Y=^SV?_<GY!\I__E_A_P#X3 K;#OP,?-]?
M0'X3OG_RA]]GT=]S_P W^0?)5OU-[/DO_&_*/IWXCX[_ -P_!>IZO]5[V!^X
M/^!OZJ8?NV_"C];_ !?_ '7^A_NA^JOC_ASO_E#\A_[7^+^$]3_T?^GZ?O?]
M7MP)W:/NW^JYQ\A^B/KCTV'[R?E'R'ZK]+Y<;],?7'P?_:_I_*/?^ ^/_9\-
M[WI?T/;@5ZCWX"?J)E^E/PA_5GSE!]._3WW,_47U!\87\L^2_+?^TOG/Q_N>
MAZ']?ZWL]S^E[,">K5^ZGZ!D7WW?=[]UWP@/JS[U?IOZ!^!^(*]+ZB^KO^[W
MPGQ7I^[\3_0]3W?9^WV8$;__ ))?W,QW_P!AU_#U\2E^DO\ [VGW,_%^NK^"
M^G?_ /"/B?B?7]+X;^EZGJ>[^WWL#L*C_#!\P>_N&^X7YK\ F^H_NC^[WYA\
MK]<WX/YW]&_\3\!\3[_I>O\ U?O^][O[?;@?:D_PT>Y,OPX_<7Z?U"/[PON3
M^@/<^J_Z[U/K+Z$_H_4/_G/;\=_Q/_C?^UP,J;_N?]*S/E7W:^A\>X??'\O^
ME_2^9_)B_FOWF?#?T/C_ *?]SXCYK_6?!^SW_P"K]F!@]B?A5^YYE^]C\/OW
M ^DQ?3OWB?=S]SWH>A_W:^2_4O\ W+]+X;_T'T/V>G_YK]F!FIGW-?3==^K]
MV7TA\XC'W3>I]*_3?S_X8WZ,^[OWO^R_G'P?O_+/EO\ 7>G[WH?T?;@<]+]U
MWU](O@OH'[T?IQM^K/A?I[Z^^DO5-^3_ %%Z7_>'Z<];W_AOB?\ AO>][W/V
M^W CVB_PL?\ ?'\,_P"'_P#^7 /O ^XO[NO_ )?^U1[GUC] ?_=CWO5]GQO]
M=[??_P#AL"28Y]VWU/.OI'Z(^L_CF?[R_ISY#]3_ #+Y;_V!]=?+/^U?COE'
M_H?S#^L^&_\ -_T,##5/X=OHZQOC/N6^[_ZE<_O<^)^AOH[ZQ^*0?.?O&]7_
M +%^I?C?A?BOF?\ Q7J^E[_]+W,#*9K]U?TZT?>+]W_TG\YCOR'ZU^G/IWZA
M^**^DOE'SW_LWYS\;[GR[T?Z_P!7W?1_I>S QI;^'O[NY!\Q^YK[IOG[C]4_
M&_1'W=_5/U+_ -K_ %!Z_P#W:^?_ %A_Z3\3_P 1\R_\?^OP,9?OPD_>4#ZG
M_#I]\'QK/Z?S[[M/O*^8?!)/I_W/F'_>CXWY=Z'P?L_I^CZ?I_T?=P)[=OE7
MRIS^>_+_ ))\O6_.?FWPWRKY5\,9\P^9_&?\)\O^$]_UO5_J_3]OO?T?;@5_
MJO\ "']2!^Y+\-_U?\ ?[OW5_=C]2?*_=U\5[OTE_P!I_ >Y[/4_]Q^S_IP)
MRE/TQ]-OOUK\A^D/E*[ZF^J?E_TW\C^',^9_/?FW_9GRGX3WO7^(_J?3]OO_
M -'VX$.5S^%;[H'O[I/P_?<'Z3]]1_=S]W/W0>C\/_WG^=_3/_<STOA/_3_7
M_9Z?_G?V8&;N'W/?'5C\T^[7YG[QOW,_,/I?X[WODQ7K_=C\1_Q'O?3_ +GO
M_*O_ -S]WV_U?LP.FN#\/OPC%]_OW.? _%+?IG[X/HGX3XWT2?F/R+ZT_J?B
MOA_3];X?^G[GN^]^SV8&0U[]U/T:3]U/W>_=[[5OP_W>_3?T;[?:+YCZ/TY_
MV)[?;[?7]W_VOO8&#T5^&#X25_AG^X7X'YW_ -^?N*^[WX3ZD]AW_P#=?T!_
M4_._9ZG_ *9_7_\ C?\ M<#/VC[LOG\_^0_0GU3ZC5]Z7RCZ?^?^K\I%\C^O
M_@O^T?4^1>WX3YC^WX3V^G_5X&+%_A\^@85Z7W-_==\^9/NY]/Z)^@?J?YF?
M].?17N_]WOGWSGU?@O@?^(^)][TOZ?MP,YG/T/\ 1\C^\KZ4^@?E*OZN^N?E
M'T?\B]/?Q_U'\_\ ^Q?E/I>WUOB?ZGW?_&_9@0Y%/PB_<ZE^A_PX_A_^=I?@
MOI3[LON=^I/FZ3X+X7Y1_P!ROG?S_P!#TO<_K_C/3]W^L]W ^@OPE_>F9[_X
M=?OL^> ]7WONT^]/ZD]$KW/4]O\ WM^>?#^Y[/;_ ,1[GN_]7LP%K?A*^IB/
MOQ_#K]8_*$OPOWK?=I]3?(?B5GP7H?5__:GRCXSXCTO=_J?5]3W?Z7O8'4S3
M\%_W.L7WA_A?_#_\WU],_6GW4_<[\]^+7^SY%\\_[E?-_C_BO_1_Z[UO5_\
M*]_ L/'/I[Z?9/I'Y+]+?*D'TY].? _3_P D^%*^5_)/EG_9WRKX+W/A_0_J
M?2]WW/Z/LP(8>_PL??E'_J3\/_XE?EH/I7YW]W7WY?*/1.]/Z?\ C_\ O]\M
M^']3V?#?U7N>]_U>W DIM^[CZZDWR?Z)^\SY2Q?67RWY%]=?(O\ BOIKZF^%
M_P"\'RG_ ,]\#\5_4_\ C^E_Y6!FV!#6OP]_=D_^S[FON:^8.WU1[/HC[LOF
MOS[?SSY_[/\ NK\P^I__ $OXC^L^/_\ .?UN!D+Y]TWU'&OJ7[NOJWY!)/H_
MYY]-?4?TM\"1]7_37Q__ &G\@^6>E\R^%_X?T/=];^A[,")[!_!G]T\0^]3\
M,?W&?%HOH'[P?NK^Z?X[W5'R[Z0^H_\ N?\ %^YZOH_!?T_9[_N_]>!8EE^3
M_)VGZ=^6?3_RU#\C^2_"_)_D_P *5\L^4_ _\%\M^"]ST/1_JO2]WW/Z/LP(
M=)_#-]^Q_H?<5^)OZ?\ ^)]'Z ^_;Z5^$#_Y_P!S_P"B!]/_  /L_P#&_P"&
M]+V?^3@9I"/NJ^G';[M_N^^D?G$A^>?1'TY].?4'Q1OU9\V^0_\ 9GSCXWW_
M )CZW]?ZOO>M_2]N!CE<_A\^8(OND^YOYK]&)?EWW<_1/S#[O/G:_P""^"^F
M?^)^C/J3XKTO3_X'X[U?=_K??P, D?X*?@5/U=^%SY9]:R?XSZC^Z;X'[QO1
M;_K/XGYG_P /]:_#_"_,_?\ ^.]STO7_ &>Y@28M^X[Z!C?S'[J/NO\ F,=^
MD/C?I#Z!^;?-"?I+Z;]?_N]\Q^=>G\N^%_K?BO=]'^L]F!*^ P& P& P& P&
M P/#?URS+#?UE/$[N UITE(JN(A&4:_L1#F+VT=?A?M)9#G(MY4!T(7_ $EI
/Q?T=;%_T:]N![D,!@?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
